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Effects of pioglitazone on atrial ionic channel remodeling in diabetic rabbits
hearts
C. Liu, G. Li, H. Fu, J. Li, L. Cheng, W. Yang, and T. Liu
2nd Hospital of Tianjin Medical University, Department of Cardiology, Tianjin, China,
People’s Republic of
Objective: We investigated the effects of pioglitazone on atrial ionic channel remodeling in
alloxan-induced diabetic rabbits, and electrophysiological mechanisn of pioglitazone on atrial
ﬁbrillation.
Methods: 32 rabbits were divided into CN group, DM group, DPG group and DPI group.
Langendorff-perfused rabbit hearts were used to isolate single atrial myotcyte, and whole-cell
patch-clamp technique was used to record action potential duration (AP) and atrial ionic
channel currents (ICa,L and INa).
Results: Compared with controls, APD90 and APD50 of left atrial myocytes were signiﬁcantly
prolonged in DM group (P, 0.05 vs. CN), and APD90 rate adaptation was no signiﬁcant dif-
ferences (P . 0.05 vs. CN). The densities of INa were reduced and the densities of ICa,L were
increased in DM group (P, 0.01 vs. CN). The above were markly attenuated in DPG and DPI
group.
Conclusion: Pioglitazone may prevent atrial ionic channel remodeling in diabetic rabbits, even
play an important prevention to DM-related AF.
Adjunctive dose of oral ﬂecainide or propafenone in acute management of
atrial ﬁbrillation patients on top 1 C antiarrhythmic drug therapy
M.G. Bolognesi, L.R. Rossi, G.R. Rusticali, F.G. Groppi, D.B. Bertoncelli, M.S.P. Pisati,
and G.Q. Villani
Guglielmo di Saliceto Hospital, Piacenza, Italy
The management of atrial ﬁbrillation (AF) in patient on chronic antiarrhytmic therapy, with ar-
rhythmia recurrences is a common clinical problem.
Besides the initial therapy after onset of AF should always include adequate antithrombotic
treatment and control of ventricular rate, an early rhythm control is a valid opportunity in par-
ticular in symptomatic and young patients [1,2].
With this strategy not only we can treat the clinical problem , but we prevent the worsening of
the disease that can ﬂow into persistent atrial ﬁbrillation related to many electrical and anatom-
ical changes and it ’s more difﬁcult to defeat.
Now because many people are in treatment with antiarrhythmic drugs to maintain sinus
rhythm, it rises the problem of rhythm control of symtomatic atrial ﬁbrillation recurrences in
this setting. In literature data about this matter are few.
96 of 100 consecutive patients admitted for recurrence paroxysmal AF, in chronic therapy with
Propafenone (PNF) or ﬂecainide (FL) , were randomised to a further oral adjunctive dose of the
same drug taken chronically (Flecainide treatment 100 mg [FL- T] and PNF tretament 300 mg
[PNF-T]) or to a clinical observation.
Sinus rhythm restoration was observed in 15/26 PNF – T patients 58%, in 17/24 FL-T patients
(72%) (p = 0,05), in 7/21 ﬂecainide group control (FL – C) and 5/25 propafenone group
control (PNF-C) 21% (p = 0.001); the therapeutical goal was reached faster in FL-T (Group
PNF- T 6+ 2,9 hours vs FL – T 3+ 0,5 hours, p = 0,05).
Atrial ﬂutter 2:1 was observed in 5/26 (21%) PNF – T and in 7/24 (28%) FL-T.
Sinus pauses (, 2 sec) were observed in 6/26 PNF-T (2%) and in 4/24 FL – T (15%) patients
at the time of sinus rhythm restoration. None of the patients presnted an AFL 1:1 atrio ventricu-
lar conduction.
In patients with recurrence of AF, on top class IC agents for rhythm control, a further adjunctive
oral dose of propafenone or ﬂecainide can be safe and successful in restoring sinus rhythm.
Comparing the efﬁcacy, hospitalization time and safety of vernakalant to
propafenone in recent-onset atrial ﬁbrillation in the emergency department
M. Aragon, D. Conde, J.P. Costabel, M.F. Lambardi, M. Trivi, and A. Giniger
Instituto Cardiovascular de Buenos Aires, Ciudad AutO´noma de Buenos Aires, Argentina
Purpose: Intravenous Vernakalant (V) has effectively converted Recent-Onset Atrial Fibrillation (ROAF) to Sinus Rhythm
(SR) and demonstrated superior effectiveness to placebo and intravenous amiodarone. The objective of this study was to
compare the efﬁcacy, Hospitalization Time (HT) and safety of V and oral loading dose of Propafenone (Pr) for the acute con-
version of ROAF to SR in the Emergency Department (ED).
Methods: A total of 40 adult patients (P) with AF (3 to 48 hours duration) eligible for cardioversion with Pr were enrolled. P
received either a 10-minutes infusion of V (3 mg/kg), followed by a 15-minutes observation period, and a second 10-minutes
infusion (2 mg/kg) if still in AF (n = 20), or an Pr with 600 mg (n = 20). Efﬁcacy end point was the conversion of AF to SR
within 90 minutes of ﬁrst exposure to the study drug.
Results: Conversion from AF to SR within the ﬁrst 90 minutes was achieved in 18 of 20 V P compared with 1 of 20 Pr P
(p , 0.0001). The median time to conversion from AF to SR in P who received V was 9 (6-18) minutes and 166 (120-300)
minutes in P who received Pr (p , 0.0001). The median HT was 238 (189.7-277.7) minutes in V group and 416 (336.7-740.5)
minutes in Pr group (p , 0.0001). There were no serious adverse events.
Conclusions: Intravenous vernakalant demonstrated superior efﬁcacy to oral loading dose of propafenone for acute conversion
of ROAF and a shorter HT in the ED. Both were safe and well tolerated.
Clinical and procedural features associated with high risk of multiple
procedures to achieve PAF ablation
S. Amraoui, N. Derval, F. Sacher, M. Hocini, M. Haissaguerre, and P. Jais
University Hospital of Bordeaux - Hospital Haut Leveque, Bordeaux-Pessac, France
Introduction: Catheter ablation of paroxysmal AF has proven efﬁcacy and safety. However,
more than 20% of patients require more than one procedure to obtain clinical success.
We aimed to identify groups of patients associated with higher risk of AF recurrence after PAF
ablation.
Methods: All patients referred for catheter ablation of PAF (,7 days) in our institution were
included in the study. All patients had lasso-guided PVI, additional LA substrate ablation
(complex fractionated electrogram (CFE), linear ablation) was performed if spontaneous or
induced AF was sustained after PVI. Follow-up visit were performed at 1, 3, 6 and 12 months
with clinical evaluation, TTE, 24 holter monitoring. Recurrence was deﬁned by more than
30sec of documented AF or typical symptoms of palpitation. We used uni- and multivariable
models to identify predictors of AF recurrence over 12 months follow-up.
Results: A total of 338 Pts (55+ 11 yrs, 25% females) underwent a ﬁrst ablation for PAF
between 2004 and 2010. Median longest reported AF episode was 12 hours, range 1 to 168H.
After 11 + 2 mo., 78% of pts were free of AF after a mean of 1.5 + 0.8 procedures. After
single procedure, criteria associated with recurrences were: female gender (p , 0.0001),
hypertension (p = 0.009), longest episode . 24H (p = 0.05). Patients with longest episode 
24h had more chance to obtain success after 1 procedure (0R= 1.9).
Conclusion: In PAF ablation longest episode of AF . 24h, hypertension, and female gender
are associated with higher risk of AF recurrence.
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Progression of atrial ﬁbrillation and clinical correlates in patients
hospitalized for systolic heart failure
G. Marchetti1, A. Barbieri2, R. Roncuzzi1, M.A. Ribani1, and S. Urbinati1
1Ospedale Bellaria AUSL Bologna, Bologna, Italy; and 2University of Modena & Reggio
Emilia, Modena, Italy
Background: Development of atrial ﬁbrillation (AF) in patients (pts) with congestive heart
failure (HF) remains one of the leading causes of clinical deterioration.Furthermore a rhythm
control strategy has not been shown to improve long term outcomes in AF pts.
Study: We conducted a study on 90 pts hospitalized for HF and new onset AF from January
2009 through December 2012. Onset date of AF was determined retrospectively and assigned
to the date when AF was ﬁrst documented by electrocardiogram. Mean age was 73 (+14)
years, 44% women ,mean ejection fraction 39% (+9). Rhythm control strategy was randomly
attempted in Day Hospital 4 weeks after hospital discharge. Almost all patients during hospital-
ization and after discharge received amiodarone, b-blockers, spironolactone (MRA), angioten-
sin-converting-enzyme inhibitor (ACEI) or angiotensin receptor blocker (ARB), diuretics,
warfarin . In the group not treated with EC amiodarone was stopped after 4 weeks.
Ischemic etiology was present in 22.2%, hypertensive cardiopathy in 57.7%, idiopathic cardio-
myopathy in 18%; mean left atrium size was 55 mm(+7). Patients’ medical records and elec-
trocardiograms were reviewed and data were collected for all clinic visits through December
2012. Patients were considered to be permanently in atrial ﬁbrillation when sinus rhythm was
subsequently after discharge never recorded. The proportion of patients who remained free of
progression to permanent atrial ﬁbrillation was calculated.
Results: During the follow up 42 pts had developed permanent AF (46.6% of entire group):
21% of pts treated with EC versus 51% not receiving EC.
Pts treated with EC had a signiﬁcant reduction in rehospitalization for HF : 22% versus 42%.
Conclusions: Rhythm control with EC may be beneﬁcial in pts with heart failure and ﬁrst
documented AF.
Recurrence of AF may not deﬁne failure of the therapy in this setting because frequency, dur-
ation and severity of recurrences must all be considered in the contest of the pattern of HF and
respect to the patient’s quality of life.
Lipid peroxidation disorders in patients with recent-onset atrial ﬁbrillation
A.P. Penev1, M.N. Negreva1, and A.A. Aleksandrova2
1Medical University of Varna, Varna, Bulgaria; and 2Bulgarian Academy of Sciences, Institute of Neurobiology,
Soﬁa, Bulgaria
Purpose: To study malondialdehyde (MDA) as an indicator of lipid peroxidation in patients with recent-onset (,
48 hours) atrial ﬁbrillation (AF) without structural heart diseases.
Methods: Blood samples were collected from 51 consecutive patients (mean age 59.8+ 1.6 years, 26 males).
MDA in plasma (P-MDA) and erythrocytes (Er-MDA) were measured at baseline prior to medical treatment, on
24th hour and 28th day after sinus rhythm (SR) restoration. In the study 52 healthy controls (mean age 59.5+ 1.5
years, 26 males) were also enrolled matched by gender and sex to patients. The arrhythmia was treated with propa-
fenone in all patients.
Results:Most patients were hospitalized on 5th hour after the onset of arrhythmia. The mean duration of AF epi-
sodes was 8.1 hours (from 2 to 24 hours). At baseline both P-MDA and Er-MDA in patients with AF were substan-
tially increased (0.143+ 0.007 vs 0.125+ 0.004 nmoles/mg pr, p , 0.05; 1.368+ 0.069 vs 0.386+ 0.027
nmoles/mg pr, p , 0.001 respectively) as compared to the controls. On the 24th hour after SR restoration Er-
MDA values were still elevated (0.916+ 0.047 vs 0.386+ 0.027 nmoles/mg pr, p , 0.001; P-MDA -
0.125+ 0.005 vs 0.125+ 0.004 nmoles/mg pr, p . 0.05). 28 days after the arrhythmia termination, no signiﬁ-
cant difference was established in P-MDA and Er-MDA concentrations in the patients and controls
(0.117+ 0.004 vs 0.125+ 0.004 nmoles/mg pr, p . 0.05; 0.419+ 0.039 vs 0.386+ 0.027 nmoles/mg pr,
p . 0.05).
Conclusions: Increased values of Er-MDA and P-MDA in patients with recent-onset AF and structurally normal
hearts allow us to assume that an enhanced process of lipid peroxidation is present. We suppose that it may be
closely related both to the onset of the disease and to its medical treatment.
Clinical implications of and factors inﬂuencing spontaneous activities in
dissociated pulmonary veins
S. Chen, G. Chen, and S. Liu
Department of Cardiology, Shanghai First People’s Hospital, Medical College, Shanghai
Jiaotong Unive, shanghai, China, People’s Republic of
Introduction: Factors inﬂuencing spontaneous activities (SAs) in the pulmonary veins (PVs)
in atrial ﬁbrillation (AF) patients undergoing circumferential PV isolation have not been inves-
tigated. Furthermore, the clinical implications of such SAs remain controversial.
Methods and results: Circumferential PV isolation as a ﬁrst ablation procedure was performed
in 689 consecutive patients with AF (460 men; mean age, 58.9+ 10.5 years). Acute PV isola-
tion was achieved in 680 (98.7%) patients. A total of 579 (42.6%) ipsilateral PVs with SAs
were documented in 379 (55.7%) patients (SAs group). Multivariate analysis revealed that
male gender (Exp[B], 1.901; 95% conﬁdence interval [CI]: 1.349–2.674; P, 0.001) and par-
oxysmal AF (Exp[B], 1.761; 95% CI: 1.215–2.551; P = 0.003) were independent factors for
SAs. The incidence of acute and intraoperative PV reconnection (PVR) was higher in the SAs
group than in the control group (33.0% vs. 17.9%, P, 0.001 and 44.3% vs. 28.2%, P, 0.001,
respectively). After the ﬁrst procedure, 244 (65.4%) SAs-group patients and 168 (56.4%,
P = 0.017) control-group patients were free from AF recurrence. During repeat procedures,
PVR incidence was similar in the SAs group (81.8%, 27/33) and control groups (83.3%, 35/
42; P = 0.863).
Conclusion:Male gender and paroxysmal AF were independent risk factors for SAs in patients
undergoing circumferential PV isolation. SAs had a signiﬁcant impact on acute and intraopera-
tive PVR but not on chronic PVR. The outcomes of the ﬁrst ablation procedure were better in
patients with SAs.
Quantitative assessment of a new generation cryoballoon ablation catheter
with new cooling technology
S. Knecht, M. Kuehne, S. Osswald, and C. Sticherling
University Hospital Basel, Department of Cardiology, Basel, Switzerland
Purpose: Despite being engineered as a simple device for isolation of the pulmonary veins, the ﬁrst generation cryoballoon
(CB) had heterogeneous cooling behavior resulting in non-uniform temperature distribution. Recently, the novel CB generation
has been released with improved cooling technology but the changes have not yet been quantiﬁed independently.
Methods: We submerged 3 ﬁrst (Arctic Front) and 3 new generation (Arctic Front advanced) 28mm CB catheters, in a 378C
warm water bath for 300 s and 240 s, respectively. Pictures of the CB catheters with the resulting ice caps were taken, the
covered surface area quantiﬁed and compared. Thawing behavior was compared by measuring the time until complete dissolv-
ing of the ice cap after termination of the freezing cycle. Theoretical, in silico reﬂections on various left atrial anatomies were
performed to identify and compare improvements and risks.
Results: Ice caps covered 90% of the anterior half-sphere of the new generation CB, whereas the ﬁrst generation CB catheter
showed an inhomogeneous distribution with 4 small ice caps, resulting in coverage of less than 40% of the anterior half-sphere
(Figure). The dissolving of the ice caps with a maximum thickness of 3.2 mm on the ﬁrst generation CB lasted,15 seconds in
all cases. In contrast, the ice cap on the new generation CB had a maximum thickness of 5.0 mm and dissolving lasted more
than 25 s in all cases.
Conclusions: The new generation CB showed more powerful and homogeneous cooling-behavior, especially at the pole of the
balloon. The impact of the longer dissolving duration of the ice cap of the new generation CB on procedural safety needs to be
investigated.
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Perimitral atrial ﬂutter ablation by transaortic radiofrequency application
A. Estrada1, J. Figueroa1, D. Doiny1, S. Castrejon1, D. Filgueiras1, M. Ortega1, R. Delgado1, I. Plaza2,
J.L. Lopez-Sendon3, and J.L. Merino1
1University Hospital la Paz, Arrhythmia and Cardiac Electrophysiology Robotic Unit, Madrid, Spain; 2Hospital
Infanta Soﬁa, Department of Cardiology, Madrid, Spain; and 3University Hospital La Paz, Department of
Cardiology, Madrid, Spain
Purpose: Ablation of perimitral atrial ﬂutter (PM-AFL) is performed by linear RF application from the mitral
annulus to a pulmonary vein. This procedure is often challenging due to the difﬁculty to achieve transmural lesion
all along the ablation line. We report a 71 year-old female with mitral prosthesis and incessant PM-AFL, who had
undergone 2 previous initially successful ablation attempts.
Methods: The diagnosis of PM-AFL was established (370 ms). Voltage mapping showed a large anterior scar and
both electranatomical post-pacing interval (Figure) and activation mapping found the conduction gap in the
middle of the ablation line performed from the mitral annulus to the right superior pulmonary vein during the ﬁrst
ablation procedure and which was the same gap that that one found and ablated during the ﬁrst and second proce-
dures.
Results: A second irrigated tip ablation catheter was introduced through the aorta and positioned on the wall of
the non-coronary cusp (NNC) just in front of the ﬁrst ablation catheter positioned at the conduction gap. RF appli-
cation (50 W) at the NNC lead to ﬂutter termination. Ablation was completed with additional RF application from
the other catheter located on the LA anterior wall. PM-AFL was no longer inducible and bidirectional conduction
block was demonstrated along the anterior line. The patient had no arrhythmia recurrences at 12 month of follow-
up. RF application from the aorta has been described in patients with focal atrial and ventricular tachycardias.
However, this has been never reported to complete linear ablation of macroreentrant tachycardias.
Conclusions: RF application from the aortic NNC may be needed to achieve transmurality of linear lesion created
by endocardial RF application on the LA anterior wall.
Low voltage areas in atrial ﬁbrillation do not correlate to LGE-MRI deﬁned
scar in patients with persistent atrial ﬁbrillation
N.A. Qureshi1, W. Bai1, B. Ariff1, S. Kim2, S. Hayat1, S. Jamil-Copley1, W. Davies1, P. Kanagaratnam1, N. Peters1,
and P.B. Lim1
1Imperial College London, London, United Kingdom; and 2St Jude Medical, St Paul, MN, United States of
America
Introduction: Late-gadolinium enhancement (LGE) cardiac magnetic resonance imaging (CMR) can detect pre-
existing left atrial (LA) scar. Low voltage areas mapped in sinus rhythm (SR) have been shown to correlate with
LGE-deﬁned scar. We studied LGE-deﬁned LA scar and the corresponding voltage in AF.
Methods: Ten patients with persistent AF underwent LGE-CMR prior to their ablation to obtain LA scar maps
using our previously described validated automated method. Bipolar voltage mapping was performed in AF
(point density 3.25+ 1.1/cm2) and low voltage electrograms (LVE) were deﬁned as ,0.1mV. LA scar maps
were registered with the LA geometry and areas with LGE.3SD above the mean blood pool intensity (LGE-scar)
were outlined. Voltage maps were registered to LA scar map to identify overlapping segments.
Results: LGE-scar was present in all patients, corresponding to an area of 17.3+ 13.9cm2 accounting for
16.6+ 13.0% of the total LA surface area. LVE accounted for 31.2+ 31.3% of the total LA surface area. There
was little correlation between areas of LGE-scar and LVE, with the area of overlap being only 3.0+ 2.6 cm2 cor-
responding to 2.8+ 2.5% of the total LA surface area. 3,360 points were exported and no signiﬁcant correlation
(Pearson’s) was found between the bipolar voltage and intensity of LGE at its corresponding LA surface point at
the Bonferroni corrected signiﬁcance threshold p , 0.05/10. There was no correlation between voltages and LGE
intensity levels from SD 0 to 3.
Conclusions: Unlike in SR, LA endocardial voltages in AF do not correlate to LGE-deﬁned LA scar in patients
with persistent AF. This may reﬂect a distinct electrophysiological phenomenon as a result of functional electrical
changes in AF.
Biomarkers of myocardial injury with different energy sources for atrial
ﬁbrillation catheter ablation
E. Russo1, M. Casella1, A. Dello Russo1, G. Izzo1, M. Zucchetti1, G. Fassini1, L. Di Biase2,
A. Natale2, C. Carbucicchio1, and C. Tondo1
1Cardiac Arrhythmia Research Centre, Centro Cardiologico Monzino IRCCS, Milan, Italy;
and
2
Texas Cardiac Arrhythmia Institute at St. David’s Medical Center, Austin, United States
of America
Introduction: Our study aims to compare acute myocardial injury biomarker rise after atrial
ﬁbrillation ablation performed with different technologies.
Methods: One hundred and ten patients (pts) were treated with Pulmonary Vein (PV) isolation
with 4 different technologies: open-irrigated tip RF catheter in 35 pts (Group A), cryoballoon
in 35 pts (Group B), visually guided laser balloon in 20 pts (Group C), open-irrigated tip RF
catheter with contact-force-sensing technology in 20 pts (Group D). Post-procedure samples of
cardiac Troponin I (cTnI) and Creatinine Kinase-MB (CKMB) were collected at 19+3 and
43+3 hours after ablation.
Results: At the ﬁrst postprocedural sample, cTnI and CK-MB levels were found elevated in all
110 pts with a median value of 2.09 ng/mL and 8.95 ng/mL respectively. Group B pts showed
cTnI levels increased (6.21+ 3.46 ng/mL) compared to the other groups (Group A
1.92+ 1.04 ng/mL, Group C 1.62+ 0.87 ng/mL, Group D 2.53+ 1.93 ng/mL; p , 0.001).
Also CK-MB levels resulted higher in cryoablation (35.87+ 24.51 ng/mL) compared to other
groups (Group A 6.20+ 3.18 ng/mL, Group C 7.11+ 2.20 ng/mL, and Group D 8.41+ 5.04
ng/mL; p, 0.001). No signiﬁcant correlation was observed between biomarkers levels and re-
currence of AF at 1, 3, 6, 12 months of follow up.
Conclusions: Highest markers for myocardial injury were observed in cryoballon group. These
results may reﬂect the role of protein denaturation and a different pattern release of biomarkers
in these settings. The higher levels of cardiac biomarkers did not translate into a better outcome
and its physiologic signiﬁcance is unknown.
Retinal microvascular changes and atrial ﬁbrillation incidence: the ARIC
Study
S.K. Agarwal1, T. Shah2, F. Lopez3, E.Z. Soliman4, T. Wong5, R. Klein5, G. Heiss6, J. Coresh2, A. Alonso3,
and R. Sharrett2
1Johns Hopkins University, Department of Medicine, Baltimore, United States of America; 2Johns Hopkins
Bloomberg School of Public Health, Baltimore, United States of America;
3
University of Minnesota, Minneapolis,
United States of America; 4Wake Forest University School of Medicine, Winston-Salem, United States of America;
5University of Wisconsin-Milwaukee, Milwaukee, United States of America; and 6University of North Carolina,
Chapel Hill, United States of America
Background: Microvascular abnormalities seen in the retina and assessed in the kidneys as micro-albuminuria
may be associated with microvascular abnormalities in coronary beds. Their relationship with atrial ﬁbrillation
(AF) remains unstudied.
Methods: We examined the association of retinopathy (alone and in combination with micro-albuminuria
(.30mg/g)) with AF incidence in a biracial cohort of middle aged men and women.
Results: Of the 10009 study participants at baseline, 7.1% (n =711) had retinopathy (retinal hemorrhage 3%,
retinal micro-aneurysms 4%) and 7.2% had micro-albuminuria. During an average follow up of 13.6 (3.7) years,
1100 participants had incident AF. AF incidence rates were 24.4, 16.8, 8.9, and 5.7 per 1000 person-years for
those with retinopathy and micro-albuminuria, micro-albuminuria only, retinopathy only, and neither, respectively.
The age, race, and sex-adjusted hazard ratio (95% conﬁdence intervals) of AF comparing those with retinopathy vs.
those without was 1.86 (1.54-2.24). After additional adjustment for blood pressure, diabetes, other CV risk factors, and
prevalent CVD, the HR was 1.37 (1.12-1.67). The association of retinal hemorrhage with AF in a model adjusted for
covariates as above was 1.60 (1.23-2.07) and it was 1.47 (1.14-1.90) with retinal micro-aneurysms. Importantly, an
additive interaction was seen between retinopathy andmicro-albuminuria in relation to AF incidence (ﬁgure 1).
Conclusions: Signs of micro-vessel disease in retina and kidneys are independently and interactively associated with
higher risk of AF. The mechanisms underlying the association are unclear but may include cardiac remodeling, endo-
thelial dysfunction, autonomic dysfunction, and atrial ﬁbrosis.
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Chronic atrial ﬁbrillation is a risk factor for cognitive impairment?
N. Diaconu1, A. Grosu1, C. Gratii1, V. Racila1, and G. Pavlic2
1Institute of Cardiology, Chisinau, Moldova, Republic of; and 2Institute of Neurology and
Neurosurgery, Chisinau, Moldova, Republic of
Introduction: Atrial ﬁbrillation (AF), in addition to stroke, may also produce multiple cerebral
ischemic areas due to microembolic phenomena and transient hypoperfusion, eventually
leading to a progressive cognitive impairment.
Aims: To determine if atrial ﬁbrillation (AF) in stroke-free patients is associated with cognitive
impairment.
Methods: 218 patients with atrial ﬁbrillation patients with non-valvular atrial ﬁbrillation and
no history of stroke, transient ischaemic attack were consecutively admitted. All cases under-
went physical examination, blood chemistry, urinalysis, chest radiography ECG, Doppler echo-
cardiography. To investigate the cognitive status, subjects underwent the neuro-psychological
rating scale Mini Mental State Examination (MMSE).
Results: The 218 patients (mean age 70.1+ 0.65 years; 59% W) were stratiﬁed according to
ECG features into 3 groups: : (I) those with AF de novo (n ¼ 6; 2.8%), (II) those with paroxys-
mal atrial ﬁbrillation (ie, history of .1 episode of arrhythmia lasting ,48 hours) (n ¼ 40;
18.4%), and (III) those with chronic AF (ie, arrhythmia lasting .6 months) (n ¼ 172; 78.9%).
Cognitive status as assessed by MMSE was found to be signiﬁcantly different in the 3 groups:
group I- 28.1+ 1.9; group II - 25.9+ 2.9; and group III - 24.9+ 2.9 (P, 0.01). The Table 1
shows the association of atrial ﬁbrillation with cognitive impairment. In the group with cogni-
tive impairment there were more older subjects (.65 years) - 73%, patients with sever heart
failure, with ejection fraction , 40 % (63%), with arterial hypertension grade III (88%) and
diabetes mellitus - 33%. The anticoagulation rate in these patients was 18%, with 8% on an
optimal treatment level (INR 2.0-3.0).
In conclusion, chronic atrial ﬁbrillation is a factor which correlate with low cognitive function.
The use of anticoagulant therapy whenever is indicated might prevent not only major cerebro-
vascular accidents but also the less obvious clinical outcome of cognitive function loss.
Rhythm Cognitive impairment
(MMSE , 26)
p
YES NO
Novel AF (nr.6) 1 (16,6%) 5 (83,4%)
Paroxysmal AF (nr.40) 10 (25%) 30 (75%) ,0,05
Chronic AF (nr.172) 90 (52,3%) 82 (47,7%)
Atrial ﬁbrillation occurrence and clinical impact in heart failure patients
treated with cardiac resynchronization therapy deﬁbrillators
M. Santini1, R. Ricci1, M. Lunati2, M. Landolina3, A. Proclemer4, G. Botto5, M. Gasparini6,
L. Padeletti7, A. Grammatico8, G. Boriani9, and , Italian ClinicalService Project
1
San Filippo Neri Hospital, Department of Cardiology, Rome, Italy;
2
Niguarda Ca’ Granda
Hospital, Department of Cardiology, Milan, Italy; 3Foundation IRCCS Polyclinic San Matteo,
Department of Cardiology, Pavia, Italy; 4University Hospital "Santa Maria della
Misericordia", Department of Cardiology, Udine, Italy; 5Sant’Anna Hospital, Department of
Cardiology, Como, Italy; 6Clinical Institute Humanitas IRCCS, Rozzano, Italy; 7Careggi
University Hospital, Department of Cardiology, Florence, Italy; 8Medtronic Clinical Research
Institute, Rome, Italy; and 9Sant’Orsola-Malpighi Polyclinic - University of Bologna, Bologna,
Italy
Purpose: Atrial ﬁbrillation (AF) is a frequent comorbidity in patients with heart failure and has
been associated with compromised hemodynamics, heart rate irregularity, uncontrolled ven-
tricular rate, quality of life and in general with a worse prognosis. Aim of our research was to
assess the occurrence and clinical effects of AF in patients with implantable cardioverter deﬁ-
brillators with cardiac resynchronization therapy (CRT-ICD).
Methods: 1404 CRT-ICD patients (1118 males, 67+ 10 years) were prospectively followed
up in 74 Italian cardiology centres. Device diagnostics allowed to detect AF occurrence and
duration and its association with ventricular rate (VR), biventricular pacing and inappropriate
ICD therapies. Clinical data, such as AF-related hospitalizations or interventions, were col-
lected during in-hospital scheduled and unscheduled visits.
Results: AF history was present in 362 patients. In a median follow-up of 31 months AF
lasting .10 minutes occurred in 556 patients, of whom 237 had AF history and 319 were new
onset AF patients. AF was classiﬁed according to its duration in 5 AF proﬁles: 144 patients had
AF lasting between 10 minutes and 6 hours, 88 patients between 6 hours and 1 day, 72 patients
between 1 day and 7 days, 193 patients between 7 days and 6 months, and 59 patients suffered
AF episodes longer than 6 months. AF caused 1) loss of biventricular pacing, deﬁned as a
pacing percentage ,95%, in 400/556 (72%) patients, 2) uncontrolled VR during AF, deﬁned
as mean VR . 80 bpm and a maximum VR . 110 bpm, in 189/556 (34%) patients and 3) in-
appropriate ICD shocks in 60/556 (11%) patients. AF caused unscheduled in-hospital visits in
116/556 (21%) patients; in 37/116 (32%) patients were hospitalized and 31/116 (27%) were
treated by pharmacological or electrical cardioversion, AV node ablation of pulmonary veins
ablation.
Conclusions: AF is a common occurrence in CRT-ICD patients and causes uncontrolled ven-
tricular rate, loss of biventricular pacing and inappropriate ICD shocks in a consistent portion
of patients leading to an important health care resource utilization.
The effects of eosinophil on the left atrial thrombus in patients with atrial
ﬁbrillation
S. Keceoglu, M. Demir, U. Uyan, and M. Melek
Yuksek Ihtisas Hospital, Bursa, Turkey
Background: Atrial ﬁbrillation (AF) is the most common cardiac rhythm disorder. AF causes a
5-fold increased risk for thromboembolic stroke . It is known that eosinophils play an important
role in thrombosis. We aimed to compare the numbers of eosinophil counts of the patients with
and without thrombi in the left atrium (LA) or in the left atrial appendage (LAA) and to ascer-
tain the association of eosinophil counts with the presence of thrombi.
Method: The study included 84 patients were diagnosed with persistent AF who were per-
formed transesophageal echocardiography and designated to be undergone cardioversion. The
patients were divided into two groups; the group 1 consisted of 40 patients (18 male; average
age 63.27+ 1.4) who had thrombus formation in the LA or LAA, and the group 2 consisted of
49 patients (23 male; average age 66.53+ 1.56) who did not have any thrombus in the LA or
LAA. These patients were performed concurrent routine biochemical tests and eosinophil
count on whole blood count.
Results: Baseline characteristics of the study groups were comparable. Group I patients had a
higher eosinophil and MPV value than group II (233.0+ 30.7 vs 118.9+ 11.8 and
9.77+ 0.20 vs 8.27+ 0.12 ﬂ p , 0.001. respectively). In group I the patients’ left atrium
(LA) diameter is higher than the group II.
Conclusion: As a result our study revealed a relationship between eosinophil count and LA
thrombus in patient with nonvalvular AF.
Group I (n=40) Group II (n=49) p
Fasting glucose (mg/dl) 92.5+ 13.2 95.2+ 14 0.423
Creatinin (mg/dl) 0.9+0.3 0.8+ 0.2 0.224
Hb (g/dL) 12.8+ 0.240 12.7+ 0.294 0.67
Wbc (10^3/mI) 9389+ 574 8108+ 320 ,0.001
Eosinophil count(10^3/mI) 233.0+ 30.7 118.9+ 11.8 ,0.001
MPV (fL) 9.77+ 0.20 8.27+ 0.12 , 0.001
MCV (fL) 87.88+ 0.77 87.04+ 1.18 0.57
HTC (%) 38.22+ 0.88 38.31+ 0.71 0.93
Platelet (10^3/mI) 238.05+ 12.44 219.12+ 9.19 0.28
The association of biomarkers of inﬂammation and neurohumoral activation
with the progression of atrial ﬁbrillation to permanent arrhythmia
M. Polovina, T. Potpara, M. Licina, and MC. Ostojic
Clinical Center of Serbia, Clinic for Cardiology, Belgrade, Serbia
The Purpose of the present study was to determine the signiﬁcance of biomarkers of inﬂamma-
tion (e.g. C-reactive protein, CRP) and neurohumoral activation (e.g. B-type natiuretic peptide,
BNP) for the progression of atrial ﬁbrillation (AF) from paroxysmal and persistent AF to per-
manent arrhythmia.
Methods: we prospectively enrolled 275 symptomatic AF pts with paroxysmal and persistent
AF (mean age 63+ 14 yrs, 58% men; parox. AF, n = 197; perist. AF, n = 88), without an acute
myocardial infarction, heart failure or signiﬁcant valvular disease. Rhythm control strategy was
employed in accordance with the European Society of Cardiology clinical practice guidelines,
which included the pharmacological or electrical cardioversion, as appropriate, and treatment
with at least one antiarrhythmic agent and anticoagulation as indicated. Clinical and echocar-
diographic parameters and CRP and BNP levels were determined at baseline. Patients were
regularly followed-up and AF recurrence (symptomatic or detected on regular control exams
every 3 months) was notiﬁed. Development of permanent AF, deﬁned as failure of all attempts
at restoration and maintenance of sinus rhythm, was recorded.
Results: after a median 17-month follow-up (range 5-29 months) AF recurrence was detected
in 107 pts (38.9%) and progression to permanent AF occurred in 32 pts (11.6%). Both CRP and
BNP were associated with AF progression in the univariate analysis and optimal cut-off values
to predict AF progression were determined. In the multivariate regression analysis, after adjust-
ments for age, gender, prior AF duration, comorbidities, left atrial volume (LAV), left ventricu-
lar ejection fraction (LVEF), medications, creatinine clearance, smoking and alcohol
consumption, baseline CRP had no independent prognostic signiﬁcance for AF recurrence,
while baseline BNP .548 pg/mL emerged as an independent predictor of permanent AF de-
velopment (HR = 2.48, 95%CI 1.06-3.78, P = 0.008).
Conclusions: the present study has demonstrated that CRP has no independent prognostic
value for AF progression to permanent arrhythmia. On the other hand, elevated BNP levels
have an independent prognostic signiﬁcance for AF progression and may help identify pts at
risk from permanent AF development.
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Continuous rhythm-monitoring following catheter ablation of paroxysmal or
persistent atrial ﬁbrillation, long term data of patients with implanted
pacemaker or ICD
H. Servatius, C. Schad, B.A. Hoffmann, J. Lueker, A. Sultan, B. Schaeffer, M.A. Aydin,
D. Schreiber, S. Willems, and D. Steven
University Heart Center Hamburg, Department of Cardiology specialising in
Electrophysiology, Hamburg, Germany
Introduction: Recurrent AF after catheter ablation (CA) may be asymptomatic and success
may therefore be overestimated. An implanted pacemaker (PM) or ICD allows for continuous
long-time rhythm monitoring and facilitates an objective follow-up (FU) after CA.
Methods: Since 2005 79 pts with PM or ICD with atrial holter function (holter) underwent CA
for persistent (persAF) or paroxysmal AF (PAF) and were followed since then PVI alone or
CA using the "stepwise approach" were performed according to the entity of AF. Holter interro-
gation was used to determine AF burden at the last available FU and at the time of CA.
Indications for PM or ICD were: 54% (n = 43) sick sinus syndrome, 21% (n = 13) AV block
and 14% (n = 12) bradyarrhythmia. ICD was implanted in 10% (n = 11).
Results: In 36 pts (46%) CA for PAF and in 43 pts (54%) CA for persAF (43 male (54%), age
65.1+ 12.4 years) was conducted. Holter data before CAwere available for 7.1+ 3.4 months
and showed a mean AF-burden of 41%+ 32%.
There was a signiﬁcant difference between AF-burden before and after ablation in all patients
(41%+ 32% to 9%+ 22%, p, 0,001), in patients with PAF (26%+ 25% to 1%+ 5%, p,
0,001) and with persAF (56%+ 31% to 16%+ 28%, p, 0,001). (Table 1)
Conclusion: The holter function allows an objective continuous rhythm monitoring for AF
recurrences and shows the signiﬁcant difference with regard to AF-burden before and after ab-
lation. Depending on AF entity freedom from AF after CA can be achieved in up to 70%, al-
though a substantial amount of asymptomatic recurrences could be detected by continuous
rhythm monitoring.
all (n = 79) PAF (n = 36) persAF (n = 43) p
FU after indexprocedure (years) 2,4+ 1,9 1,9+ 1,7 2,8+ 2 ns
Arrhythmia recurrence (n [%]) 35 [44] 11 [31] 24 [56] 0,156
Symptomatic recurrences
(n [% of recurrences])
18 [51] 4 [36] 14 [58] 1
procedures/ patient 1,7+ 1 1,5+ 0,9 1,9+ 1 ns
Outcome of thoracoscopic epicardial left atrial posterior box lesion with
bipolar radiofrequency energy in treatment of longstanding persistent atrial
ﬁbrillation
M.G. Compier1, J. Braun2, P. Klein2, K. Zeppenfeld1, R.J.M. Klautz2, M.J. Schalij1,
and S.A. Trines1
1Leiden University Medical Center, Department of Cardiology, Leiden, Netherlands; and
2Leiden University Medical Center, Department of Cardiothoracic Surgery, Leiden,
Netherlands
Purpose: Catheter ablation of longstanding (.1 year) persistent atrial ﬁbrillation (AF) is asso-
ciated with poor outcome. Biatrial surgical Maze is highly successful, but requires extensive
surgery. Minimally invasive surgical ablation with unipolar radiofrequency (RF) energy may
lack transmurality and intraoperative testing of transmurality is challenging.
Therefore, feasibility and efﬁcacy of a box isolation of the posterior left atrium (LA) including
the pulmonary veins using bipolar RF energy performed by the cardiothoracic surgeon and
with intraoperative testing of transmurality by the cardiologist was investigated with this study.
Methods: Patients underwent a bilateral thoracoscopic isolation of the box using a bipolar RF
clamp. Ablation was performed using 7-8 applications on each side. Entrance block of the pul-
monary veins and box was tested by recording electrograms at 0.05 mV/mm, while exit block
was conﬁrmed with pacing at 10.0 V/2 ms. Efﬁcacy of ablation was established after 3, 6,12
and 24 months follow-up with ECG and 24-hour Holter recordings.
Results: A total of 24 consecutive patients were included (75% male, age 58+7 years, LA size
45+5 mm, persistent AF duration 2.0+ 0.8 years). In all patients, intraoperative entrance and
exit block was achieved. After a mean follow up of 14+7 months (with a minimum
of 7 months), 83% of patients were in sinus rhythm (SR). Four patients had AF-recurrences, of
which two regained SR after an additional catheter ablation procedure for paroxysmal AF and
one patient after reintroduction of anti-arrhythmic drugs. After the thoracoscopic procedure,
one patient required surgical evacuation of pericardial ﬂuid and one patient died within a
month due to a cerebral-vascular accident.
Conclusions: Treatment of longstanding persistent AF with thoracoscopic epicardial LA pos-
terior box isolation using bipolar RF energy and with intra-operative testing of conduction
block by the cardiologist is feasible and highly effective.
Mesh ablator vs. Cryoballoon vs. PVAC for pulmonary vein ablation of
symptomatic paroxysmal atrial ﬁbrillation: acute and long term results
A. Pappalardo, A. Avella, P.G. De Girolamo, and F. Laurenzi
San Camillo Forlanini Hospital, Rome, Italy
Background: Pulmonary Vein Isolation (PVI) is the mainstay of catheter ablation for Atrial
Fibrillation (AF). New energy sources and catheter designs have been developed to achieve
PVI safer, faster, and with equal efﬁcacy as compared with the conventional radiofrequency ap-
proach. Balloon or ring -based catheter ablation systems are promising because they allow for a
‘single shot’ PVI.
We report our data of atrial ﬁbrillation ablation with three different systems: HD Mesh Ablator
(MESH), Arctic Front Cryoballoon (CRYO), Pulmonary Vein Ablation Catheter (PVAC) ring-
shaped multielectrode.
Methods: Sixty-four patients underwent PV ablation for symptomatic paroxysmal AF using
the MESH (24 pts, group A) the CRYO (20 pts, group B) or PVAC (20 pts, group C). PVI was
assessed by MESH or PVAC catheter itself or with a multipolar circular catheter for CRYO and
if not achieved, PVI was completed with radiofrequency (RF) retouch with a 4 mm irrigated tip
ablation catheter.
Primary endpoints were acute complete PVI and freedom from AF at long-term follow-up.
Results: Patients’ mean age was 56.1 years and 50 pts (78%) were male. PVI was achieved
with the catheter alone in 59/89 PVs (66%) of group A (MESH), 75/80 PVs (94%) of group B
(CRYO) and in 75/78 (96%) of group C (PVAC). With RF retouch PVI was achieved in 87/89
PVs (98%) of group A (MESH), 80/80 (100%) of group B (CRYO) and 78/78 (100%) of
group C (PVAC). Reversibile phrenic nerve palsy was documented in 2 pts of CRYO group. No
major complications and/or clinically evident stroke were observed in each group.
After at least 1 year follow-up (range 13- 60 months), pts free from AF were: 8/24 (33 %) of
group A (MESH), 18/20 (90%) of group B (CRYO) and 17/20 (85%) of group C (PVAC).
Conclusions: The present study revealed a superiority of the Arctic Front Cryoballoon and
PVAC with respect to HD Mesh ablator concerning acute complete PVI and long-term freee-
dom from AF recurrences.
Pulmonary vein isolation for atrial ﬁbrillation has no short-term effect on
cognitive function: a comparison of different ablation techniques
A. Kiss, E. Nagy-Balo, I. Edes, and Z. Csanadi
University of Debrecen, MHSC-Faculty of Medicine, Institute of Cardiology, Debrecen,
Hungary
Purpose: Clinically silent cerebral ischemia (SCI) on diffusion MRI has been recently demon-
strated after pulmonary vein isolation (PVI) by several investigators. The occurence of these
lesions has been shown to correlate with the ablation technology used: phased radiofrequency
technique using circular multipolar catheter (PVAC) has been associated with the highest while
cryoballoon ablation (CBA) with the lowest incidence of SCI. As the clinical relevance of these
brain lesions is unknown, we studied the effect of PVI on cognitive function using different ab-
lation techniques and antiocagulation protocols.
Methods: Consecutive patients undergoing PVI were randomized to PVAC ablation and intrao-
perative target ACT .250 sec (10 patients, Group 1); PVAC ablation and ACT . 320 sec (25
patients, Group 2) and CBA (9 patients, Group 3). Six patients with AF but no catheter ablation
were selected as age-, sex-matched controls.A battery of neuropshychologic tests were per-
formed at baseline and 6 weeks postablation including Rey Auditory Verbal Learning,
Halstead-Reitan Trail Making Tests Parts A and B, Wechsler Adult Intelligence Scale, Verbal
Fluency Test, Brickenkamp D2 Test of Attention. All groups were similar for baseline charac-
teristics. Between-group differences in cognitive performance were analyzed using analysis of
covariance. Post-intervention performance was used as the outcome variable, and baseline per-
formance and group membership as explanatory variables. In addition to each cognitive test
analyzed separately, a compound test score obtained as the sum of standardized, direction-cor-
rected test scores was also evaluated.
Results: Clinical signs of cerebral ischemia did not occur in any of the patients. A signiﬁcant
decline was observed in both PVAC groups during Trailmaking A Test (p = 0.007 in Group 1
and p = 0.008 in Group 2). No statistically signiﬁcant difference in the compound test scores
was found at an individual level in the whole study cohort (p = 0.8). Similarly, no group differ-
ence was found.
Conclusions: Our results suggest no clinically signiﬁcant short-term effect of PVI on global
cognitive function using CBA or PVAC techniques.
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Intra-tissue ablation & visualization system to monitor lesion formation to
minimise extracardiac ablation
M.J. Wright1, D. Haines2, E. Harks3, F. Zuo4, F. Budzelaar4, D. Rankin5, W.C. Stoffregen5,
J. Nguyen5, V. Reddy6, and P. Jais7
1St Thomas’ Hospital, London, United Kingdom; 2William Beaumont Hospital - Michigan,
Royal Oak, United States of America; 3Philips Healthcare, Best, Netherlands; 4Philips
Research, Eindhoven, Netherlands; 5Boston Scientiﬁc, San Jose, United States of America;
6Mount Sinai Hospital, New York, United States of America; and 7Hopital Cardiologique du
Haut Le´veˆque, CHU Bordeaux, Pessac, France., Bordeaux, France
Aim: Ablation beyond the cardiac boundary can have devastating consequences. We developed
an RF ablation catheter with multiple ultrasound (US) transducers to monitor in real time atrial
wall thickness, extra-cardiac tissue and visualise lesion formation in real time. The aim of the
present study was to differentiate between tissue types and visualise ablation of cardiac and
extra-cardiac tissue.
Methods: 16 sheep were used in this study with a total of 104 attempts of lesion formation in
the atria. Lesions were made using a 7Fr open irrigated RF ablation catheter with 4 US transdu-
cers in the 5.3mm ablating electrode to assess in real time the atrial wall boundary and lesion for-
mation. Mean power delivery was 32+ 4W, with RF delivered between 13-120 seconds. Lesion
geometry and US images were blindly assessed by a pathologist or 3 operators respectively.
Results: Characteristic atrial contraction was seen at all sites where lesion delivery was attempted.
RF delivery resulted in 69 (66 %) lesions detectable at pathology, 61 of which were transmural,
and were correctly seen on US in 73% of cases. In 53 lesions the lung was within 0.9+ 0.7 (0.2-
2.8) mm of the cardiac boundary as assessed by US. Ablation of the adjacent lung occurred in 29
lesions and was identiﬁed by US in 82%. When the lung was not visualised on US there were no
adjacent lung lesions.
Conclusion: US integrated into a RF ablation catheter can accurately differentiate between tissue
types based upon reﬂection and contraction patterns. This allows lesions to be delivered safely,
minimising extra cardiac damage.
A segmental approach is superior to a circumferential approach for
pulmonary vein isolation using the endoscopic laserballoon
A. Metzner, P. Rausch, RR. Tilz, A. Rillig, S. Mathew, S. Deiss, F. Ouyang, KH. Kuck,
and E. Wissner
Asklepios Clinic St. Georg, Hamburg, Germany
Purpose: Pulmonary vein isolation (PVI) can successfully be performed using the endoscopic
laserballoon. To date, the feasibility of a circumferential as compared to a segmental PVI ap-
proach has not been assessed.
Methods: Patients with paroxysmal or short-standing persistent atrial ﬁbrillation (AF) were
assigned in a 1:1 fashion to circumferential (group A) or segmental PVI (group B).
Circumferential PVI could only be attempted if the ipsilateral inferior PV was visible while the
laserballoon was positioned within the superior PV and vice versa. Otherwise, segmental PV
was performed.
Results: A total of 36 patients were enrolled (group A: 18 patients, age 61+7 years, LA-diam-
eter 43+5 mm and group B: 18 patients, age 62+ 10 years, LA-diameter 43+4 mm). In
group A, circumferential PVI was attempted in 2/18 (11%) right-sided PVs (RPV) and in 18/
18 (100%) left-sided PVs (LPV) and ultimately successful in 2/2 (100%) RPVs and 10/18
(56%) LPVs. In the remaining patients in group A, 15/18 (83%) right superior PVs (RSPV),
16/18 (89%) right inferior PVs (RIPV), 5/18 (28%) left superior PVs (LSPV) and 5/18 (28%)
left inferior PVs (LIPV) were isolated using a segmental approach. RF touch-up was necessary
in 1/18 (6%) RSPVs and in 3/18 (17%) LPVs. In group B, 18/18 (100%) RSPVs, 18/18
(100%) RIPVs, 17/18 (94%) LSPVs and 17/18 (94%) LIPVs were successfully isolated. In
1/18 (6%) LSPVs and in 1/18 (6%) LIPVs, RF touch-up was performed. Procedure and ﬂuor-
oscopy times were 204+ 59min and 28+ 10min in group A and 187+ 24min and
26+ 6min in group B.
Conclusions: Circumferential laserballoon-based PVI is difﬁcult to achieve for the right-sided
PVs and only moderately successful for the left-sided PVs. In addition, RF touch-up is more
frequently necessary to achieve successful circumferential PVI. Hence, the preferred ablation
strategy should be a segmental approach.
Optimization of electrogram ﬁltering enables activation mapping of
wavelets during human atrial ﬁbrillation. insights from multi-electrode
mapping in AF
A. Jadidi1, S. Kim2, H. Lehrmann1, C.I. Park1, R. Weber1, J. Schiebeling-Roemer1, J. Allgeier1, P. Jais3,
M. Haissaguerre3, and T. Arentz1
1Universitaets-Herzzentrum Freiburg-Bad Krozingen, Arrhythmia Department, Bad Krozingen, Germany;
2StJMed, St. Paul, MN, Saint Paul, United States of America; and 3Hoˆpital Cardiologique du Haut-Le´veˆque,
Universite´ Victor Segalen Bordeaux II, Bordeaux, France
Introduction: Activation mapping of AF drivers (sources & rotors) is challenging because of the presence of
EGM fractionation & multiple deﬂections during AF. We assessed the impact of EGM recording and ﬁltering
technique on degree of EGM fractionation and ability to map Af wavelets.
Methods: Regional AF mapping was performed in 10 pts with persist. AF in uni- & bipolar modes using two 20-
pole catheters (AFocus, PentaRay). AF was recorded for 60 sec. EGM fractionation (deﬂection number) & the
ability to map AF wavelet activation were compared between different recordings (uni- vs. bipolar) and ﬁlterings
(1-25 Hz vs. 30-250Hz and 1-250Hz).
Results: Continuous fractionation was found at 38þ/-8% vs. 14þ/-7% of LA when bipolar CFE maps were
created with 30-250Hz vs. 1-25Hz (p , 0.01). AF wavelet mapping was feasible at 78þ/-11% of mapped regions
when ﬁlters were set to 1Hz to 250Hz, especially in unipolar recording mode. Conventional EGM ﬁltering (30-
250Hz) was associated with high frequency multi-component (fractionated) EGMs that hindered activation
mapping of AF. Number of EGM deﬂections was 2,2 fold higher with bipolar recording (at 30-250Hz) than in uni-
polar mode at 1-250Hz: (84 þ/-16 vs. 34þ/-12 deﬂections per sec AF, p , 0,001). EGM ﬁltering at 1-250Hz
revealed repetitive regional pivoting and slow conduction channels in AF.
Conclusions:Activation mapping of AF wavelets is feasible using high pass EGM ﬁltering from 1Hz instead of
30Hz both in bi- & unipolar recording mode. Regional disparities in conduction with pivoting can be observed.
Introduction of these novel EGM ﬁltering methods enables visualization & identiﬁcation of AF drivers.
A three-year improvement in quality of life, hospitalizations and working
incapacity after ablation for paroxysmal versus long-standing persistent
atrial ﬁbrillation
V. Bulkova1, M. Fiala2, S. Havranek3, L. Souckova3, J. Simek3, J. Pindor2, J. Januska2, M. Novak1,
and D. Wichterle3
1Masaryk University, ICRC, St. Anna Hosp., 1st Dept of Internal Medicine/Cardiology, Brno, Czech
Republic; 2Hospital Podlesi, Trinec, Czech Republic; and 3Charles University Prague, 1st Faculty of
Med., 2nd Dept of Medicine-Dept of Cardiology & Angiology, Prague, Czech Republic
Introduction: This prospective study compared quality of life (QoL), hospitalization for cardiovascular
reasons (HCR), and working incapacity (WI) between patients with paroxysmal AF (PAF) and long-
standing persistent AF (LSPAF) undergoing catheter ablation.
Methods: The study consecutively included 285 PAF and 127 LSPAF patients (aged 57+ 10 vs.
59+9 years, p = 0.04; 33 vs. 21% F, p = 0.78) who underwent their ﬁrst AF ablation between I/2007
and VII/2009. Annually assessed QoL using EQ-5D questionnaire, and sum of HCR and WI days were
collected at baseline and during subsequent 3 years. Respondence rate was 100%, 95%, 95%, and 90%.
Results: In PAF vs. LSPAF groups, 86 vs. 87% patients were in stable SR at the end of 53+9 month
follow-up after 1.4+ 0.6 vs. 1.7+ 0.8 procedures/patient (p = 0.00004). LSPAF patients exhibited
worse baseline values of EQ-VAS/EQ-5D; however, their improvement was steeper reaching QoL com-
parable to PAF patients after 3 years (Table). HCR/WI were reduced signiﬁcantly already in the ﬁrst
post-ablation year in both groups. After 3 years, HCR days per/patient/year decreased from baseline
3.8+ 7.4 to 0.8+ 2.9 vs. from 3.7+ 6.0 to 0.8+ 5.7 (both p , 0.0001) in PAF vs. LSPAF patients.
Similarly, WI days decreased from 12.5+ 41.4 to 1.2+ 10.2 days (p = 0.0001) vs. from 20.5+ 61.6
to 0.7+ 5.7 days (p , 0.0001) without signiﬁcant inter-group differences.
Conclusion: LSPAF patients have signiﬁcantly worse QoL at baseline than PAF patients. They required
more repeat ablation procedures to reach comparable clinical outcome. However, overall beneﬁt from
SR restoration in terms of QoL was higher in LSPAF patients. Ablation signiﬁcantly reduced HCR/WI
in both groups.
PAF LSPAF p
EQ-VAS baseline 66.4+ 14.2 61+ 14.2 0.0005
EQ-5D baseline 71.4+ 9.2 67.7+ 13.8 0.002
EQ-VAS 1 year 69.0+ 13.9 65.8+ 14.6 0.04
EQ-5D 1 y year 74.2+ 11.3 73.1+ 15.0 0.40
EQ-VAS 2 years 73.1+ 15.0 70.5+ 14.5 0.11
EQ-5D 2 years 77.7+ 14.8 75.9+ 15.2 0.26
EQ-VAS 3 years 71.4+ 16.4 71.1+ 14.2 0.86
EQ-5D 3 years 77.2+ 15.4 77.1+ 14.0 0.95
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Homogenous lesion formation as mechanism for higher procedural
efﬁciency of the novel entire-tip irrigated rf ablation technology
(thermocool sf ) in patients undergoing pulmonary vein isolation
P. Schurr1, C.I. Park1, H. Lehrmann1, R. Weber1, J. Schiebeling-Roemer1, J. Allgeier1, C. Herrera Siklody1,
D. Shah2, T. Arentz1, and A. Jadidi1
1
Universitaets-Herzzentrum Freiburg-Bad Krozingen, Arrhythmia Department, Bad Krozingen, Germany; and
2University Hospital of Geneva, Department of Cardiology, Geneva, Switzerland
Background: Irrigated tip RF catheter ablation is the most frequently used technology for PVI. We assessed RF
lesion size between the novel entire-tip irrigated SF catheter and the classical distally irrigated-tip catheter
(ThermoCool, (TC)).
Methods: Lesion formation was assessed using both types of irrigated RF catheters (TC & SF) in an ex-vivo
model using a porcine heart in a 37,38C NaCl 0,9% perfused bath. RF was applied for 60sec in (ortho & parallel),
at 20W, 30W and 40W & 10g, 20g, 30g&variable cooling rates. RF lesions were stained using TTC and measured
by surface planimetry in 3 planes.
Results: Up to 30W, the irrigation rate was 8ml/mn vs 17ml/mn and above 30W, 15ml/mn vs 30ml/mn for SF
vs. TC. At 20W and 30W both catheters produced similar lesion sizes in all 3 planes.
However, at power settings .30W with higher irrigation rates (15 ml/mn & 30 ml/mn for SF and TC), lesions
were more homogenous (see ﬁgure) with lesion surface areas 12%þ/-5% larger with SF vs TC. Under high irriga-
tion rates, the TC catheter produced irregular lesions, because of asymmetrical, more distal electrode cooling. In
contrast, the SF catheter with its homogenous & slow ﬂow cooling, produces lesions without evidence of inhomo-
genities/gaps.
At 40W& 10g, 80% vs 25% of lesions showed inhomogenities at the ablated myocardium (TC vs SF, respectively,
p , 0,05). Furthermore, at 40W & 20g, steam pop ocurred in 58% vs 22% of RF applications (TC vs SF, respect-
ively, p , 0,05).
Conclusion: The clinically observed shorter RF duration for PVI with SF vs TC, may be due to more homogenous
lesion formation with the novel SF catheter, especially at high cooling volumes. Ablationists should be aware of
these differences, to avoid complications by adjusting for power & CF during ablations.
Biventricular distribution of human ventricular ﬁbrillation rotors
D.E. Krummen, D.J. Morris, J. Ho, MR. Smetak, W.-J. Rappel, and S.M. Narayan
Veterans Affairs San Diego Healthcare System and University of California, San Diego, United States of America
Introduction: Rotors have been demonstrated in human ventricular ﬁbrillation (VF), but their distribution is
unknown. We hypothesized that VF rotors would exist in both ventricles at electrophysiology study.
Methods: In patients presenting for ventricular arrhythmia ablation, we induced VF per approved protocol. We
recorded endocardial activation during VF using 64-electrode catheters in the left (LV) and right (RV) ventricles
during deﬁbrillator charging. We used Focal Impulse and Rotor Modulation (FIRM) mapping () to identify rotors
during VF, deﬁned as rotational activation about a singularity point for4 revolutions.
Results: In 22 patients (65+ 10 years, EF 45+ 19%), 30 episodes of VF were induced. VF was initiated in 12/
12 (100%) patients with structural heart disease vs 4/10 (40%, p = 0.003) with preserved EF. VF episodes requir-
ing deﬁbrillation were 11.5+ 2.9 seconds in duration; average cycle length was 208+ 25 ms. Rotors were identi-
ﬁed in 18 of 30 (60%) episodes. Figure shows a rotor in the posteroseptal LV (curved arrows) in a 73 year old
patient with nonischemic cardiomyopathy and frequent ICD shocks. In the 18 episodes of VF with rotors, 23
rotors were observed, with a similar distribution in the LV (n = 14) and RV (n = 9, p = 0.4).
Conclusions: VF rotors are common in human VF, observable using a percutaneous FIRM mapping approach,
and present in both ventricles. These ﬁndings may have implications for future therapies of VF.
Association between endocardial and epicardial unipolar mapping and late
enhancement imaging scar characteristics in patients with prior
myocarditis-related ventricular tachycardia
J. Silberbauer1, G. Maccabelli1, A. Esposito2, D. Tsiachris1, C. Colantoni2, F. Baratto1,
C. Bisceglia1, F. De Cobelli2, A. Del Maschio2, and P. Della Bella1
1San Raffaele Hospital (IRCCS), Arrhythmology, Electrophysiology and Cardiac Pacing Unit,
Milan, Italy; and 2San Raffaele Hospital (IRCCS), Department of Radiology, Milan, Italy
Purpose: Substrate-based ablation of ventricular tachycardia (VT) relies on electroanatomical
mapping (EAM) and information from late enhancement (LE) imaging may provide supple-
mentary information. We assessed the relation between EAM and LE imaging scar characteris-
tics in patients with prior myocarditis-related VT.
Methods: We analyzed endocardial and epicardial uni/bipolar voltage maps and LE imaging
data in 19 patients with prior myocarditis-related VT. Cardiac MR imaging was used in 15
patients and multidetector CT in 4 patients. EAM during the baseline rhythm was performed
using the CARTO system (Biosense Webster Inc, Diamond Bar, CA). A value of 1.5 mV
deﬁned normal LV bipolar electrogram amplitude and a value of 8 mV deﬁned normal LV uni-
polar electrogram amplitude both at the endocardium and epicardium. Dense scar was deﬁned
as an area with bipolar amplitude 0.5 mV and unipolar amplitude 5 mV. Intermediate
values deﬁned border zone. The LV location (using a 17-segment model) and pattern (subendo-
cardial, mid-wall, subepicardial, or transmural) of LE were assessed in all patients. EAM scar
location was also based on the same 17-segment model.
Results: LE scar was localized to the basal and mid inferolateral walls in the majority of
patients. Scar extension was only subepicardial (SS) in 10/19 patients and reached the mid-
wall layer (MS-SS) in the remaining 9 patients. Endocardial bipolar mapping revealed border-
zone scar in 1 patient and unipolar mapping (,8mV) in 12/19 patients (63.2%). Segment per
segment correspondence of LE scar localization with endocardial bipolar map was only 1%
and with endocardial unipolar map was 23.7%. Epicardial bipolar mapping revealed border-
zone scar in 14 of 19 patients (73.7%) and unipolar mapping in 18/19 patients (94.7%).
Segment per segment correspondence of LE scar localization with epicardial bipolar map was
39.8% and with epicardial unipolar map was 66.2%.
Patients with a greater extension of scar (MS-SS vs. SS pattern) had more frequently identiﬁ-
able epicardial bipolar dense scar (70% vs. 22.2%, p = 0.037). Endocardial unipolar compared
to bipolar mapping detected a scar more frequently (44.4% vs. 0%, p = 0.023) in patients with
only SS pattern. Endocardial unipolar compared to bipolar mapping detected a scar more fre-
quently (80% vs. 10%, p = 0.002) in patients with MS-SS pattern.
Conclusion: Epicardial unipolar mapping (cutoff of 8 mV) appears superior in scar identiﬁca-
tion in patients with prior myocarditis. Epicardial bipolar and endocardial unipolar mapping
may identify scars extending from the subepicardium to the mid-wall layers of the LV.
Electroanatomical substrate-guided catheter ablation of ventricular
tachycardia: is additional activation mapping required to improve results?
G. Izzo1, E. Russo1, V. Marino1, A. Dello Russo1, M. Casella1, M. Zucchetti1, L. Di Biase2,
A. Natale2, C. Tondo1, and C. Carbucicchio1
1Centro Cardiologico Monzino, Milan, Italy; and 2St. David’s Medical Center, Texas, United
States of America
Introduction: Advanced mapping techniques efﬁciently guide complex ventricular tachycar-
dia (VT) ablation by identifying putative arrhythmogenic sites in sinus rhythm: the adjunctive
value of activation mapping (AMap) has not been elucidated. We sought to deﬁne the role of
AMap in patients with structural heart disease undergoing electroanatomical substrate-guided
ablation of VT.
Methods: We prospectively enrolled 89 patients (age 66.2+ 11.9, ejection fraction
37.6+ 11.0%) with ischemic (64) or idiopathic (25) dilated cardiomyopathy undergoing endo-
cardial or endo-epicardial electroanatomical mapping and ablation of hemodynamically toler-
ated and non-tolerated VT(s). The efﬁcacy of AMap was assessed with respect to VT
suppression when predeﬁned safety criteria were met. A substrate-guided ablation strategy tar-
geting surrogate markers of reentry was accomplished in all patients; an epicardial approach
was required in 15. VT-free survival at one year was assessed by ICD interrogation.
Results: AMap successfully guided ablation in 51/82 patients (62.2%) with inducible VT(s).
At one year, 5/89 patients (5.6%) died; VT recurred in 18/89 (20.2%). No signiﬁcant differ-
ence in VT recurrence rate was observed between patients in whom AMap proved effective
versus those who were treated only by a substrate-guided ablation strategy (10/51, 19.6%
versus 8/38, 21.1%; p: ns).
Conclusions: Our ﬁndings support the efﬁcacy of a substrate-guided ablation strategy targeting
speciﬁc markers of arrhythmogenicity identiﬁed during sinus rhythm. AMap was effective in
most patients but did not contribute to a higher VT-free survival, suggesting that in patients
with advanced cardiac disease life-threatening arrhythmias can be effectively treated by abla-
tion in sinus rhythm, thus limiting procedural risks.
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Lower catheter tip temperatures are associated with inhomogeneous lesion
formation during radiofrequency catheter ablation in a canine thigh muscle
model
F. Akca1, E. Zima2, E. Vegh2, G. Szeplaki2, J. Skopal2, M. Hubay2, Z. Lendvai2, B. Merkely2,
and T. Szili-Torok1
1Erasmus Medical Center, Thoraxcenter, Rotterdam, Netherlands; and 2Semmelweis
University, Heart Center, Budapest, Hungary
Purpose: Previous studies on open irrigation radiofrequency (RF) ablation catheters focused
on created lesion volumes, and did not evaluate lesion quality. The aim of this study was to
evaluate the effect of different irrigation levels on lesion quality and volume.
Methods: A canine thigh model was used. A skin incision was made and a cradle was created
and ﬁlled with blood (37 8C, 250 ml/min). The ablation catheter was positioned parallel or per-
pendicular to the muscle surface using a constant force of 10 g. RF lesions were created using a
gold tip electrode catheter with 12 irrigation holes and a PtIr catheter with 6 irrigation holes
(Biotronik, Berlin, Germany). Both catheters were 7F and had a 3.5 mm electrode tip. RF
current was delivered for 60 s at either 50 W (n = 18) or 30 W (n = 39). Temperature probes
were inserted immediately below the surface and at 3.5 and 7 mm depth. Histological examin-
ation was performed to evaluate lesion size as well as the homogeneity of the RF lesions.
Inhomogeneity was deﬁned as a visual observed multi-band lesion pattern indicating different
histological characteristics. Electrode temperature and lesion dimensions were measured.
Results: Data of 57 lesions, created in a mongrel dog model, were analyzed. A total number of
47 inhomogeneous and 10 homogeneous lesions were detected. Inhomogeneous lesions were
deeper (7.5 + 1.4 vs. 6.3 + 2.1 mm, p = 0.036), however lesion volume was comparable
between the two groups (652+ 487 vs. 834+ 396, p = 0.249). Lesions with inhomogeneous
histological characteristics had lower maximum electrode temperatures during ablation (42.9
+ 6.6 vs. 48.2 + 8.6 8C, p = 0.049). The mean temperatures at 3,5 and 7 mm below the
muscle surface were lower for inhomogeneous lesions (41.2 + 8.1 vs. 50.2 + 21.4 8C, p =
0.035; 38.7+ 4.0 vs. 45.2 + 19.0 8C, p = 0.034). Inhomogeneity of the lesion was not asso-
ciated with catheter type (p = 0.164), orientation (p = 0.185), amount of saline infusion (p =
0.305) and power output (p = 0.213).
Conclusions: Our data suggest that lower catheter tip and tissue temperatures are associated
with the development of inhomogeneous acute RF lesion formation. The presence of inhomo-
geneous RF lesions can theoretically be responsible for the differences between acute and
chronic ablation success rates.
Local ventriculo-atrial intervals during tachycardia and entrainment:
diagnostic value for supraventricular tachycardia mechanism
D. Calvo Cuervo1, P. Avila2, J. Garcia-Fermandez3, E. Gonzalez-Torrecilla2, J.M. Rubin1, F. Atienza2,
G. Eidelman2, and A. Arenal2
1University Hospital Central de Asturias, Oviedo, Spain; 2University Hospital Gregorio Maran˜o´n, Madrid, Spain;
and 3University Hospital of Burgos, Burgos, Spain
Purpose: Septal accessory pathways (AP) or AV nodal re-entrant tachycardias (AVNRT) commonly mediates supra-
ventricular tachycardia with concentric atrial activation. When long ventriculo-atrial (VA) intervals are observed, add-
itional maneuvers are required for diagnosis. We described the behavior of septal VA intervals during tachycardia and
entrainment from right ventricular apex (RVA), which predicts the tachycardia mechanism.
Methods: Electrophysiological evaluation concluded atypical AVNRT or ortodromic tachycardia (AVRT) by septal
APs based on classical maneuvers.We focus on the differential behavior of the septal VA intervals (parahisian location)
during tachycardia and entrainment. We compute the local VA difference (VADif) as the subtraction deﬁned by: VA
during entrainment from RVA – VA during tachycardia. We hypothesized that, in contrast with AVNRT, an invariable
sequence of activation during septal-APmediated tachycardias will remained the subtraction closer to 0.
Results: we analyzed 42 atypical AVNRT and 40 AVRT (AP location: 16 parahisian, 5 midseptal and 19 posteroseptal).
VADif was longer for AVNRT (101.5 + 41.9 ms) compared with AVRT mediated by septal AP (-7.4 + 21.8 ms;
p, 0.05). A cut-off value of 35 ms showed 93% sensibility and 95% speciﬁcity for the tachycardia mechanism (area
under COR curve 0.99; CI 95%: 0.98-1). According with physiological criteria, a negative value as a result of the subtrac-
tion remains unobserved if AVNRT support the tachycardia mechanism (Positive Predictive Value 100% for AVRT).
Conclusions: Differences in the subtraction between septal VA intervals add additional information for discrimination
between atypical AVNRT and AVRT mediated by septal AP. Also, a negative value remains diagnostic of a tachycardia
mechanism based on septal AP.
Single center experience of ﬂuoroless AVNRT ablation guided by
electroanatomic reconstruction in children and adolescents
E. Ebrille1, M. Scaglione2, D. Caponi2, A. Blandino1, P. Di Donna2, A. Siboldi3, G. Bertero3,
F. Gabbarini4, M. Marasini3, and F. Gaita1
1University of Turin, San Giovanni Battista "Molinette" Hospital, Department of Cardiology,
Turin, Italy; 2Cardinal Massaia Hospital, Department of Cardiology, Asti, Italy; 3G. Gaslini
Institute, Department of Pediatric Cardiology, Genoa, Italy; and 4Regina Margherita
Children’s Hospital, Department of Cardiology, Turin, Italy
Purpose: Anatomical considerations and risks related to x-ray exposure make atrio-ventricular
nodal reentrant tachycardia (AVNRT) ablation in pediatric patients a concerning procedure. We
aimed to evaluate the feasibility, safety and efﬁcacy of performing ﬂuoroless slow pathway
cryoablation guided by the electroanatomic (EA) mapping in children and adolescents.
Methods: Twenty one consecutive patients (mean age 13.5 + 2.4 years) symptomatic for
AVNRT were prospectively enrolled to right atrium EA mapping and electrophysiological
study prior to cryoablation. Cryoablation was guided by slow pathway potential and performed
using a 4-mm tip catheter.
Results: Sustained slow-fast AVNRT was inducible in all the patients with a dual AV nodal
physiology in 95%. Acute success was achieved in 100% of the patients with a median of 2
cryo-applications. Fluoroless ablation was feasible in 19 patients, while in 2 subjects 50 and 45
seconds of x-ray were needed due to difﬁcult vascular accesses. After a mean follow-up of 25
months AVNRT recurred in 5 patients. All the recurrences were successfully treated with a
second procedure. In 3 patients a ﬂuoroless cryoablation with a 6-mm tip catheter was success-
fully performed, while in the remaining 2 patients a single pulse of 60 s of radiofrequency
energy was applied under ﬂuoroscopic monitoring. No complications occurred.
Conclusions: Combination of EA mapping systems and cryoablation may allow to perform
ﬂuoroless slow pathway ablation for AVNRT in children and adolescents in the majority of
patients. Fluoroless slow pathway cryoablation showed a high efﬁcacy and safety comparable
to conventional ﬂuoroscopy guided procedures.
A new criterion based on virtual unipolar electrogram morphology
to distinguish left from right outﬂow tract tachycardia origin
A. Radinovic, N. Trevisi, P. Vergara, G. Maccabelli, and P. Della Bella
San Raffaele Hospital (IRCCS), Arrhythmology, Electrophysiology and Cardiac Pacing Unit, Milan, Italy
Purpose: The aim of our study was to develop a new criterion for distinguishing right ventricular outﬂow tract
(RVOT) from left ventricular outﬂow tract (LVOT) origin, in patients with idiopathic outﬂow tract tachycardia, by
analyzing virtual unipolar electrograms (vEGMs) using a non-contact mapping system.
Methods: All patients who underwent a successful ablation procedure for RVOT/LVOT premature ventricular
contractions (PVC) or ventricular tachycardias (VT) were included. We analyzed the virtual unipolar EGM
morphology of the PVCs or VTs, measuring the voltage peak negative (VPN) of the unipolar EGM and time to
VPN from the earliest activation (EA). We then calculated the gradient of the downslope of the vEGM by evaluat-
ing voltage amplitude at 10, 15 and 20 ms after EA and ratio between voltage amplitudes at 10,15 and 20 ms after
EA and VPN.
Results: We analyzed retrospectively the virtual EGM morphology of 100 patients (mean age 37.27+ 14.5
years) who underwent a successful ablation procedure. Patients with RVOT foci had a signiﬁcantly higher peak
negative voltage (p , 0.001) and shorter time to peak negative voltage (p , 0.001) than patients with LVOT foci.
The gradient of the downslope of the vEGM was signiﬁcantly steeper in patients with RVOT origin (p , 0.001).
In a multivariate logistic regression the strongest predictor of left sided origin was the the ratio between the
voltage amplitude at 20ms after EA and VPN (p = 0.0002, OR ,0.0001). AV20/VPN ratio 0.505 had a sensi-
tivity of 95% and a speciﬁcity of 90% for right sided foci. A receiver operating characteristic curve for V20/VPN
is illustrated in Figure 1.
Conclusions: The V20/VPN ratio is a new criterion that can be useful for ablation procedures to distinguish left
from right outﬂow tract tachycardia origin
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Utility of a contact force catheter on atrial based right sided radiofrequency
ablation
J. Chaumont1, M. Badra2, J.F. Roux2, S. Rivera2, D. Arseneau1, and F. Ayala Paredes2
1Biosense Webster, Montreal, Canada; and 2University Hospital of Sherbrooke, Sherbrooke,
Canada
Background: The force applied to ablations catheters is now available as a new tool in order to
increase security and to better ascertain when the catheter is in close contact to tissue interface.
The only other ways to indirectly know these variables were the bending of a catheter when
applied perpendicular to a heart wall, or the amplitude of the signals (in absence of scar) as a
surrogate, the higher the amplitude, the better the contact.
Methods: Consecutive patients (pts) undergoing atrial based ablations in a non ﬂuoroscopic
program were studied by the same operator, blinded to the force measured while acquiring the
right atrium 3-D anatomy, with an 8 F commercially approved ablation catheter (SmartTouch,
Biosense Webster). All points acquired were post processed validating the amplitude (mV) and
force (g) measured, all points acquired in the ventricle were manually deleted. A good contact
was deﬁned as having 10g or higher force for each point.
Results: Eleven pts were studied, age range 33-73 years old, 6 men; one EP study, 4 AVNRT, 2
AVRT and 4 ﬂutter. Mean total procedural time (105min Flutter, 100min ANVRT, and 167min
AVRT), ablation time (208-449 seconds) and number of lesions applied (3-12) were similar to
previous non ﬂuoroscopic based ablations for each arrhythmia studied. Median number of
points acquired for each right atrium was 363 (range 139-772), median number of points with
good contact was 118 (range 19-257). There was no difference in volume when the right atrium
was assessed using all points versus the ones with good contact (227.5 cm2 vs 215.1 cm2).
There was absolutely no subjective difference between forces ranging from 1-77g to ascertain
good or poor contact. There was no correlation between the force measured and the voltage
recorded (mean r = 0.19 -Spearman’s rank correlation coefﬁcient- range: -0.05 to 0.48). For
AVRNT and AVRT pts all effective lesions were applied with a force less than 10 g. In ﬂutter
ablation half of the points did not have good contact (extreme posterior and extreme anterior
isthmus), but it doesn’t preclude at the end to achieve bidirectional block.
Conclusion: In normal healthy right atrial myocardium, a good contact does affect neither the
acquisition of 3-D geometry, nor the acute success of the ablation; however a higher voltage is
not a surrogate of good contact. As a wide variation in force/contact does not correlate with
subjective sensation of force applied, or electrogramme’s amplitude, this new tool does add to
the security of the procedure, especially when dealing with thin chambers as atria.
Catheter ablation of arrhythmias with exclusive electroanatomic mapping: a
case series
L.M. Pires, T.L.L. Leiria, M.L. Kruse, R. Ronsoni, C.S. Gensas, and G.G. De Lima
Institute of Cardiology of Rio Grande do Sul - University Foundation of Cardiology, Porto
Alegre, Brazil
Purpose: Catheter ablation provides a curative treatment for cardiac arrhythmias. Fluoroscopy
is required for catheter maneuvering inside the heart. This leads to unnecessary exposing of
patients and staff to ionizing radiation that has no therapeutic use at all. Today there are several
tools for non-ﬂuoroscopic mapping to be used in electrophysiological procedures. The electro-
anatomical mapping (MEA) is one of this tools. The objective of this study is to describe a
series of patients in which catheter ablation was performed without the use of ﬂuoroscopy.
Methods: a prospective series of consecutive patients sent to catheter ablation for arrhythmias
that were refractory to pharmacologic treatment using only MEA for catheter guidance.
Measured outcomes were the total length of the procedure, success rate and complications.
Also we describe the number of cross-overs to ﬂuoroscopy.
Results: A total 11 patients were included; 7 females (63%).Mean age was 50+ 16.5 years.
There were 4 cases (35%) of atrial ﬂutter, 3 cases (27%) of pre-excitation syndrome, 2 cases
(19%) of paroxysmal supraventricular tachycardia and 2 cases (19%) of ventricular outﬂow
tract tachycardias. The mean procedure duration was 86.6+ 26 min. The immediate success (at
discharge) occurred in 9 patients (81%). Failures were due to the requirement of ﬂuoroscopy (2
cases). There were no complications during the procedures.
Conclusion: This study demonstrated the feasibility of catheter ablation of cardiac arrhythmias
adopting a zero ﬂuoroscopy posture.
Impact on catheter design and orientation on contact force in magnetically
guided catheters
G. Noelker, B.G. Muntean, D. Horstkotte, and K.J. Gutleben
Department of Cardiology, Heart and Diabetes Center North Rhine-Westphalia, Ruhr University Bochum, Bad
Oeynhausen, Germany
Purpose: Magnetically guided ablation has been introduced several years ago. Tip to tissue contact is critical for
lesion formation. Data comparing contact forces (CF) in this type of catheters is lacking. We evaluated two estab-
lished catheters and a newly designed one in two identically constructed versions in an experimental setting.
Methods: Three different types of catheters were inserted in an 8.5 Fr, 65 cm sheath. A highly sensitive measuring
instrument centered in between the 2 magnets in a conventional magnetic lab was targeted in two different orienta-
tions by application of magnetic power (0.1 Tesla) and a motor-drive (V-cas, Stereotaxis). Distance between the
distal part of the sheath and the measuring instrument was 55 mm. Due to the different magnet conﬁgurations of
RMT and Trignum catheters in perpendicular setting the most proximal magnet of the RMT catheter was bearly
out of the sheath while the most proximal magnet of the Trignum Flux eXtra Gold and the Trignum Flux Gold
were fully out of the sheath. Measurements were repeated two times in every orientation with every catheter.
Results: See table 1.
Conclusion: CF markedly varies between different types of magnetic catheters. Moreover, CF is dependent on
orientation of the catheter in relation to the targeted structure in some catheters. This is likely to have major
impact on lesion formation in magnetically guided ablation. Magnetic strength and distribution of the magnets as
well as catheter ﬂexibility may be crucial. Catheter behavior and potential beneﬁt of more homogenous CF has to
be evaluated.
Magnetic
Catheter
Catheter version Tip Orientation Contact Forces (g) Average SD (+)
# 1 #2 #3
NaviStar
Thermocool
parallel 6.6 6.2 6.0 6.3 0.3
NaviStar
Thermocool
perpendicular 16.6 15.6 16.0 16.1 0.5
Trignum Flux
Gold
parallel 6.0 6.3 6.3 6.2 0.2
Trignum Flux
Gold
perpendicular 15.2 14.4 14.3 14.6 0.5
Trignum Flux
eXtra Gold
(A) parallel 6.6 7.0 6.9 6.8 0.2
Trignum Flux
eXtra Gold
(A) perpendicular 7.9 8.1 7.8 7.9 0.2
Trignum Flux
eXtra Gold
(B) parallel 6.2 6.1 5.8 6.0 0.2
Trignum Flux
eXtra Gold
(B) perpendicular 7.0 6.8 5.7 6.5 0.7
Relationship between pressure and depth in an experimental model of
cavoriscuspid isthmus ablation with force monitoring contact systems
R. Matia, A.H. Madrid, L. Carrizo, A. Delgado, H. Del Castiilo-Carnevali, S. Fernandez-
Santos, C. Lazaro, C. Pindado, C. Moro, and J. Zamorano
University Hospital Ramon y Cajal, Department of Cardiology, Madrid, Spain
Objectives: The main objective of this study was to determine in an experimental model in pigs
the depth of the lesions after performing cavotricuspid isthmus ablation with a new contact system
that provides continuous pressure monitoring during radiofrequency ablation procedures.
Methodology: we performed the procedure in 8 pigs in an experimental electrophysiology labora-
tory. The ablation procedure was performed after right femoral vein dissection and insertion of a
12 Fr. introducer during general anesthesia and endotracheal intubation. The animals were sedated
with 10 mg/kg intramuscular ketamine (ketolaw) and 20 mg/kg of sodium thiopental (tiobarbital
Braunw). We programmed a maximum pressure of ,10 grs. (axial or lateral), 10-20 grs., 20-30
grs. and. 30 grs. in 2 pigs each. The power set was 40Watts with a maximum target temperature
of 45 8 C. We performed a RF line dragging from the tricuspid valve to the inferior vena cava in
the 8 pigs. Euthanasia of the animals was performed a week after the procedure. The heart was sec-
tioned and ﬁxed in 10% formalin and a pathological exam of the lesions was performed. External
surface was examined searching for transmural lesions and injury of extracardiac adjacent organs.
In the endocardial macroscopic analysis the extent and depth of lesions, the presence of thrombus,
transmurality and endothelial rupture was assesed.
Results: the mean force pressure applied was 20.3+ 7.5 grs. and the mean depth of the lesions
was 2.5+ 1.6 mm. There is positive correlation (r ¼ 0.59) between the average force pressure and
depth of the lesions (ﬁgure).
Conclusions: Catheter-tissue contact is critical for effective lesion creation. This information is
important for improving ablation efﬁcacy.
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Underlying scar tissue signiﬁcantly inﬂuences impedancebBased catheter
tip-to-tissue contact assessment
M. Izquierdo De Francisco, J.M. Sanchez-Gomez, J. Nunez, A. Ferrero, A. Martinez,
V. Gonzalez, S. Morell, J. Chorro, and R. Ruiz-Granell
University Hospital Clinic, Department of Cardiology, Valencia, Spain
Introduction: Ablation efﬁcacy depends on catheter tip-to-tissue contact. The Ensite Contact
technology (St. Jude Medical) has been developed to predict catheter-tissue contact by measur-
ing the complex impedance (ECI) at the tip/tissue interface. It correlates well with pressure, al-
though it may be also inﬂuenced by the type of underlying tissue. The purpose of this study is
to demonstrate if the ECI value depends on the underlying tissue, i.e. healthy or scar tissue.
Methods: Ten patients that underwent VT catheter ablation, late after myocardial infarction,
were studied. The EnSite NavX system was used. During sinus rhythm, a point-by-point LV
mapping was performed; each point had information on local bipolar voltage (EGV) and local
ECI value. Each endocardial point (EP) was registered when high contact was supposed to be
achieved by the operator. EP were divided into groups according to their EGV: ,0.5, 0.5-1, 1-
1.5, 1.5-2, 2-2.5, 2.5-3, 3.5-4, 4-5, 5-6, 6-8 and .8 mV. A cardiac MRI was performed in 4
patients before ablation to delineate myocardial scar.
Results: A stepped increase of median ECI was observed when moving from low to high EGV
groups: 92 (IQR 22), 100 (IQR 23), 110 (IQR 36), 113 (IQR51), 115 (IQR 48), 130 (IQR 43),
129 (IQR55), 125 (IQR 44), 147 (IQR 76), 157 (IQR 69), 172 (IQR 74), 165 (IQR 63),
p , 0.001. ECI dispersion (IQR) also exhibited a stepped increase. An inter-person variability
was found. In a multivariate analysis, left ventricle diameter and age also had an inﬂuence on
ECI. There was a good correlation between myocardial scar deﬁned by MRI, voltage (cut-
off , 1,5mV) and ECI value (cut-off for each patient consisting in the upper limit of the inter-
quartilic range of EP, 1,5mV).
Conclusion: ECI depends on the type of underlying tissue and presents lower values in scar
tissue even when tip-to-tissue high contact is achieved. There is an inter-person variability
probably related to ﬁbrosi.
Incremental His-to-coronary sinus ostium distance maneuver for complete
cavo-tricuspid isthmus conduction block Assessment
E. Valles Gras, V. Bazan, B. Benito, M.E. Jauregui, J. Bruguera, and J. Marti
Hospital del Mar, Barcelona, Spain
Background: Achievement of complete cavo-tricuspid isthmus (CTI) conduction block reduces typical atrial
ﬂutter recurrences after ablation. The lack of increase in the His-to-Coronary sinus ostium (CSO) interval during
incremental pacing (IP) from the low lateral right atrium (LLRA) may distinguish slow conduction from complete
CTI conduction block.
Methods: Sixty-six consecutive patients (age 65+ 13 years, 18% female) were prospectively included. A , 10
ms increase in the His-to-CSO distance during LLRA incremental pacing at cycle length of 600 ms through 300
ms was confronted to the previously reported IP maneuver for the conﬁrmation of complete CTI block.
Results: On the basis of the IP maneuver complete CTI block (phase 2) was achieved in 59 patients, in 13 of
whom an intermediate phase of functional CTI block (phase 1) was observed. In the remaining 7, the IP maneuver
did not allow for assessment of complete CTI block due to the presence of inconclusive potentials in the CTI abla-
tion line. As confronted to the IP maneuver, the incremental His-to-CSO maneuver was consistent with functional
CTI block during phase 1 in all cases and conclusive of complete CTI block in 98% of cases during phase 2.
Conclusion: The incremental His-to-CSO maneuver is analogous to the IP maneuver in order to distinguish com-
plete CTI block from persistent CTI conduction. This maneuver may permit for conﬁrmation of CTI block in
those patients in whom assessment of local electrogram-based criteria is not feasible due to the observation of in-
conclusive potentials in the CTI ablation line.
Cryotherapy ablation for septal accessory pathways in children
M. Swissa1, T. Dagan2, E. Bruckheimer2, E. Birk2, and R. Fogelman2
1Kaplan Medical Center, Rehovot, Israel; and 2Schneider Children’s Hospital, Petach Tikva,
Israel
Background: Radiofrequency (RF) ablation has become established therapy for tachy-arrhyth-
mias in the pediatric population. Cryotherapy is a comparable alternative to RF current for cath-
eter ablation in both adult and pediatric population. Septal accessory pathways (APs) especially
para-Hisian and antero-septal APs can be challenging targets for RF ablation due to the proxim-
ity of the normal atrioventricular (AV) conduction tissues, especially for pediatric patients.
However, cryotherapy is characterized with lower acute successful rate and high rate of recur-
rence. This study sought to investigate the safety and efﬁcacy of cryotherapy ablation (Cry-Ab)
in the treatment of pediatric patients with septal accessory pathways.
Methods: A total of 54 patients aged 5.3-20.4 years with SVT or overt AP underwent 72 Cry-
Ab procedures. They had para Hisian, right antero-septal or right mid-septal accessory path-
ways (37, 13 and 4, respectively). Cryo-mapping was performed at -358C for a maximum of 60
seconds and Cry-Ab for 4 minutes at -808C. An acute success was deﬁned as noninducibility of
SVT and conduction block over the AP.
Results: The mean age was 14.9+ 3.8. The acute successful rate for the ﬁrst ablation was 50/
54 (93%). Thirteen out of the 50 (26%) had recurrence of arrhythmia, all of them had second
successful ablation, but 4 of them had recurrence and success again on the third procedure. The
total long term (mean follow-up of 49+ 21 months) successful rate was 93% (50/54). The
average ﬂuoroscopy time was 28.5+ 21.3. The total Cry-Ab time was signiﬁcantly higher in
the second compared to the ﬁrst procedure (808+ 380 second vs 607+ 417, respectively,
P, 0.01). One patient had mechanical ablation of the AP and one patient had transient com-
plete AVB.
Conclusions: Cry-Ab is a safe and effective treatment for the ablation of APs with close prox-
imity to the AVN in children. However, characterized with high rate of recurrence and repeated
procedures to achieved high successful rate.
Electro physiological study and ablation in children with asymptomatic
Wolff-Parkinson-White syndrome
M. Swissa1, G. Yager-Yarom2, T. Dagan2, E. Bruckheimer2, E. Birk2, and R. Fogelman2
1Kaplan Medical Center, Rehovot, Israel; and 2Schneider Children’s Hospital, Petach Tikva,
Israel
Purpose: Asymptomatic WPW syndrome is deﬁned as an isolated ventricular pre-excitation
without any arrhythmia symptoms (palpitations, pre-syncope or syncope) or documented atrio-
ventricular reentry tachycardia (AVRT) or atrial ﬁbrillation (AF). Induction of AVRT, a shortest
pre-excited RR interval (SPRRI) during AF and/or an accessory pathway effective refractory
period (APERP) of less than 240 ms, the presence of multiple pathways, septal and right-sided
pathway locations and younger age may identify a high risk group. Recently, an Expert
Consensus Statement on the Management of the Asymptomatic Young Patient with WPW was
published. Since 2002, we routinely offer an electro-physiological study (EPS) for asymptomat-
ic children with WPW syndrome; it happens that this policy is in complying with recently pub-
lished recommendations. In this work we would like to describe our experience in this group of
patients.
Methods: Invasive EPS were performed in 142 (111 boys and 31 girls) asymptomatic children
aged 5 to 19 years old (12.8+ 3.5) with WPW. Children with high risk for SCD (SPRRI
during AF and/or APERP, 240 ms) or inducible AVRT or both underwent ablation of the AP.
Results: Seventy eight out of 142 (55%) children had a negative EPS, the rest of children 64
(45%) reached the high risk criteria or inducible AVRT or both. Among them 60/64 (93.5%)
had successful ablation of the AP. The ﬂuoroscopy time for the ablated children was 5-82
minutes (30.9+ 21.3) compared to 1-14 min (3.5+ 2.7) for the non-ablated children. The
ablated AP were located to the left side in 20/64 (31%), para-Hisian, anteroseptal or midseptal
in 13 (20.5%), right posterior in 23 (36%) and right lateral in 8 (12.5%) children. Eight children
had cryoablation of the AP located in para-Hisian or antero septal region (5 and 3, respectively),
the rest had RFA. One patient had transient atrio-ventricular block during cryomapping.
Conclusions: About half of "asymptomatic WPW" children had high risk criteria for SCD or
were inducible for AVRT or both. Electrophysiological study and ablation of this population is
safe and highly successful and compatible with the recently published expert consensus
statement.
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Clinical impact of late revealing ECG abnormalites in patients with
idiopathic ventricular ﬁbrillation and unknown cause ventricular
tachycardia undergoing impantable cardioverter deﬁbrillator
K.H. Lee, H.Y. Park, J.G. Cho, NS. Yoon, K.H. Park, D.S. Sim, Y.J. Hong, Y.K. Ahn,
M.H. Jeong, and J.C. Park
Chonnam National University Hospital, The Heart Center, Gwangju, Korea, Republic of
Purpose: The implantable cardioverter deﬁbrillator (ICD) is used to treat life-threatening ven-
tricular arrhythmias and to prevent sudden cardiac death (SCD). Despite of meticulous evalu-
ation to reveal the cause of SCD, some patients have been implanted ICD without deﬁnitive
cause. However, they might have certain electrocardiogram (ECG) abnormalities during follow
up. We aimed to evaluate late revealing ECG abnormalities in patients with idiopathic ventricu-
lar ﬁbrillation (VF) or unknown cause ventricular tachycardia (VT).
Methods:We analyzed 145 patients (55.8+ 16.6 years old, 95 males) who underwent ICD im-
plantation from January 1999 to June 2012. 43 patients (29.7%) were designated as idiopathic
VF or unknown cause VT without organic nor ECG abnormalities. ECG abnormalities includ-
ing early repolarization (ER) were analyzed during 3.7+ 2.4 years median follow-up duration.
Patients were divided into Group I (n = 30, patients with ECG abnormalities) and Group II (n =
13, patients without ECG abnormalities).
Results: 30 patients (69.8%) showed ECG abnormalities during long-term follow-up after ICD
implantation. 3 patients (7.0%) revealed Brugada type 2 ECG abnormalities, and 29 patients
(67.4%) revealed ER. There were no differences in the clinical characteristics except that serum
N-terminal pro brain natriuretic peptide level was higher in Group I (404.5 pg/ml vs. 75.1 pg/
ml, p = 0.011). Electrophysiology study (EPS) before ICD implantation was performed in 31
(72.1%) patients. There were no signiﬁcant differences in the rate of EPS and induced VF/VT
between the 2 groups. Appropriate shock was dominantly delivered in patients with ER with
horizontal/descending STE (40.4% vs. 17.4%, p = 0.038) and in patients with ER in inferior
leads (43.5% vs. 10.0%, p = 0.015). ER in inferior leads with horizontal/descending ST
segment was a signiﬁcant predictor for the appropriate shock (adjusted hazard ratio [HR] 4.89,
95% conﬁdence interval [CI] 1.17-17.41, p = 0.024) as well as inducible VF/VT in EPS
(adjusted HR 7.5, 95% CI 1.02-14.2, p = 0.035).
Conclusions: Considerable patients had ECG abnormalities after ICD implantation, although
initial meticulous evaluation did not reveal any structural or ECG abnormalities. ER with
Horizontal/descending ST segment in inferior leads might predict further appropriate ICD
shock.
Flecainide therapy suppresses exercise-induced ventricular arrhythmias in
patients with CASQ2 associated catecholaminergic polymorphic ventricular
tachycardia
I. Marai, M. Boulos, M. Suleiman, M. Blich, and A. Khoury
Rambam Health Care Campus, the Technion, Israel Institute of Technology, Dept of
Cardiology, Haifa, Israel
Background: Calsequestrin (CASQ2) associated Catecholaminergic polymorphic ventricular
tachycardia (CPVT2) can cause sudden death in young individuals in response to stress. Beta
blockers are the mainstay medical treatment for CPVT2 patients. However, they do not prevent
syncope and sudden death in all patients. Flecainide was reported to reduce exercise-induced
ventricular arrhythmias (EIVA) in patients with RyR2 associated CPVT (CPVT1). The role of
ﬂecainide in CPVT2 is not known.
Objective: To summarize our experience in combining ﬂecainide and beta blockers in high
risk CPVT2 patients.
Methods: All CPVT2 patients who have high risk features (syncope, EIVA, or appropriate ICD
shocks) despite beta blockers with or without calcium channel blockers were treated with com-
bination of ﬂecainide and beta blockers. Exercise test was done before and after starting treat-
ment with ﬂecainide.
Results: Seven patients were treated with ﬂecainide, 4 patients because of appropriate ICD
shocks, and 3 because of EIVA. All patients already had ICD implantation. All patients have
ventricular arrhythmia (ventricular premature beats and or ventricular tachycardia ) during ex-
ercise test while on high dose beta blockers with or without calcium channel blockers before
treatment with ﬂecainide. In all patients combination of ﬂecainide and beta blockers suppressed
EIVA. At 24 months follow-up, 5 patients kept symptoms free. Two patients had one VT storm
episode with recurrent ICD shocks each, despite negative stress test and symptoms free.
Conclusion: Flecainide can completely prevent ventricular arrhythmia during exercise test and
partially prevent recurrent ICD shocks in high risk CASQ2 associated CPVT patients.
Assessment of heart rate turbulence in ischemic cardiomyopathy patients
with implantable cardioverter deﬁbrillator (ICD) shock therapy
E. Cekirdekci, N. Cakmak, I. Tekkesin, C. Turkkan, B. Erer, T. Alper, and K. Gurkan
Siyami Ersek Thoracic and Cardiovascular Surgery Center, Department of Cardiology,
Istanbul, Turkey
Introduction: Recent studies have revealed that patients with severe left ventricular (LV) dys-
function (ejection fraction ,35%), are associated with increased risk of mortality and implan-
table cardioverter deﬁbrillator (ICD) shock therapy. Abnormal heart rate turbulence (HRT) is
strong independent predictor of sudden cardiac death in patients with ischemic cardiomyopathy
(IC). We assessed HRT parameters named Turbulence onset (TO) and Turbulence slope (TS)
in IC patients with appropriate ICD shocks.
Methods: We prospectively enrolled 30 (25 men and 5 women; mean age 62 + 9 years ) IC
patients (mean LVEF 23+ 4%) with appropriate ICD shock therapy (4.4+ 1.8 shock/day).
Exclusion criteria were as follows: non-sinus rhythm (atrial ﬁbrillation, paced rhythm), revers-
ible causes of ventricular arrhythmic events. We evaluated HRT parameters by using 24-hour
ambulatory Holter monitoring.
In this study, patients were deﬁned as HRT positive when both TO and TS were abnormal (TO
 0% and TS  2.5 ms/RR interval), and as HRT negative when TO and/or TS were normal
(TO , 0% and/or TS . 2.5 ms/RR interval). We compared HRT parameters and other risk
factors for cardiac mortality including age (.65 years), gender, presence of diabetes mellitus
(DM), hypertension(HT), renal insufﬁciency (RI), hyperlipidemia(HL), presence of nonsus-
tained ventricular tachycardia (NSVT), number of ventricular premature contraction( VPC) and
frequent ICD shock therapy(4 shock/day).
Results: 6 of 30 patients were not utilized because very frequent VPCs unable to be computed.
Of 24, 12 (50%) were HRT positive. HRT was not related to gender and other risk factors in-
cluding HT, DM and HL (P . 0.05). Abnormal HRT parameters signiﬁcantly correlated with
age (P = 0.01), RI (P = 0.036), documented NSVT (P = 0.005), frequent and more complex
VPC’s (P = 0.037) and frequent ICD shock therapy. (P = 0.01).
Conclusions: Our study reveals that abnormal HRT can predict frequent ICD shocks in IC
patients with ICD. However, further prospective investigations with larger populations are
needed to get more accurate results.
Heart rate turbulence, implantable cardiac deﬁbrillator shock therapy, ischemic cardiomyopathy.
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Syncope in primary prevention
G. Goldenberg, T. Bental, R. Zarabroski, J. Kusniek, U. Kadmon, G. Golovchiner, M. Haim,
B. Strasberg, and , Syncope in Primary Prevention
Rabin Medical Center, Petah Tikva, Israel
Background: Syncope may be the ﬁnal common symptom for a number of clinical conditions
spanning from benign conditions to life threatening diseases. Accordingly, its prognosis varies
widely and 1-year mortality may range from 0% in the case of vasovagal events up to 30% in
the presence of heart disease.
There is limited information regarding outcomes of patients who receive device therapy for
primary prevention in patients with history of syncope (of unknown cause).
Objective: The aim of this study is to assess the outcomes and prognosis of patients who under-
went ICD implantation with indication of primary prevention and compare patients that pre-
sented with or without prior syncope
Methods: We reviewed charts of 75 patients that underwent ICD implantation with the indica-
tion of primary prevention with history of syncope and compared to a control group of 80
patients without prior syncope. We assessed the number of Ventricular Tachycardia (VT),
Ventricular Fibrillation, Shock, antitachycardia pacing (ATP) and death in each group during
the follow up.
Results:Mean follow up was 30 months (no difference between groups). There was no signiﬁ-
cant gender difference. Although patients with prior syncope were slightly younger
(65.0+ 13.4 vs. 68.9+ 11.7 p = 0.058), had a higher EF (35.5+ 12.6 vs. 31.4+ 8.76 p =
0.02), they had more episodes of VT (21.3% vs. 3.8%, p = 0.001), VF (8% vs. 0%, p = 0.01)
and also received more electrical shocks (18.7% vs. 3.8%, p = 0.004) and ATP (17.3% vs.
6.2%, p = 0.031). There were no differences in inappropriate shocks (6.7% vs. 5%, p = 0.74), in
cardiovascular mortality (cumulative 5 year estimate 29.9% vs. 32.2% p = 0.97) and any death
(cumulative 5 year estimate 38.1% vs. 48.9% p = 0.18) during the follow up.
Conclusions: According to our data, patients that present with syncope before the ICD implant-
ation seem to have more episodes of VT/VF and shock or ATP. However no differences in mor-
tality were observed.
Mortality in ICD recipients and the relationship with renal function
M.S. Buiten1, A.C. Van Der Heijden1, J.I. Rotmans2, J.W. Jukema1, M.J. Schalij1, and L. Van Erven1
1Leiden University Medical Center, Department of Cardiology, Leiden, Netherlands; and 2Leiden University
Medical Center, Department of Nephrology, Leiden, Netherlands
Introduction: Patients with chronic kidney disease represent a special group within ICD recipients. Sudden
Cardiac Death (SCD) is an important cause of death in these patients, but they also suffer from a high burden of
comorbidity and have been excluded from all pivotal ICD trials. We investigated the relationship between mortal-
ity, cause of death and renal function in a large single center cohort of ICD recipients.
Methods: All ICD and CRT-D recipients in our center since 1996 were analyzed. Patients were categorized into 4
groups based on estimated glomerular ﬁltration rate (eGFR). An eGFR . 90 mL/min/1.73 m2 was deﬁned as
normal. We categorized cause of death as cardiac, sudden, noncardiac or unknown death. Kaplan Meier analysis
was used to compare mortality.
Results:We included 3276 patients. During follow-up 871 (27%) patients died (median time to death 3.1yrs i.q.r.
1.2-5.6). Survival was worse in each group with lower GFR (p , 0.001, ﬁg). Patients with GFR , 90 received ap-
propriate therapy sooner after ICD implant when compared to patients with normal renal function (2.1+ 0.1 vs
2.5+ 0,1yrs p = 0.02). Patients with a GFR . 90 died most frequently from a non-cardiac cause (39%) whereas
patients with a lower GFR died more often from a cardiac cause (44%). Heart failure was the most common cause
of death in all patients (34%) SCD occurred in 1% of patients.
Conclusion: Patients with kidney dysfunction receive appropriate ICD therapy sooner after device implantation
then patients with normal kidney function. Furthermore, survival in these patients is signiﬁcantly lower, despite
their device. A trial analyzing the beneﬁt of ICD therapy in in patients with kidney dysfunction is badly needed.
Predictive value of deceleration and acceleration capacity for risk
stratiﬁcation of sudden cardiac death in patients after myocardial infarction
E. Okisheva, D. Tsaregorodtsev, and V. Sulimov
I.M. Sechenov First Moscow State Medical University, Moscow, Russian Federation
Purpose: To evaluate predictive value of deceleration and acceleration capacity (DC/AC) for sudden cardiac
death (SCD) risk stratiﬁcation after myocardial infarction (MI).
Methods: Study group: 111 patients after MI occurred more then 60 days before inclusion (77 men; age
64,1+ 10,5 years). Control group: 60 comparable subjects without any cardiovascular diseases. All subjects had
24-hour ambulatory ECG monitoring with DC/AC evaluation. Follow-up was 12 months; primary endpoint was
SCD, secondary endpoint included all deaths from cardiovascular (CV) diseases.
Summary: DC values were signiﬁcantly lower after MI then in healthy subjects (4.2 [2.2;6.0] vs. 6,0 [4.7;7.1], re-
spectively, ,0,001). b-blockers signiﬁcantly improved DC values (4.0 [1.3;5.7] vs. 4.8 [2.6;6.1] with b-blockers,
,0.001), as well as amiodarone (1.7 [0.4;3.3] vs. 3,0 [2,2;4,7] with amiodarone, ,0.001). There were 15 cases of
SCD and 8 cases of non-sudden CV deaths. AC values showed no predictive value. DC values were signiﬁcantly
lower in all subgroups of lethals compare with survivals. ROC-analysis showed high diagnostic value of DC for
all-cause and CV mortality (AUC 0.7 and 0.67, respectively), and for SCD (AUC 0.7). DC was characterized by
high sensitivity and speciﬁcity, as well as very high NPV (98.1% for all-cause mortality and 92.9% for SCD). DC
values below threshold (4.15 for all-cause mortality and 2.0 for SCD) resulted in a signiﬁcant increase in risk of
all-cause mortality (OR 4.96, 95% CI 1.69 to 14.57, p ¼ 0.002) and SCD (OR 6,97, 95% CI 2.19 to 22.2,
p ¼ 0.001).
Conclusion: DC is a signiﬁcant and reliable independent risk predictor for all-cause and CV mortality, and SCD
in patients after MI. It is characterized by high sensitivity, speciﬁcity and negative predictive value of result.
Implantable cardioverter deﬁbrillator therapies and mortality in elderly
patients. Long term follow up
N. Galizio, N. Martinenghi, M. Mysuta, X. Vallejos, F. Robles, A. Palazzo, G. Carnero,
A. Gargano, and J. Gonzalez
University Hospital. Favaloro Foundation., Capital Federal, Argentina
Background: Implantable cardioverter deﬁbrillator (ICD) therapy has increased in elderly
people from the results of randomized studies performed in adults, but the elderly pts have been
poorly represented in these studies. Therefore, the magnitude of the survival beneﬁt is still not
well-deﬁned. The age, probably, should not be a limitation for ICD indication.
Purpose: To compare ICD therapies and mortality between elderly patients (pts) and adults pts
during a long term follow up.
Methods: A prospective analysis was performed in 257 pts with ICD and ischemic or idiopath-
ic dilated cardiomyopathy, including 76 elderly pts (70 years) and 181 adults pts (21-69
years). Pts with CRT-D were excluded. Appropriate ICD therapy (AT), inappropriate ICD
therapy (IT), all-cause mortality, cardiovascular (CV) mortality, survival at 5 years and a com-
bined endpoint of survival free of heart transplant (HT) or death at 5 years were assessed.
Median follow-up time was 29.3 months (range 1-99). Variables were analyzed with t-Mann-
Whitney or chi2 test and survival curves with Kaplan-Meier method and log-rank test. ICD
therapies (ATP/shocks) were programmed with the same protocol in pts implanted for primary
prevention.
Results: Mean age was 74.5+ 4.4 years in elderly pts and 58.1+ 8.1 in adults pts
(p , 0.001). ICD as primary prevention of sudden cardiac death was implanted in 53.9% vs
64.6% (ns) respectively. The elderly pts had signiﬁcantly higher prevalence of ischemic eti-
ology, hypertension, renal impairment, atrial ﬁbrillation, stroke and also higher mean percent-
age of right ventricular pacing (all p values,0.05).
The AT rate was 23.6% vs 35.3% (p:0.06) and the IT was 17.1% vs 21.5% (p:0.2) among
elderly and adults pts respectively.
Elderly pts had higher all-cause mortality (32.9% vs 19.3% p:0.019) but CV mortality was not
signiﬁcantly different (15.7% vs 11.6%, p:ns). The survival at 5 years was 48.3 % vs 71.4%
(p:0.024) but the survival free of HT/death at 5 years was 48.3% vs 62.1% (p: 0.54) between
elderly and adults pts, respectively.
Conclusions: The rate of ICD therapies and CV mortality was similar in both groups. Elderly
pts had a signiﬁcantly higher all-cause mortality than adults pts, probably due to their co-
morbidities, but the combined endpoint of survival free of HT/death was similar between the 2
groups. In our study population, ICD therapy was effective for the treatment of potentially life-
threatening arrhythmias in both groups.
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Additional criteria of long QT diagnostics and primary prevention of sudden
cardiac death in athletes
L.A. Balykova1, L.M. Makarov2, V.N. Komolyatova2, I.A. Gorbunova3, and N.V. Zhekina3
1Medical Institute of the Mordovian State University, Saransk, Russian Federation; 2Center for
Syncope & Cardiacs Arrhythmias in Children & Adolescents of Federal Medical-Biol. Agency,
Moscow, Russian Federation; and 3Children’s Clinical hospital 2 of Mordovian Republic,
Saransk, Russian Federation
Background: Over the past few years there has appeared evidence that stress tests are valuable
to diagnose different variants of long QT syndrome (LQTS) -inherited arrhythmia, highly asso-
ciated with sudden cardiac death, and in come causes help to make an accurate diagnosis
without genetic testing. On the other hand, many young athletes have got acquired QT
prolongation.
Purpose: To develop simple and efﬁcient methods of noninvasive diagnostics for LQTS in athletes.
Methods: We have examined 100 healthy children and 100 athletes (11-15 years old) using a
bicycle test by Bruce protocol: incessant stage test with synchronic ECG recording at rest, during ex-
ercise and at minutes 3-4 of recovery period. Estimation of RR and QT intervals was performed
manually. Corrected QT interval was assessed by Bazett’s and Fridericia’s formulas.
Results: Young athletes had lower heart rate (HR) at rest with gradual increase at physical load,
while untrained children had a “jerky” heart rate growth, but at maximal loading HR in both groups
did not differ. Athletes had higher values of QT interval duration at rest and at initial load stages,
probably due to myocardial hypertrophy and vago-dependent sinus bradycardia. At peak load signiﬁ-
cant QT reduction (QT “hyperadaptation”) occurred in athletes, while in untrained group minimal
values were noted during recovery. QTc interval duration were somewhat increasing at the ﬁrst load
stage, beginning to decrease at the second exercise step, going down beyond the original level at
maximal load and resuming the initial level by minute 4 of the recovery (like in untrained). In both
healthy untrained adolescents and young athletes maximal QTc by Bazett was recorded at Stage 1,
not exceeding 450-460 ms in untrained boys and girls and 460-470 ms in sportsmen. Inadequate QT
shortening (QTc at maximal load. 400ms), absence of QTc restoration to the initial values by min
4 of recovery (QTc at early recovery .450ms), and signiﬁcant QTc variation (difference between
maximal and minimal QTc during exercise and recovery time.90ms) revealed signs of myocardial
electric instability and required further examination for LQTS diagnostics. If 3 criteria are used sensi-
tivity amounts up to 92% and speciﬁcity up to 68%.
Conclusions: Inadequate QT shortening during exercise test in combination with the other Schwartz
criteria, was evidenced the inherited or acquired LQTS. QTc prolongation at the peak of load and
early recovery were noted to be additional criteria of LQTS diagnostics and primary sudden cardiac
death prevention in athletes.
I123-MIBG prognostic value in patients with idiopathic cardiomyopathy
candidate to ICD : a pilot study
F. Rabajoli1, G. Scrima1, G. Bertuccio1, G. Canavese1, C. Tolardo1, C. Checchinato1, M. Imazio2, E. Brscic3,
and M.T. Spinnler1
1Santa Croce Hospital, Moncalieri, Italy; 2Maria Vittoria Hospital, Torino, Italy; and 3Maria Pia Hospital,
Torino, Italy
Patients with idiopathic cardiomyopathy and EF, of 35% are a class 1 indication for ICD , currently doesn’t exist
another screening test to select more effectively the patients : so many of them will never utilize the device but are
exposed to the risk of implant /replacement.
The MIBG scintigraphy provides information of cardiac innervations and demonstrated to be useful in prognostic
stratiﬁcation , it hasn’t been possible identify a HM or washout rate cut-off with an high sensibility to select
patients for ICD . More trials have enrolled patients with heterogeneous features (pts with ischemic and idiopathic
etiology together).
Methods: Our pilot study has selected a group of 20 patients with idiopathic cardiomyopathy (EF, 35%).
Coronary disease was excluded. All have indication for ICD alone (no indication to resynchronization). We have
studied cardiac innervation after MIBG scintigraphy through the Heart/Mediastinum rate, the wash-out rate ,
evaluating a possible correlation with the left ventricular diameter.
The aim of our study is to verify if these MIBG data could be connected with arrhythmic events.
Results: Clinical and instrumental data of study group are shown in TAB
During ICD control (12 months F-U), we have observed in 3 pts : 3 VF treated with shock and 1 sustained VT .
The H/M late ratio shows lower value in pts with events.
Ventricular sizes seem to have a good correlation with the H/M rate and with arrhythmias: more the left ventricle
is dilated minor is the H/M late ratio.
Conclusions: Our experience seem to endorse the prognostic validity of this method comparable with ADMIRE
study data: H/M late ratio.1.8 identify a group of patients with a low risk of arrhythmic events. In these patients
it could be possible procrastinate ICD implant, while an H/M late,1.4 should identify a group with high arrhyth-
mic risk.
It should be required a large cohort of patients to identify a right H/M cut-off , to reduce the grey zone with a H/
M ratio between 1.4 and 1.8.
Age EF LVDD H/M late ratio
total group 65,2 29,1 65,6 1,67
arrhythmic pts 25,3 69,1 1,31 (1,2-1,4)
No arrhythmic pts 30,3 64,5 1,76 (1,43-2,1)
Efﬁcacy of primary preventive icd therapy in an unselected population of
patients with reduced left ventricular ejection fraction
R. Borgquist1, I. Litterfeldt2, J. Brandt2, C.-J. Hoijer2, F. Holmqvist2, and P.G. Platonov2
1Lund University Hospital, Department of Arrhythmias, Lund, Sweden; and 2Lund University,
Skane University Hospital, Department of Arrhythmias, Lund, Sweden
Introduction: Sudden cardiac death (SCD) primary prevention guidelines advocate ICD-
therapy in patients with reduced left ventricular ejection fraction (LVEF), but real-life data
suggest that the beneﬁt from ICD therapy may be lower than expected from controlled studies.
The aim of our study was to evaluate primary preventive ICD performance in an unselected
population of patients with congestive heart failure in regard to their risk proﬁle.
Methods: Using ICD registry data, 104 patients with reduced LVEF, who received ICD for
primary prevention of SCD during 2006-2010 in a tertiary care hospital, were identiﬁed (age
63+ 13 years, 86% men, ischemic ethiology in 65%). The patients’ records were scrutinized
for the presence of clinical risk factors (age .70 years, QRS duration . 120 ms, NYHA class
III-IV, presence of atrial ﬁbrillation (AF) or creatinine . 106 mmol/l), survival status and ICD
discharge. Mean follow-up was 38+ 11 months.
Results: In 12% no risk factors (low-risk) were identiﬁed, 58% had 1-2 risk factors (medium-
risk) and 30% had 3-5 risk factors (high-risk). Mean LVEF in the total population was
24+ 6% and did not differ between groups. Yearly mortality was 6.1%, increased proportion-
ally with risk factor group (p = 0.03), and a total of 17 patients (19%) died: 8 fromheart failure
progression, 9 from other causes, none from primary arrhythmia.
Conclusions: These data support previous work that patients with medium risk score have the
most beneﬁt for primary prophylactic ICD therapy while low-risk patients do not show measur-
able beneﬁt. Despite the similar rates of appropriate ICD therapies, all-cause mortality is twice
as high in the high-risk than in the medium-risk group.
Remote monitoring for implantable deﬁbrillators: the nation-wide
Italia-RPM survey
M. Luzi1, A. De Simone2, C. Amellone3, S. Favale4, E. Pisano5, M.G. Bongiorni6, R. Luise7,
F. Folino8, F. Accardi9, and G. Buja8, ITALIA-RPM SURVEY participants
1Riuniti Hospital, Department of Cardiology, Ancona, Italy; 2San Michele Maddaloni Clinic,
Maddaloni, Italy; 3Civic Hospital, Cirie` (Turin), Italy; 4Polyclinic of Bari - Hospital, Bari,
Italy; 5Vito Fazzi Hospital, Lecce, Italy; 6Cisanello Hospital, Pisa, Italy; 7“San Salvatore”
Hospital - ASL n 4, Department of Cardiology, L’Aquila, Italy; 8University of Padua Medical
School, Department of Medical Diagnostic Sciences and Special Therapies, Padua, Italy; and
9Boston Scientiﬁc Italy, Milano, Italy
Purpose: Remote patient management(RPM) systems permit home interrogation of implanta-
ble deﬁbrillators (ICDs),and provide an alternative option to frequent in person visits. The
Italia-RPM survey was conducted to assess the current Italian clinical practice in the use of
RPM for the follow-up of ICD patients.
Methods: An ad-hoc questionnaire focusing on RPM adoption and resource use during in-
clinic and remote follow-up sessions was completed in 201 Italian implanting centers.
Results: In the centers participating to the present survey, the mean visit time for routine in-
clinic device check is 15+ 7min,16+ 8min,20+ 9min for single-chamber, dual-chamber
and biventricular ICD, respectively. Device reprogramming is required in 10% [258-758per-
centile:7-20] of visits. Follow-up visits are performed by a cardiologist in 99% of centers and
by more than a single healthcare personnel in 89%.The frequency of routine ICD in-clinic
visits is 2/year in 78% of the responding centers, 3/year in 17% and 4/year in 5% of centers.
Sixty-seven per cent of centers are currently using RPM, scheduling remote ICD interrogations
every 3 [258-758percentile:1-3] months. After adoption of RPM, the frequency of in-clinic
visits was decreased in 71% of centers previously performing 4visits/year,63% of centers with
3visits/year and 39% of centers with 2 visits/year. Overall, the mean time between visits
increased from 5 to 8 months.
Conclusions: In the current practice of a large number of Italian implanting centers, the
follow-up of ICDs requires important resources in terms of time dedicated by healthcare per-
sonnel, in particular by cardiologists. In centers routinely performing frequent in-clinic visits,
the adoption of RPM allows to decrease the number of hospital accesses, while in all centers it
permits to reduce the interval between ICD interrogations.
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Location and degree of conductor externalization in recalled St. Jude
Medical Riata deﬁbrillator leads. Results of a nation-wide ﬂuoroscopic
screening
J.M. Larsen1, S. Riahi1, J.C. Nielsen2, R. Videbaek3, J. Haarbo4, K.M. Due5, D.A.M.J. Theuns6,
and J.B. Johansen7
1Aalborg University Hospital, Department of Cardiology, Aalborg, Denmark; 2Aarhus
University Hospital, Department of Cardiology, Aarhus, Denmark; 3Rigshospitalet -
Copenhagen University Hospital, Heart Centre, Copenhagen, Denmark; 4Gentofte Hospital -
Copenhagen University Hospital, Department of Cardiology, Gentofte, Denmark; 5Aalborg
University Hospital, Center for Cardiovascular Research, Aalborg, Denmark; 6Erasmus
Medical Center, Department of Clinical Electrophysiology, Rotterdam, Netherlands; and
7Odense University Hospital, Department of Cardiology, Odense, Denmark
Purpose: The recalled St. Jude Medical Riata deﬁbrillator leads pose a challenge to lead man-
agement as the unique insulation defects with inside-out conductor externalization most often
are electrically silent due to an intact inner insulation. The objective of the present study was to
determine the occurrence, location and degree of conductor externalization in recalled St. Jude
Medical Riata deﬁbrillator leads.
Methods: A nation-wide cohort of 298 patients with active recalled Riata leads were screened
with device interrogation and ﬂuoroscopy performed in three projections at ﬁve ICD implanting
hospitals in Denmark. The location of externalization was divided into three zones from lead
tip to can. The degree was graded into four levels: 1. localized abnormal conductor spacing
without overt externalization; 2. externalization ,1cm length; 3. externalization .1cm length
in one zone; and 4. externalization .1cm length crossing adjacent zones. Time-to-event ana-
lysis assumed interval censoring due to the common electrical silent nature of externalization.
Results: The prevalence of conductor externalization was 11% (32/298) at a mean lead dwell
time of 5.1 years. The prevalence of electrical abnormalities was 6% both in patients with and
without externalization. Two additional patients had abnormal conductor spacing without overt
externalization. No difference was seen in the estimated hazard of externalization for 7 French
vs. 8 French leads (P = .73) and single vs. dual coil leads (P = .95). The location of externaliza-
tion was more common in the most distal part of the lead below the tricuspid valve annulus in
dual coil leads (69%) vs. single coil leads (16%), P = .004. A higher degree of externalization
was associated to longer lead dwell time with Spearman’s rho = .37, P = .03.
Conclusions: The prevalence of externalization in a nationwide screening of recalled Riata
leads is at the same level as reported in previous studies. The location of externalization is dif-
ferent between single and dual coil leads. The degree of externalization is associated to lead
dwell time.
Is post-mortem evaluation of cardiac rhythm management devices useful?
P. Nolan, S. Hynes, S. Tuohy, B.D. Macneill, P.J. Nash, J. Crowley, and K. Daly
University Hospital Galway, Galway, Ireland
Introduction: The number of pacemakers and implantable cardioverter deﬁbrillators (ICD’s)
continues to rise worldwide. Recently there are increasing concerns about long term reliability
in the setting of recalls such as Sprint Fidelis and Riata. The Heart Rhythm Society recommend
explant of devices during post mortem to facilitate returned product analysis and improve moni-
toring of device performance. Overall little data exists on the rate, feasibility and information
garnered from device interrogation post mortem.
The aim of the study was to investigate whether device interrogation provided additional infor-
mation for the pathologist and whether device function was normal.
Methods: Devices were explanted from 32 consecutive post mortems, performed according to
hospital protocol, between 2008 and 2011 and were sent for interrogation to the Cardiology de-
partment. Interrogation and interpretation of the device data was performed blinded to the post-
mortem ﬁndings. Battery voltage, charge time, lead impedances, thresholds and intrinsic ampli-
tude measurements were recorded. Data related to potential arrhythmias was also recorded, as
was pacemaker dependency, deﬁned as pacing .80%. After data collation the investigators
jointly decided as to the value of the interrogation on a case by case basis.
Results: 24 pacemakers and 8 ICD’s were studied. The mean age of patients at time of death
was 75(range 31.8-95)yrs and the device had been implanted for a mean of 3.2(range 0-9.6)yrs.
No pacemakers were subject to an advisory but 3 ICDs and 1 ICD lead were. Reassuringly all
devices demonstrated normal function. Mean battery voltage was 2.75V amongst the pace-
makers and 2.92V amongst the ICD’s and lead impedances and intrinsic amplitude measure-
ments were within normal ranges for all devices.
Pacemaker interrogation demonstrated high ventricular rates in 9/24 cases with three of these
occuring on the date of death. Device data was consistent with cause or mode of death in 9
cases. It was discordant in 4 cases, 3 of these devices did not have EGM storage capability and
reported cause of death was fatal arrhythmia. In the fourth no high rates were recorded although
a VF arrest was documented in ED.
2/8 ICD interrogations were consistent with cause of death. However 3 were discordant, inter-
rogation revealing no arrhythmia despite the reported cause of death being fatal arrhythmia,
suggesting asystole or PEA as the potential fatal arrhythmia.
Conclusion: Post-mortem device interrogation is feasible and useful, providing additional in-
formation in 14/32 cases with concordance with cause or mode of death in 11/32.
Prevalence of Riata lead failure according to lead-speciﬁc relative risk
among 680 ICD carriers
K. Kouraki, M. Strauss, A. Skarlos, R. Zahn, and T. Kleemann
Clinical Center of Ludwigshafen, Medical Clinic B/Department of Cardiology, Ludwigshafen am
Rhein, Germany
Purpose: The problem of premature insulation failure of Riata ICD leads manufactured by St. Jude
Medical Inc. is well documented. According to the manufacturer, there is a lead-speciﬁc relative risk:
Riata 8F single coil leads are regarded as high risk, Riata 8F dual coil and Riata ST 7 F single coil leads
are of intermediate risk and Riata ST 7F dual coils carry the lowest risk of lead failure. Aim of this ana-
lysis was to evaluate the rate of lead failure between the different Riata lead types at our hospital.
Methods: We performed a single-center retrospective analysis of 680 Riata leads implanted between
03/2002 and 01/2009. These included 39 high risk leads (1572, 1582), 574 intermediate risk leads
(1572, 1582, 1570, 1571, 1580, 1581) and 67 low risk leads (7000, 7001, 7040). Patients with lead revi-
sion due to dislodgement or infection were excluded from the study. Lead failure was deﬁned as an insu-
lation failure or fracture requiring surgical revision.
Results: During a follow-up time of three years, 111 (16.3%) of the leads had to be replaced, 37 (5.4%)
because of pacing/sensing problems and 74 (10.9%) because of lead failure. The distribution of
replaced leads among the three risk groups is demonstrated in the table. The median time of lead re-
placement was 1056 days (IQR 628-1669) after implantation and did not statistically differ between the
three groups. Two thirds of the patients presented for routine control (3-6 months), whereas 26% pre-
sented with ICD shock, 4% with ICD alarm and 5% with other symptoms such as syncope, bradycardia
and muscle twitching. The median time of presentation for these patients was 52 days after the last
normal control and did not statistically differ between the three groups.
Conclusions: Ten percent of implanted Riata leads had to be replaced due to lead failure after a median
time of 1056 days after ﬁrst implantation One fourth of these patients presented with an inadaquate
schock. Rate of lead failure did not differ between the various Riata groups.
High risk
n = 39
Intermediate risk
n = 574
Low risk
n = 67
Cohort
n = 680
Sensing/pacing problem 3 (8%) 31 (5%) 3 (4%) 37 (5.4%)
Insulation failure or fracture 2 (5%) 67 (12%) 5 (7%) 74 (10.9%)
Days since last normal control 76 49 30 52
Days since implantation 986 1040 1326 1056
Single centre experience on multi-brand implantable cardioverter-
deﬁbrillator (ICD) replacements, what is their real longevity?
R. Salgado Aranda, E. Mejia Martinez, A. Fontenla Cerezuela, M. Lopez Gil, R. Salguero Bodes,
S. Mayordomo Gomez, J. Molina Martin De Nicolas, B. Diaz Anton, B. Rubio Alonso, and F. Arribas
Ynsaurriaga
University Hospital 12 de Octubre, Department of Cardiology, Madrid, Spain
Introduction and objective: Increase in life expectancy of patients with ICD bolds the relevance of
choosing ICD with the longest service life. The aim of this study is to assess the average life of different
marketed ICD implanted in a single center.
Methods: ICD implanted from January of 1995 to December of 2012 were analyzed. Replacement due
to battery depletion was the marker for ICD longevity. Different ICD were analyzed separately: single
(V) or dual chamber (D) ICD versus CRT-D; V-ICD and D-ICD were classiﬁed together due to the low
number of D-ICD in our series and the high percentage of D-ICD programmed as V-ICD. Analysis was
also done for companies (Boston Scientiﬁc/Guidant, Medtronic and St Jude Medical) and for "old" and
"new" ICD (taking 2004 as cut off). Longevity was calculated as the time from ICD implantation to the
time of replacement. ANOVA and T-Student analysis were performed taking p value ,0,05 as statistic-
ally signiﬁcant.
Results: During the study period 192 replacements were analyzed out of 861 implanted ICD in 656
patients (1.3 devices/patient) Age at implant 56.8+ 15.6 years, male 85.3%. 20.2% CRT-D. Table
As it is shown in the table Medtronic ICD longevity was better than that of Boston ICD (p = 0,015).
St Jude Medical ICD did not show signiﬁcant difference, probably due to small number of replacements.
(p = 0,093).
Longevity of ICD implanted before 2004 was not different than that of ICD implanted after 2004
(6,64+ 1,71 vs 5,42+ 1,65 years, p = 0,66)
Conclusions:Medtronic ICD longevity was superior to Boston Scientiﬁc ICD in our series. The longev-
ity of ICD implanted after 2004, is not better than that of the older ICD, with trend to a shorter service
life. The implementation of new diagnostic features may limit the enhancement in longevity. As a limi-
tation, some ICD with long service life have not been already replaced and thus were not include in the
analysis. This might inﬂuence on the results
ICD CRT-D
N Longevity (years) N Longevity (years)
Boston Scientiﬁc/Guidant 105 6,10+ 1,72 15 4,52+ 0,96
Medtronic 51 6,97+ 1,59 1 4,17
St. Jude 15 5,86+ 2,14 5 4,62+ 1,25
Total 171 6,34+ 1,76 21 4,52+ 0,98
Results are expressed as mean+ standard deviation
P247 P248
P249 P250
ii29
Implantable cardioverter deﬁbrillator oversensing in the operating room
P.M. Dejong, A.M. Baranchuk, K.A. Michael, D.P. Redfearn, H. Abdollah, and C.S. Simpson
Queen’s University, Kingston General Hospital, Kingston, Canada
Purpose: Oversensing of extraneous electrical signals by implantable cardioverter deﬁbrilla-
tors (ICDs) may occur in the operating room. This can potentially lead to inappropriate delivery
of anti-tachycardia therapies. The purpose of this study was to examine the incidence of intra-
operative ICD oversensing in a diverse range of surgical procedures.
Methods: From December 1, 2010 to August 1, 2012, all patients with an ICD who required
surgery were identiﬁed. Surgical procedures below the hips, pacemaker dependent patients, or
surgical procedures after 1700h or on weekends were excluded. Pre-operatively, anti-tachycar-
dia therapies were programmed off, but sensing remained enabled as per the patients’ usual set-
tings. Post-operatively, the device was interrogated and anti-tachycardia therapies were re-
enabled. Two patients underwent cardiac surgery urgently; these devices were not repro-
grammed pre-operatively but were interrogated post-operatively.
Results: Thirteen patients were included. Surgical procedures included: craniotomy, cholecyst-
ectomy, exploratory laparotomy, lumbar laminectomy (2), transurethral resection of the pros-
tate, transurethral resection of a bladder tumour, open reduction and internal ﬁxation of a distal
radius, wide local excision with graft, and coronary artery bypass grafting (4). In the nine
patients undergoing non-cardiac surgery, no events were detected. There were 11 intra-opera-
tive events detected among three of the patients undergoing cardiac surgery. One episode con-
sisted of sustained electrical noise which was classiﬁed by the device as ventricular ﬁbrillation.
This episode was of sufﬁcient duration that it would have been treated with a shock had device
therapies been enabled. Nine additional episodes of noise were detected and classiﬁed by the
devices as non-sustained ventricular tachycardia (VT). No therapies would have been delivered.
The ﬁnal episode was true non-sustained VT. The fourth patient undergoing cardiac surgery
had 3 short V-V intervals detected during surgery.
Conclusions: Among patients undergoing a diverse range of surgical procedures, patients
undergoing cardiac surgery appear to be at high risk of oversensing which could lead to in-
appropriate device therapy. Non-cardiac surgery appears to pose a lower risk.
Impact of body mass index on the development of pocket hematoma
JP. Guo, and WYT. Wang
China PLA General Hospital, Department of Cardiology, Beijing, China, People’s Republic of
Aims: The aim of this study was to evaluate the impact of Body mass index (BMI) on the de-
velopment of pocket hematoma related to Cardiovascular implantable Electronic Device
(CIED) implantations.
Methods and results:We conducted a retrospective review of 672 patients receiving implanta-
tions with CIED between 2008 and 2011 in a tertiary hospital. The patients with pocket hema-
toma were analyzed to determine the possible predictors of hematoma. Two percent of the
population (n = 12) developed severe pocket hematoma. Eighty-three percent of hematoma (n =
10) developed within the ﬁrst week after the procedure. The mean BMI of the patients with
pocket hematoma was 22.8+ 3.8 kg/m2. The hematoma rate (6%, n = 6) of patients with BMI
,22 kg/m2 was signiﬁcantly higher compared to that of the patients with BMI 322 kg/m2
(1.06%, n ¼ 6). Pocket hematoma was treated with aggressive external compression and needle
drainage. With this approach, pocket evacuation was only performed in 1 case. In multivariate
regression analysis, BMI ,22 kg/m2, dual antiplatelet therapy, complex device, and renal in-
sufﬁciency (,60 ml/min/1.73 m2) were found to be independent predictors of severe pocket
hematoma. An decrease of 1 unit in BMI was associated with a roughly sevenfold increase in
hematoma formation (OR 7.33, 95% CI 1.79 to 30.08, p = 0.006).
Conclusion: In conclusion, BMI,22 kg/m2 was associated with a higher incidence of pocket
hematoma. The data supports that effort should be made on careful hemastasis and aggressive
external compression of the wound in patients with BMI,22 kg/m2.
Transvenous Lead Extraction in Octagenarians
EV. Dovellini1, A. Michelucci2, L. Giurlani1, G. Cerisano1, R. Valenti1, M. Trapani1,
and D. Antoniucci1
1Careggi University Hospital, Department of Cardiology, Invasive Cardiology 1, Florence,
Italy; and 2Careggi University Hospital, Department of Cardiology, General Cardiology I,
Florence, Italy
Background: As the population ages, the number of elderly patients with cardiac implantable
electronic devices is expected to increase as well as the number of patients referred for
Transvenous Lead Extraction (TLE). This population, according to recent studies, are affected
from multiple comorbidities, and therefore TLE may be at higher risk.
Purpose: Evaluate the safety and efﬁcacy of transvenous lead extraction in octogenarians.
Methods and results: Between 2003 and 2012, we performed 283 TLE procedures in patients
because of device infection or malfunction with removal of 591 leads: 83 procedures were per-
formed in elderly subjects (29.3%) with age  80 years (mean age 84 years, range 80-94, 78
males %); 200 procedures were performed in younger subjects (mean age 68 years, range 25-
79, 80% males). Device infection was the main indication to TLE, being present in 240 (85%)
cases. Compared to younger patients, unexpectedly, octogenarians presented a lower rate of co-
morbidities such as diabetes (11% vs 22%, P = 0.039), ischemic heart disease (29% vs 44%,
P = 0.019), and higher values of left ventricular ejection fraction (47% vs 36%, P ,0.001).
Octogenarians had higher prevalence of COPD. No signiﬁcant differences between the two groups
were found with regard to hypertension and renal failure. The average lead time from implant to
extraction was signiﬁcantly longer in the octogenarians compared to younger group (median 83
months vs 63 months; P = 0.024). Exclusively adopting mechanical technique, were extracted 171
leads in the octogenarians and 420 leads in the younger group. No deaths occurred in the octogen-
arians group, 1 death occurred among younger subjects. Major complications occurred in 1 patient
(1.2%) among the octogenarians and in 2 patients (1%) in the yonger group; minor complications
occurred rispectively in 13 and in 16 patients (15.6% vs. 7.5%; P = 0.05). Complete procedural
success was achieved in 93% (77/83) of octogenarians and in 94.5% (189/200) in the younger
subjects. Clinical success (following the latest Heart Rhythm Society consensus document on
TLE) was achieved in 100% among octogenarians and in 98.5% in the younger subjects.
Conclusions: Transvenous lead extraction can be performed with safety and efﬁcacy in octogenar-
ians. Procedural and clinical success are equally high in octogenarians and younger subjects. There
are no signiﬁcant differences between the two age groups regard the rate of complications. Minor
complications tend to be more frequent in octogenarians.
Frequency of thrombotic vessel obstruction after pacemaker- or
ICD -implantation
H. Bogossian1, I. Ninios1, F. Hasan1, D. Mijic1, Z. Karosiene1, B. Lemke1, M. Zarse2,
and A. Kloppe3
1Ma¨rkische Kliniken GmbH, Klinikum Lu¨denscheid, Luedenscheid, Germany; 2University of
Witten/Herdecke, Witten, Germany; and 3BG University Hospital Bergmannsheil, Department
of Cardiology, Bochum, Germany
Introduction: Thrombotic vessel alterations(VA) are usually clinically asymptomatic. Within
revisions, replacement and system-upgrade pose an operative challenge. Target of the assay
was to detect the frequency of VA and to deﬁne possible predictors in an unselected consecutive
collective.
Methods: 53 patients(P) with severe heart failure were tested using phlebography. The average
examination period was 4+ 0,7years after the initial operation. The mean EF was 26%+ 7%.
28 P with VVI-ICD were upgraded to DDD- respectively BIV-ICD, 9 P with DDD-ICD were
upgraded to BIV-ICD and 2 P with BIV-ICD were treated due to lead revision. 1 P with VVI-
PM was upgraded to DDD-PM, 12 P with DDD-PM on DDD-ICD or BIV-ICD and 1 P with
BIV-PM was upgraded to BIV-ICD. The angiographic evaluation was categorized into four
groups: I = no vein obstruction(VO), II = VO ,50%, III = VO .50%, IV = vessel occlusion.
Regarding the predisposing factors, the association to the number of leads, the patients age and
sex, the anticoagulating drugs, and the cardiovascular risk (CVR) were analysed.
Results: 22% of the P (12 out of 53) showed thrombotic VO. The frequency appeared depend-
ing on the number of leads: In P with VVI-ICD 10% (3 out of 29) show VO (group II). In P
with DDD-ICD or DDD-PM, 33% (3 out of 9, respectively 4 out of 12) showed VO (2 P in
group II, 4 P in group III, and 1 P in group IV). In P with BIV ICD, 66% (2 out of 3) showed
VO (1 P in group III and 1 P in group IV). The P with BIV-PM didn’t present any alterations. P
of old age showed an increased incidence of VO (average age: 67y in P without VO versus 76y
in P with VO). Regarding the sex, there was no relevant discrepancy (2 out of 10 women = 20 %,
10 out of 43 men = 23 %).The anticoagulation treatment with acetylsalicylic acid (ASA) or
Phenprocoumon didn’t inﬂuence the frequency of thrombotic VA.Concerning the CVR, only the
overweight factor showed a relevant higher frequency.
Conclusions: In 22 % of the P, who need a second operation after ﬁrst-time PM or ICD
Implantation, thrombotic VAmay occur. At the same time, an incremental number of leads is asso-
ciated with a higher risk for VA. Anti-coagulating drugs do not decrease the occurrence of VO.
P251 Pacing P252
P253 P254
ii30
Safety and efﬁcacy of dabigatran therapy in patients undergoing cardiac
rhythm devices interventions
J. Kosiuk, S. Nedios, A. Darma, E. Koutalas, M. Doering, S. Richter, G. Hindricks,
and A. Bollmann
Heart Centre, Department of Electrophysiology, Leipzig, Germany
Background: Safety and efﬁcacy of new oral anticoagulation in patients undergoing pace-
maker (PM) or implantable cardioverter-deﬁbrillator (ICD) interventions have not been yet
studied.
Here, we present early experience of a high-volume centre with dabigatran in patients with
atrial ﬁbrillation undergoing cardiac rhythm devices interventions.
Methods: In 76 consecutive patients (mean age 71+ 11 years, 68% male, mean CHA2DS2-
Vasc score 3.9+ 1.5) undergoing cardiac rhythm devices interventions the perioperative com-
plications and thromboembolic events were analysed. The patients were treated with 150mg or
110mg dabigatran twice-daily according to creatinine clearance. The anticoagulation was dis-
continued 12h before and initialised within 48h after the procedure. All procedure related com-
plications and thromboembolic events occurring within 30 days were reported.
Results: 28 (37%) ICD and 48 (63%) PM procedures including 58 (76%) de novo implanta-
tions, 9 (12%) generator changes and 9 (12%) systems upgrades were analysed. The mean pro-
cedural time was 61+ 32 min. Most of the patients received dual (36 patients, 37%) as
opposed to single chamber systems (23 patients, 30%) and cardiac resynchronization devices
(17 patients, 22%). There were two pocket hematomas (3%) and one pneumothorax (1%). No
thromboembolic events were noted. The median time to discharge was 2 days [IQR 1-3 day].
Conclusion: The bleeding complications following cardiac rhythm devices interventions under
dabigatran therapy are rare. Periinterventional interruption of anticoagulation was not asso-
ciated with thromboembolic events.
Use of Transesophageal Echocardiogram in patients undergoing laser lead
extraction
Y. Okamoto1, C. Balabanoff2, and R. Carrillo2
1Kurashiki Central Hospital, Okayama, Japan; and 2University of Miami, Leonard M. Miller
School of Medicine, Miami, United States of America
Introduction: The number of patients undergoing lead extraction is increasing over the last
decade. Echocardiograms are helpful during the procedure. Use of Transesophageal
Echocardiogram (TEE) has been documented in small reports. There are no large reports in the
use of peri-procedure TEE
Methods: From a prospective registry at a tertiary referral center from January 2004 to October
2012, 641 patients were studied. All the patients underwent laser lead extraction. All the
patients had TEE during the procedure. Clinical outcomes were analyzed. Tricuspid valve func-
tion was evaluated before and after the extraction of the leads.
Result: From 641 patients Male was 478(75%), and Female was 163(25%, Age 68+ 15 years,
EF 36+ 15, NYHA 2.5+ 1.0, BMI 27.2+ 6.6. Signiﬁcant comorbidities were CAD 57%,
DM 40%, and Hemodialysis 10.2%. Devices extracted were PM 36.8%, ICD 40.6%, CRT
22.6%. Indication for LLE were infection 65.3%, malfunction 30.6%. An average of 2.0+ 1.0
leads were extracted per patient, totaling 1305 leads (PM lead 67.2%, ICD lead 31.9%).
Procedural success rate was 99.9%. There were 46 laser related adverse events (major 14,
minor 33, including 2 deaths). TEE ﬁndings helped reveal the presence of: cardiac vegetations
in 210 patients, vascular avulsion or tears in 3 patients, cardiac avulsions or tears in 10 patients;
pericardial effusion not requiring intervention in 1 patient. Ten patients (1.6%) had large peri-
cardial effusions before starting the procedure. The degree of tricuspid valve insufﬁciency
became less in 96 patients (15.0%) and worsens in none.
Conclusion: TEE was helpful to evaluate tricuspid valve function and to diagnose pericardial
effusions and intra-cardiac thrombus or vegetations
Pocket infections treated by negative pressure wound therapy
T. Mcgarry, R. Joshi, H. Kawata, J. Patel, G. Feld, U. Birgersdotter-Green, and V. Pretorius
University of California, San Diego, Department of Cardiology, San Diego, United States of
America
Purpose: Cardiac implantable electronic device (CIED) infections are increasingly common as
the number of device implants increases. Management of CIED infection is frequently challen-
ging and requires prolonged hospitalization. Traditionally, after CIED removal and debride-
ment of an infected pocket, the wound can either be treated with a drain or allowed to heal by
delayed primary closure. Negative pressure wound therapy (NPWT) has been used to promote
the healing of a wide variety of surgical wounds, but has not been reported in the treatment
CIED infections. Here we describe the ﬁrst series of patients in which NPWT was successfully
used to treat CIED pocket infections.
Methods and results: Infected CIEDs and leads were extracted in 23 patients with pocket
infections. After debridement, the wound was packed with a GranuFoamTM sponge and a
drainage tube was inserted under an occlusive dressing. The tube was connected to a Wound-
VacTM (WV) device and negative pressure of 125 mm Hg continuously applied. The WV was
left in place for a median of 5 days (range 2-15 days), and drained an average of 220 ml sero-
sanguineous ﬂuid (range 35-600 ml). After removal of the WV, the pocket was closed loosely
with 1-0 prolene mattress sutures and allowed to heal by delayed primary closure. All infected
pockets healed without complications and without evidence of recurrent infection over a
median follow-up of 43 days (range 10 – 370 days). The median length of stay after CIED ex-
traction was 9 days (range 2-26 days). Re-implantation of a CIED in the contralateral hemi-
thorax was performed a median of 15 days after extraction (range 3 – 55 days). One patient
developed recurrent infection when a new device was implanted at the same site 2 weeks after
extraction. A second patient who continued to abuse IV drugs developed re-infection of the
new CIED leads four months after initial extraction.
Conclusions: This is the ﬁrst report of the use of negative pressure wound therapy (NPWT) in
the treatment of CIED pocket infections. We found that NPWT was a safe and effective means
to promote healing of infected pockets with a low incidence of recurrent infection.
Inﬂuence of remote monitoring systems on prognosis in an unselected
population of ICD recipients
J. Fernandez-Pastor, JL. Pena- Hernandez, FJ. Alzueta- Rodriguez, C. Medina-Palomo,
A. Linde- Estrella, A. Barrera-Cordero, and E. De Teresa-Galvan
University Hospital de Malaga, Malaga, Spain
Purpose: Remote cardiac monitoring (RCM) is a new and emerging tool that supports in the
aftercare follow-up of ICD- implanted patients, although there is still limited evidence on direct
patient beneﬁts.
Methods:We conducted a retrospective study of ICD carriers implanted at our institution since
2004 by collecting clinical data and their outcome. Those who have adequate support were
trained in the use of telemonitoring devices since these became available.
Results: Atotal of 696 ICD patients (age: 61+ 13 years, 18% female, baseline EF: 31%, 69%
in primary prevention; 25% CRT- D, 59% ischemic, 24% NYHA III-IV) were included. 45%
of them were followed by a RCM system at home. After a mean follow-up of 33+ 28 months,
patients with RCM systems suffered less MACE (death, heart transplantation or heart failure
hospitalizations; 27% vs 7.5%, p ,0.001). Remote monitoring was identiﬁed as an independ-
ent factor of better clinical outcome (OR: 0.19, 95% CI 0.13 to 0.24; p, 0,001).
Conclusions: Cardiac remote monitoring systems seem to improve the prognosis in implanta-
ble cardioverter deﬁbrillator- implanted patients.
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Mid-long term follow-up of patients submitted to Percutaneous Lead
Extraction (PLE): a single centre experience
G. Mascioli, B. Nikoloz, E. Lucca, C. Belvito, F. Canevese, and F. Michelotti
Cliniche Humanitas Gavazzeni, Bergamo, Italy
New guidelines have widened the indication to PLE. As a result, the number of patients (pts)
who undergo this procedure is continuously growing. Recently some studies have reported the
long - term survival of pts submitted to PLE, especially in pts who underwent PLE for infection
of the pacing/ICD system.
Aim of our study was to verify is there is a difference in survival between pts who undergo PLE
for infection or for other reasons (malfunctioning/venous occlusion).
Since January 2010 to December 2012, 90 pts underwent PLE at our Centre (65 male, 72.2%;
mean age 66+ 14 yrs, range 25 - 87). 61 pts (67.8%) underwent PLE for infection, 29 for "non
infective" reasons (31.2%; 27 malfunctioning leads). PLE was attempted in 190 leads and was
successful in 173 leads (91%; 168 complete success, 5 clinical success); 16 leads were sent to
the surgeon and 1 malfunctioning lead was abandoned (failure 9%). No major complications
were observed; 2 pts (2.2%) had minor complications (1 artero-venous femoral ﬁstula; 1 partial
tricuspidal valve leaﬂet avulsion).
Survival rate at 1 and 2 years respectively was 96% and 94%, but with a signiﬁcant difference
amongst the two groups: "infective" pts had survival rate of 94.5% and 85.8% at 1 and years
whilst all "non infective" pts were alive at two years (p = .02).
Furthermore, amongst infective pts we observed a statistically signiﬁcant difference in pts with
and without vegetations over the lead or the valve. Survival rates at 1 and 2 years respectively
were 94.1% and 90.4% in pts without vegetations and 71.3% and 46.8% in pts with vegetations.
Presence of vegetations remained the only variable related to worst outcome even in a multi-
variate analysis.
Pts with vegetation were older in comparison to those without vegetations (69 + 10 yrs vs
65+ 15 yrs, p = 0.05) and they had a longer implant time (60+ 16 vs+ 36+ 18 months).
Our data, even if derived from a small number of pts, demonstrate that PLE is an effective and
safe procedure. PLE allows a signiﬁcant improvement of survival in infective pts, provided that
it is performed before the appearance of systemic signs of infection (mainly vegetations).
Impact of the Advisa MRI SureScan pacing system on the diagnostic quality
of cardiac magnetic resonance images and contraction patterns of cardiac
muscle tissue during scans
J. Schwitter1, M. Kanal2, M. Schmitt3, F. Anselme4, T.A. Albert5, D.L. Hayes6, D.B. Bello7,
A. Toth8, Y. Chang9, and T. Sommer10, Prof. Schwitter
1University Hospital Lausanne, Lausanne, Switzerland; 2University of Pittsburgh Medical
Center, Pittsburgh, United States of America; 3Wythenshawe Hospital, Manchester, United
Kingdom; 4University Hospital of Rouen - Hospital Charles Nicolle, Rouen, France; 5Salinas
Valley Memorial Hospital, Salinas, United States of America; 6Mayo Clinic, Division of
Cardiovascular Surgery, Rochester MN, United States of America; 7Mid Florida Cardiology,
Orlando, United States of America; 8Semmelweis University, Heart Center, Budapest,
Hungary;
9
Medtronic Inc., Mounds View, United States of America; and
10
German Red Cross
Hospital, Neuwied, Germany
Background: The Advisa MRI SureScan Pacing System is an MR conditional pacing system
designed to safely undergo magnetic resonance image (MRI) scans. Its inﬂuence on image
quality, particularly of cardiac MR (CMR) acquisitions, is not well known. The Advisa MRI
Study evaluated the CMR image quality and characterized the myocardial contraction patterns.
Methods: In this international trial with 35 participating centers, 269 patients were enrolled
and an Advisa MRI System was implanted in 263 patients. Of those, 177 were randomized to
the MRI group and 150 underwent MRI scans at the 9-12 week visit. Left ventricular (LV) and
right ventricular (RV) cine long-axis steady-state free precession (SSFP) MR images were
graded for quality. Signal loss along the implantable pulse generator and leads was also mea-
sured. The tagging CMR data quality was assessed as the percentage of trackable tagging
points on CSPAMM (complementary spatial modulation of magnetization) acquisitions (n =
16) and segmental circumferential ﬁber shortening was quantiﬁed.
Results: Of all cine long-axis SSFP acquisitions, 95% of the LV and 98% of the RV acquisi-
tions were of diagnostic quality, with 84% and 93% respectively being of good or excellent
quality. Tagging points were trackable from systole into early diastole (360-648 ms after the R
wave) in all segments. During RV pacing, tagging demonstrated a dyssynchronous contraction
pattern, which was not observed in non-paced (n = 4) and
right atrial-paced (n = 8) patients.
Conclusions: In the Advisa MRI Study, high quality CMR images for the assessment of
cardiac anatomy and function were obtained in patients with an implantable pacing system. In
addition, this study demonstrated the feasibility of acquiring tagging data to study the LV func-
tion during pacing.
Transvenous removal of icd leads: riata vs sprint ﬁdelis
L. Segreti, G. Zucchelli, E. Soldati, A. Di Cori, R. De Lucia, S. Viani, L. Paperini, A. Boem,
D. Levorato, and M.G. Bongiorni
University Hospital of Pisa, Cardiology Operative Unit 2, Pisa, Italy
Introduction: Sprint Fidelis (S) and Riata (R) ICD leads were recalled by the Food and Drug
Administration because of an increased rate of failure due to conductor fracture (S) or insulation
abrasion (R). Treatment options include intensifying monitoring and intervening replacing
recalled lead, with or without extraction. However, because of its mechanical separation, R
leads may be challenging to extract. Aim of this study is a comparison between S and R lead ex-
traction.
Methods: since January 1997 to June 2012, we managed 513 consecutive patients with 545
ventricular ICD leads; among these, 45 were S and 94 R. There were no signiﬁcative difference
in patients and lead characteristics in the two groups. Indications to removal were infective in
the majority of cases (73%). Mean pacing period was 39.1þ -22.1 months in S group and
36.1þ -23.4 months in R group. 91% of ICD leads in both groups were dual coil. In case of
manual traction failure, we performed mechanical dilatation using a single polypropylene
sheath technique (Cook Vascular - Leechburg PA, USA) and if necessary, other intravascular
tools (Catchers and Lassos, Osypka, Grentzig-Whylen, G); an Approach through the Internal
Jugular Vein (JA) was performed in case of failure of the standard approach.
Results: Success rate was achieved in all 45 (100%) S leads and in 93/94 (98.9%) R leads. No
major complications occurred. Manual traction effectiveness was higher in S leads (9 vs 2%)
while JA was required more frequently in R leads (8 vs 2%) (p , 0.01). Extraction time and
mean sheath size used were signiﬁcantly higher in R group. Comparing binding sites locations,
R leads exhibited higher incidence in superior vena cava, right atrium and tricuspid valve as
compared to S leads (p , 0.01). In R group presence of cable externalization was a predictor of
difﬁcult procedure and need for JA.
Conclusions: our experience shows that the extraction of recalled S and R ICD leads is feasible
and effective. However, extraction of R leads is more complex than F leads. Lack of coil back-
ﬁlling and cable externalization in R group may account for these differences. The decision to
extract or not to extract R leads should be individualized.
A comparison between lead extraction results using 80 Hz and 40 Hz
laser-powered sheaths
L. Bontempi1, M. Elmaghawry2, M. Cerini1, A. Lipari1, C. Pagnoni1, F. Vassanelli1, A. Raweh3,
E. Locantore1, F. Salghetti1, and A. Curnis1
1University of Brescia, Electrophysiology department, Brescia, Italy; 2Aswan Heart Centre,
Aswan, Egypt; and 3IRCCS San Donato Hospital, Milano, Italy
Background: Lead extraction is a technically demanding and potentially hazardous procedure.
Eighty Hertz (Hz) laser-powered sheath is new technology that facilitates lead extraction.
Comparative studies are needed to evaluate the efﬁcacy and safety of 80 Hz laser-powered lead
extraction sheath.
Methods: We compared the results of lead extraction using 80 Hz laser-powered sheaths done
during the period from 1st of January 2012 to 31st of December 2012 (Group A: number = 75;
age = 67.1 years + 13.4; female = 17.7%; leads number = 114; leads age = 103.3+ 67.2
months) with those done using 40Hz laser-powered sheath during the period from 1st of
January 2011 to 31st of December 2012 (Group B; number = 59, age = 71.4+ 11.5 years;
female = 27.1%; leads number = 91, lead age = 93.2+ 60.6 months) Efﬁcacy endpoints were
complete and partial success rates and laser irrigation time. Safety endpoints were procedure-
related complications and mortality.
Results: Complete and partial success rates were 96% and1.3% in group A vs. 98.3% and
1.6% in group B; (p = 0.63 and p = 1), respectively. Failure rate was 2.6% in group A (n = 2)
vs. zero% in group B (p = 0.508). Mean laser irrigation time was 29.84+ 38.19 in group A vs.
26.39+ 26.64 seconds in group B (p = 0.466). Complication rate was 2.6% in group A vs.
zero% in group B (p = 0.508). No procedure-related mortalities occurred in both groups.
Conclusion: There were no signiﬁcant diferrences between 80 Hz and 40 Hz laser-powered
sheaths concerning efﬁcacy and safety. In the preliminary data analysis, the number of laser de-
liveries seems lower in the 80 Hz group.
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Evaluation of same-day home discharge after cardiac pacing devices
implantation
J. Fernandez-Pastor, J. Rodriguez-Capitan, J.L. Pena- Hernandez, I. Fernandez-Perez,
C. Medina-Palomo, A. Linde- Estrella, A. Barrera-Cordero, FJ. Alzueta- Rodriguez, and E. De
Teresa-Galvan
University Hospital de Malaga, Malaga, Spain
Purpose: Due to the increase of the established indications in the clinical guidelines the
number of implanted cardiac pacing devices is growing, with the costs this entails.Our aim is to
assess the safety and feasibility of a program of early discharge after a device implantation.
Methods: A retrospective study of consecutive patients who underwent an elective implant-
ation of a pacing device between August 2011 and March 2012 was performed. We compared
the outcome of those who followed the conventional strategy (24h hospitalization) versus those
with early discharge (4- 6 h after uncomplicated procedure) when this became available.
Results: A total of 168 patients were included (65,8 + 15,3 years, 35,7% females). The per-
centaje of VVI pacemakers was 21,4% , DDD were 30.4%, and 3% of CRT-P. The rest were
ICD devices (14.2% CRT-D, 28% monocameral ICD and 3% bicameral ICD). 57,7% of
patients were managed by early discharge strategy. After a mean follow-up of 2.7+ 0.8
months, the following complications were registered: pneumothorax (0.6%), heart failure de-
compensation (0.6%), contrast nephropathy (0.6%), pocket infection (0.6%) and electrode dis-
location (4.2%). There were no signiﬁcant differences in the occurrence of complications
between both groups (conventional Vs early discharge) (7% vs. 6.2%, P 0.82)
Conclusions: The incidence of complications after implantation of cardiac pacing devices in
our series was low. These data also suggest that same-day discharge after an uncomplicated pro-
cedure is safe and may be applicable in clinical practice.
Extrathoracic subclavian vein puntcure without contrast venography for
pacemaker and deﬁbrillator leads implantation
D. Antonelli, A. Feldman, A.N. Freedberg, and Y. Turgeman
Ha Emek Medical Center, Afula, Israel
Purpose: Extrathoracic Subclavian Vein Puncture has been demonstrated to be an effective
method for pacemaker and deﬁbrillator leads implantation, without the complications encoun-
tered with the standard intrathoracic approach.
Different techniques have been adopted for the cannulation of the extrathoracic subclavian
vein. We report our experience using as ﬂuoroscopic land mark the outer edge of the 1st rib
below the inferior border of the clavicle.
Method: A subcutaneous pocket is created 1 cm medially and parallel to the delto-pectoral
groove and 2 cm below the clavicle. A 18 gauge needle from the upper border of the pocket is
directed perpendicularly to the outer edge of the 1st rib just below the inferior border of the
clavicle. If the vein is not entered the needle is withdrawn and the puncture is repeated with
slight variation of needle direction for a maximum of 4-5 times, then contrast guided vein punc-
ture is performed. Upon successful vein puncture a guide wire is inserted and positioned in the
superior vena cava. The remainder of the implantation is carried out in a routine manner.
Resuts: The extrathoracic subclavian vein was successfully cannulated in 172 of 182 consecu-
tive patients (94.5%); the vein could not be found in 10 patients (5.5%): in these patients the
vein was successfully cannulated after venography performance. No pneumothorax, hemothor-
acs or brachial plexus injury occurred.
Conclusions: Our approach of extrathoracic subclavian venipunture using ﬂuoroscopic land-
mark, without contrast venography, is simple, safe and effective.
Follow up of phrenic nerve stimulation measurements in quadripolar left
ventricular lead implanted patients
J. Alzueta Rodriguez1, F. Cabrera Bueno1, J. Olague Ros2, I. Fernandez-Lozano3, JJ. Garcia Guerrero4,
J. Fernandez De La Concha4, A. Hernandez Madrid5, and JM. Tolosana Viu6, QUARTO TEAM
1
Hospital Universitario Virgen de la Victoria, Malaga, Spain;
2
Hospital Universitario La Fe, Valencia, Spain;
3
Hospital Clinico Universitario Puerta de Hierro, Madrid, Spain;
4
Hospital Infanta Cristina, Badajoz, Spain;
5Hospital Universitario Ramon y Cajal, Madrid, Spain; and 6Hospital Universitario Clinic y Provincial,
Barcelona, Spain
Purpose: The aim of this analysis is to describe the evolution of Phrenic Nerve Stimulation (PNS) threshold per-
formance of the quadripolar LV lead over 6 months of follow up, and to assess the ability of this lead to resolve
PNS-related lead repositioning or re-intervention.
Methods: HF patients in sinus rhythm underwent CRT-D device implantation with the quadripolar LV lead at 6
investigational sites. Data were collected within 7 days of implant and at 6 month post-implant. PNS thresholds
were assessed during Bi-V pacing from all 10 LV pacing vectors: 3 traditional conﬁgurations (Tip-Ring; Tip-
RVC; Ring-RVC) and 7 non-traditional vectors unique to this quadripolar lead. PNS was considered present when
the PNS threshold was, 7.5V.
Results: 51 patients (66.5 years, 71% male, 61% NYHA III, mean EF of 25.3%, and baseline QRS of 169ms)
were included in the study. 49 of these patients were followed for 6 months and are included in this analysis.
See table 1. Non Traditional pacing vectors exhibited a lower rate of PNS than Traditional vectors, both at enroll-
ment (p = 0.001) and after 6 months (p = 0.0045). In addition, the incidence of PNS remained stable over time
both in traditional and non-traditional vectors.
At 6 months, 7/51 patients (14%) exhibited PNS in all traditional vectors. 5 of these 7 patients could be paced
with a non-traditional vector free of PNS. In these 5 cases, the quadripolar lead provided a mean of 4.8 PNS-free
alternative vectors per patient, and a mean of 2.8 PNS-free alternative vectors with a capture threshold,3V.
Conclusion: The incidence of PNS elicited by LV pacing vectors unique to the quadripolar LV lead was lower
than that with Traditional bipolar-lead-based vectors. These results were stable over a 6 month follow up period.
The availability of a broader range of pacing vectors available in this quadripolar LV lead may avoid re-interven-
tions due to PNS.
Enrollment 6 Month FU
Number of
vectors tested
Vectors with
PNS
Number of
vectors tested
Vectors with
PNS
Traditional vectors 153 51 33% *1 147 49 33% *2
Non Traditional vectors 357 68 19% *1 343 69 20% *2
Total 510 119 23% 490 118 24%
Table 1. Distribution of PNS over LV pacing vectors.*1 : p = 0.001 ; *2 : p = 0.0045.
Deterioration of left ventricular (LV) systolic function in patients (PTS)
treated with antibradycardic pacemakers (PM) and rightventricular (RV)
stimulation: is it a clinically relevant problem?
M. Ebert, T. Blum, C. Maring, C. Restle, J. Stockinger, T. Arentz, and D. Kalusche
University Heart Center, Dept. of Cardiology, Freiburg - Bad Krozingen, Germany
Purpose: RV pacing may lead to asynchronous contraction, systolic dysfunction, and heart
failure. Not much is known about the incidence in PTS treated with PM for standard anti-brady-
cardic indications.
Methods: Echocardiographic evaluation (ECHO) of a large cohort of PTS with standard PM
indications at the time of PM implantation and after a follow-up (FU) period of. 2 months.
Results: From 2005-2009 1759 PTS were treated with a PM for symptomatic bradycardia at
our institution. PTS with primary CRT- and/or ICD-indications were excluded. 1214/1759
PTS (53% male, mean age 74 yrs; a-v-block 51%, group A; sinus node disease 40 %, group B)
had an ECHO at the time of implantation and after a mean FU of 3,3 yrs (0.3-7,9yrs). Of 838
PTS with a normal systolic LV function (EF . 55%) at implant 84% still had a preserved LV-
function at last FU. Only 37 PTS (4,4%) had an EF ,46% (mean 38%), while 11,6% had a
small reduction of EF to mean 48%. 25/1214 PTS (2.1%) developed severe heart failure
(NYHA 3) and were upgraded to biventricular pacing, the incidence was 1,1% (9/838) in
PTS with an initial EF .55%. The overall risk for adverse remodeling was signiﬁcantly higher
in group A (6,1% vs. 2,3% in group B).
Conclusions: In an "everyday-PM-population" the development of severe systolic dysfunction
is a relatively rare event, when there is a normal global LV function at the time of implantation,
even in PTS with predominant RV pacing during FU (group A). Thus prophylactic implantation
of a CS electrode to enable biventricular stimulation is not recommendable.
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Discrepancy between echocardiographic and patient-reported CRT
response: results of the PSYHEART-CRT study
H. Versteeg1, J. Van ’T Sant1, S.S. Pedersen2, P.A. Doevendans1, J. Denollet2, M.J. Cramer1,
and M. Meine1
1University Medical Center, Department of Cardiology, Utrecht, Netherlands; and 2Tilburg
University, CoRPS Center of Research on Psychology in Somatic diseases, Tilburg,
Netherlands
Purpose: Left ventricular (LV) reverse remodelling is an important measure of the efﬁcacy of
cardiac resynchronization therapy (CRT). However, clinical practice shows that this echocar-
diographic response does not always infer an improvement in patient-perceived symptoms,
function and quality of life. The aim of the current study is to get more insight into the associ-
ation between echocardiographic CRT response and patient-reported health status improvement
in the ﬁrst 6 months of CRT.
Methods: Consecutively implanted CRT-deﬁbrillator patients (N = 109;mean age =
65.4+ 10.1;35 women) were recruited from the University Medical Center Utrecht, the
Netherlands. Patients participated in the prospective ‘The inﬂuence of PSYchological factors
on health outcomes in HEART failure patients treated with CRT’; (PSYHEART-CRT) study.
All patients completed the Kansas City Cardiomyopathy Questionnaire (KCCQ) at the time of
implantation and 6 months later. An absolute increase of 10 points on the KCCQ overall
summary score was used to represent clinically relevant improvement in HF-speciﬁc health
status. Echocardiographic response was deﬁned based on reverse remodelling: 15% reduction
in LV end-systolic volume after 6 months of CRT.
Results: Of all patients, 58(53%) showed an echocardiographic CRT response. Of these
responders, 25(43%) did not report health status improvement, while only 33(53%) of the 62
patients reporting better health status showed an echocardiographic response. The c-statistic
(0.50) and logistic regression result (OR = 1.79,95%CI = 0.48-6.68, adjusted for age, sex, pre-
implantation KCCQ score, NYHA functional class, QRS duration, ejection fraction, left bundle
branch block, ischemic etiology, comorbidities, and deﬁbrillator shocks) conﬁrmed that echo-
cardiographic response was not associated with a 10 point improvement in KCCQ score.
Regarding the covariates, only pre-implantation KCCQ score (OR = 0.91,95%CI = 0.87-0.95)
and QRS duration (OR = 1.03,95% CI = 1.01-1.07) were associated with health status
improvement.
Conclusions: Our results show a large discrepancy between echocardiographic CRT response
and improvement in patient-reported health status in the ﬁrst 6 months of CRT. This empha-
sizes that health status measures have additional value over traditional measures in assessing re-
sponse to CRT from the patient’s perspective. The question remains which demographic,
clinical and psychological factors may explain the discrepancy between objective and patient-
reported indicators of CRT response. Such knowledge may help with respect to further risk
stratiﬁcation and secondary intervention.
Impact of atrial ﬁbrillation-related inappropriate shocks on clinical outcome
in heart failure patients treated with cardiac resynchronization therapy
deﬁbrillators
M. Landolina1, M. Santini2, M. Gasparini3, M. Lunati4, G. Boriani5, R. Ricci2, L. Padeletti6, A. Grammatico7,
S. Bisetti7, and A. Proclemer8, ClinicalService cardiological centres
1Foundation IRCCS Polyclinic San Matteo, Department of Cardiology, Pavia, Italy; 2San Filippo Neri Hospital,
Department of Cardiology, Rome, Italy; 3Clinical Institute Humanitas IRCCS, Rozzano, Italy; 4Niguarda Ca’
Granda Hospital, Department of Cardiology, Milan, Italy;
5
Sant’Orsola-Malpighi Polyclinic, Department of
Cardiology, Bologna, Italy; 6Careggi University Hospital, Department of Cardiology, Florence, Italy; 7Medtronic
Italia, Milano, Italy; and 8University Hospital “Santa Maria della Misericordia”, Department of Cardiology,
Udine, Italy
Introduction: Patients (pts) with implantable deﬁbrillators (ICD), atrial ﬁbrillation (AF) may worsen prognosis
due to inappropriate ICD shocks. We aimed to assess incidence, causes and impact of inappropriate ICD shocks
on clinical outcome in heart failure (HF) pts implanted with biventricular deﬁbrillators (CRT-D).
Methods: 1404 CRT-ICD pts were prospectively followed in 74 Italian cardiologies. Device diagnostics enabled
the occurrence and treatment of atrial and ventricular tachyarrhythmias to be evaluated. All episodes detected as
VT/VF were reviewed by expert electrophysiologists, who classiﬁed appropriate and inappropriate detection.
Results: In a median follow-up of 31 months, AF . 10 minutes occurred in 556 pts (40%) and VT/VF in 511
(36%). Inappropriate VT/VF detections occurred in 232 (16%), inappropriate shocks occurred in 101 pts. AF was
the cause of inappropriate shocks in 60 pts: 4% of the whole population and 59% of pts with inappropriate shocks.
AF caused 144 inappropriate shocks -53% of all inappropriate shocks. The likelihood of experiencing one or more
AF-related inappropriate shocks was 2.4%, 4% and 5% at 1, 2 and 3 years, respectively (ﬁgure). According to Cox
analysis, both death and endpoint composed of HF hospitalization or death, were not correlated with shocks due to
any cause, appropriate shocks, inappropriate shocks or AF-related inappropriate shocks.
Conclusions: AF is a major cause of inappropriate shocks, constituting the mechanism of inappropriate detection
in 59% of pts with inappropriate shocks and in 53% of episodes with inappropriate shocks. Appropriate or in-
appropriate shocks did not correlate with death nor with the endpoint composed of HF hospitalization or death.
Comparison of the change of intrinsic AV intervals with increased heart rate
associated with atrial pacing between chronotropic competent and
incompetent patients: results of the RAVE study
M.R. Gold1, Y. Yu2, J.L. Sturdivant1, J. Everidge2, P. Kaveney2, and C. Athill3, RAVE study
group
1Medical University of South Carolina, Charleston, United States of America; 2Boston
Scientiﬁc Corporation, St. Paul, United States of America; and 3San Diego Cardiac Center,
San Diego, United States of America
Purpose: The programmed AV delay is important in cardiac resynchronization therapy (CRT)
to maintain biventricular pacing and optimize the hemodynamic response. Typically the AV
delay is measured at rest and is based on intrinsic AV intervals in several electrogram based AV
optimization (AVO) algorithms. Little is known regarding the effect of atrial pacing rate or ex-
ercise on intrinsic AV intervals.
Methods: RAVE was a multicenter study of 36 CRT patients in sinus rhythm. Heart rate (HR)
was increased with both submaximal exercise and with incremental atrial pacing (AP) up to
130 beats/min (bpm) for each patient. Atrial to right ventricular (ARV) and atrial to left ven-
tricular (ALV) time intervals were measured at multiple heart rates in the absence of ventricular
pacing. Chonotropic incompetence (CI) was deﬁned as a maximal HR achieved during the sub
maximal exercise test, 100 bpm or 75% of 85% of age predicted max HR.
Results: The patient population was 72% male with a mean age of 65 + 10 years old. The
mean EF was 29 + 12 and 52% had mild HF (NYHA I/II) at the time of testing. ARV and
ALV intervals increased with incremental atrial pacing for both chronotropic competent (CC)
and CI patients (Figure). However, the change in the ARV and ALV intervals were about 3-fold
greater in CI patients.
Conclusions: Patients with CI have signiﬁcant prolongation of AV intervals with increased atrial
pacing rates, suggesting that AV delays may need to be adjusted for different atrial pacing rates in
this cohort who often require such pacing. In addition, the AV response to overdrive atrial pacing
may provide a simple means of identifying chronotropic competence in CRT patients.
Follow up of capture threshold measurements in quartet lead implanted
patients
F. Cabrera Bueno1, J. Alzueta Rodriguez1, J. Olague Ros2, I. Fernandez-Lozano3, J.J. Garcia Guerrero4,
J. Fernandez De La Concha4, A. Hernandez Madrid5, and J.M. Tolosana Viu6, Quarto Team
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Barcelona, Spain
Purpose: The purpose of this analysis is to describe the evolution of capture thresholds over 6 months of follow
up in consecutive CRT patients implanted with a quadripolar LV lead.
Methods: HF patients in sinus rhythm and 18 years old underwent CRT-D device implantation with a quadripo-
lar LV lead at 6 investigational sites. Data were collected within 7 days of implant and at 6 month post-implant.
Capture thresholds were assessed during Bi-V pacing (with a pulse width of 0.4ms) from all 10 LV pacing vectors:
3 traditional conﬁgurations (Tip-Ring; Tip-RVC; Ring-RVC) and up to 7 non traditional vectors unique to the
quadripolar lead.
Results: 51 patients (average age 66.5 years, 71% male, 76% with non-ischemic heart disease, 61% NYHA III,
mean EF of 25.3%, and mean baseline QRS of 169ms) were included in the study. 49 of these patients were fol-
lowed for 6 months and are included in this analysis. Capture thresholds remained within the acceptable range
both at enrollment and after 6 months. A small clinically insigniﬁcant increase was observed at 6 months. Minimal
capture thresholds were obtained when considering all the conﬁgurations available in the quadripolar lead, allow-
ing the selection of the lowest capture threshold available in each patient over the follow up period.
Conclusion: Capture thresholds obtained from traditional and non-traditional conﬁgurations of the Quartet lead
were good both at enrollment and after 6 months follow up, suggesting that all four electrodes of this quadripolar
lead maintain good intimate contact with the myocardium in all four electrodes. The nontraditional LV pacing
vectors unique to this quadripolar lead should be considered as viable pacing vector alternatives for CRT patients
from the clinical point of view.
Enrollment 6 Month FU
Number of
conﬁgurations
evaluated
Best Capture
Threshold
mean(V)
Number of
conﬁgurations
evaluated
Best Capture
Threshold
mean (V)
Traditional vectors 146 0.79þ 0.47 *1 141 0.96þ 0.54 *1
Non Traditional vectors 294 0.97þ 0.55 *2 274 1.21þ 0.47 *2
All quadripolar available vectors 440 0.72þ 0.32 *3 415 0.90þ 0.41 *3
Evolution of the capture thresholds over 6 months follow up. *1 : p = 0.0046 ; *2 : p = 0.0095; *3 : p = 0.0013
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CRT therapy in IABP dependent heart failure patients
Z. Kis, Z. Som, P. Abraham, A. Csillik, K. Zupan, S. Szoke, Z. Piroth, P. Andreka, C. Foldesi,
and A. Kardos
’Gottsegen Gyorgy’ National Institute of Cardiology, Budapest, Hungary
Background: The intraaortic balloon pump (IABP) support on intensive care unit in case of de-
compensated heart failure makes possible further therapeutic options.
Aim: The short – and long term observation of the outcome of resynchronisation therapy in
patients with proved ventricular asynchrony (QRS .130 msec, LBBB pattern) and IABP
support due to catecholamine -resistant heart failure.
Method: 6 patients with IABP support (1 congenitally corrected Transposition of the Great
Arteries [ccTGGA], 1 critical aortic valve stenosis, 2 ischaemic cardiomyopathy [CMP], 2
dilated CMP) underwent resynchronisation therapy.
Results: The median time between IABP implantation and resynchronisation therapy was 22
days (interquartile range [IQR] 10-38). The left ventricular electrode implantation (5 lateral, 1
anterolateral position) was successful in every patient. Median procedure and ﬂuoroscopy times
measured 57,5 minutes (IQR 40-90) and 5,8 minutes (IQR 4-22,7). There was no therapy-
related adverse event. The IABP support could be stopped after a median of 14 days (IQR 2-36)
in every case. 5 out of 6 patients (83 %) acutely responded by improvement of hemodynamic
parameters with simultaneous reduction of catecholamine support. The control post-implant-
ation echocardiography examination detected a median of 10 % improvement in ejection frac-
tion; however in 1 case signiﬁcant improvement in ejection fraction could not be reached. The
QRS width was shortened from median of 179 msec (IQR 124-188) to 142 msec (IQR 112-
174). The 6 months follow- up revealed 4 out of 6 patients in NYHA II functional status. 1
patient 30 days after IABP explantation underwent transcatheter aortic valve implantation, 1
patient was referred to heart transplantation.
Conclusions: The CRT implantation due to non-corrected ventricular asynchrony (QRS .150
msec) is a safety therapy parallel with IABP support, ensuring hemodynamic stability, making
possible the explantation of the IABP support.
Is there any alternative for patients in NYHA III heart failure and low
ejection fraction not qualiﬁed for CRT?
T. Chwyczko, E. Smolis-Bak, M. Sterlinski, A. Maciag, R. Dabrowski, I. Kowalik, A. Borowiec, M. Pytkowski,
and H. Szwed
Institute of Cardiology, 2nd Department of Coronary Artery Disease, Warsaw, Poland
Background: There is large borderline group of patients with EF, 35%, heart failure in NYHA III class and
QRS , 120ms, who are not qualiﬁed to CRT. They are treated with implanted cardioverter-deﬁbrillator (ICD) and
standard pharmacotherapy.
Aim: Comparison of outcomes of rehabilitation of patients in NYHA III heart failure and patients with implanted
CRT-D device and no rehabilitation.
Methods: The study included 20 patients with ICDþ rehabilitation and 27 patients with CRT–D only. Patients
with ICD went through the training program (aerobic exercises on ergometer, 3 times a week for 3 months).
Patients with CRT-D were treated pharmacologically. All patients had echocardiography and cardiopulmonary ex-
ercise test (CPX) done before the enrollment to the study and after 6 months.
Results: See table 1.
Conclusions: Rehabilitated patients with NYHA III heart failure have better results when compared with CRT
group. Rehabilitation is a noteworthy therapy for borderline patients with no indications to CRT.
CRT, no rehabilitation ICD and rehabilitation Statistical signiﬁcance (p)
Age [years] 64,9+ 8,2 61,8+ 11,2 Ns
BMI [kg/m2] 27,7+ 4,7 27,6+ 3,8 Ns
EF [%] Before 24,4+ 8,0 25,4+ 5,4 Ns
After 28,8+ 10,4 31,3+ 9,1 Ns
0,0729 (ns) 0,0013
LVdD [cm] Before 6,9+ 1,1 6,3+ 0,8 0,0510
After 6,5+ 0,6 6,0+ 0,6 0,0169
0,0464 0,0124
LVsD [cm] Before 5,36+ 1,0 4,8+ 1,0 Ns
After 4,69+ 0,78 4,15+ 0,73 0,0390
0,0052 0,0033
Peak oxygen uptake
(VO2) [ml]
Before 10,9+ 3,8 13,3+ 4,6 0,0613
After 11,9+ 4,0 15,7+ 5,9 0,0144
ns 0,0168
BMI - body mass indexEF - ejection fractionLVdD - lef ventricle diastolic diameterLVsD - left ventricle systolic
diameter
Short electrode spacing on left ventricular quadripolar leads enables a
targeted LV site pacing for CRT despite phrenic nerve stimulation
M. Bifﬁ1, E. Schotzko2, L. Foerster2, J. Schell2, J. Sommer2, C. Bounds2, and P. Yang2
1Institute of Cardiology, Bologna, Italy; and 2medtronic CRDM, minneapolis, United States of
America
Introduction: Phrenic Nerve Stimulation (PNS) is a limiting factor for a targeted left ventricu-
lar (LV) pacing from coronary veins, occurring in 5 to 25% of CRT patients. PNS may be
avoided by electronic repositioning from the phrenic nerve (PN). A novel LV quadripolar lead
includes 4 electrodes with a short electrode spacing (1.3 mm) dipole and two conventional elec-
trode spacing (21mm) dipoles. The short electrode spacing dipole allows pacing the target LV
site that may be close to PN and provides greater ﬂexibility.
Methods: Fourteen canines have been acutely studied for evaluating PNS and cardiac pacing
of the LV lead. The canines were implanted with the LV lead in the coronary veins and an ICD
lead (Sprint Quattrow, Medtronic) in RV. The PN was surgically moved next to the short dipole
to induce PNS in the study. Three of 14 canines were studied for 12 weeks after the lead
implant. PNS and Cardiac pacing thresholds, pacing impedance, and R-wave were measured at
a variety of programmed conﬁgurations.
Results: The acute and chronic canine studies demonstrated a 2-3 fold increase in PNS thresh-
olds with the short electrode spacing dipole in comparison to the other conventional bipolar
conﬁguration as shown in the ﬁgure below. The PN remained intact and was not damaged by
the relocation as assessed during gross pathology and histopathology at 12 weeks.
Conclusions: The Medtronic LV quadripolar lead provides two viable alternatives to avoid
PNS: 1) Electronic repositioning moves the pacing electrode away from PN; 2) use of the short
electrode spacing dipole increases PNS threshold while maintaining pacing threshold at a target
pacing site.
Ofﬂine clinical performance of a hybrid left ventricular autothreshold
technology in a clinic follow-up setting
D. Mahajan1, G. Kalahasty2, C. Schulze3, M. Giudici4, M. Vloka5, A. Brisben1, S. Shome1, S. Eddy1, V. Huebert1,
and K.A. Ellenbogen2
1Boston Scientiﬁc Corp., St Paul, United States of America; 2Virginia Commonwealth University, Richmond,
United States of America; 3Cardiology Consultants of Philadelphia, Yardley, United States of America;
4
University of Iowa Hospitals, Iowa City, United States of America; and
5
Wheaton Franciscan Healthcare,
Wauwatosa, United States of America
Purpose: The hybrid Left Ventricular Autothreshold (LVAT) technology consists of an independent pace/sense
(IPS) method, in which evoked response (ER) is sensed from one electrode when the other is used for pacing in
bipolar LV leads (for unipolar vectors), and a shared cathode sensing method (SCS), in which the same cathode is
used for pacing as well as sensing ER (for bipolar vectors). Previous clinical studies have demonstrated that the
IPS method worked with high accuracy.
The objective of this analysis is to evaluate the performance of the hybrid LVAT technology for CRT devices with
bipolar leads.
Methods: Data from phase 2 and 3 of the ELEVATE study were pooled. In both phases, patients with CRT-D
devices (BSC, MN, USA) were enrolled and a programmer with custom software performed step-down threshold
(thr) tests. In phase 2, ER from 4 pacing vectors were collected using IPS, and in phase 3, ER from the 2 pacing
vectors were collected using SCS. For every test, thr was determined by observing changes in the surface ECG
(gold standard (GS)). The LVAT algorithm ran ofﬂine to determine the thr. Accuracy was deﬁned as absolute dif-
ference between algorithm and GS thr within two voltage steps.
Results: Data from 144 patients (95 with IPS and 39 with SCS) were analyzed. Bipolar LV leads from 3 major
manufacturers were used. Results are summarized in the table. None of the step-down pacing tests resulted in a thr
lower than the GS-determined thr.
Conclusion: In this study, the ofﬂine LVAT algorithm and GS had a high overall agreement (over 99%) suggesting
that the LVAT algorithm is accurate at determining pacing thr in multiple pacing conﬁgurations and a wide range
of LV leads in CRT patients.
Method No. of
tests, N
Too many
intrinsic beats
during the test,
N
Number of tests that
resulted in an expected
LVAT output, N (%)
number of tests that
resulted in threshold
measurement, N
Threshold
accuracy, N(%)
IPS 721 10 668 (94%) 642 641 (99.8%)
SCS 228 11 178 (82%) 177 175 (98.9%)
P271 P272
P273 P274
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Loss of continuous biventricular pacing in cardiac resynchronization
therapy patients: incidence, causes and outcomes
M. Pachon, M.A. Arias Palomares, T. Colchero, A. Puchol, J. Jimenez-Lopez, F. Lopez-
Sanchez, and L. Rodriguez-Padial
Hospital Virgen de la Salud, Toledo, Spain
Introduction and objectives: In recent years there has been a signiﬁcant increase in the
number of implanted cardiac devices with cardiac resynchronization therapy. The beneﬁts
obtained with such a therapy are directly related to the maintenance of continuous biventricular
pacing. The study analyzes the incidence, causes, attitude and outcomes for the loss of continu-
ous biventricular pacing.
Methods: Clinical and follow-up data of a series of consecutive patients from a single centre in
which a cardiac resynchronization therapy device was implanted were analyzed.
Results: The study included 136 patients. During a mean follow-up of 33,4 months, 45 patients
(33%) experienced loss of continuous biventricular pacing. Main causes included atrial
tachyarrhythmias (21,3%), lead macrodislodgement (18%) and loss of left ventricular capture
(13,1%). Loss of continuous biventricular pacing was mainly transient and correctable (88,5 of
cases) and it occurred earlier during follow-up when either lead macrodislodgement, oversen-
sing or extracardiac stimulation were the cause. There were no signiﬁcant differences in mortal-
ity between the groups of patients with and without loss of continuous biventricular pacing
(p = 0,88).
Conclusions: Despite technical advances in cardiac resynchronization therapy, loss of continu-
ous biventricular pacing is a common clinical situation but it is frequently correctable. A close
monitoring and follow-up of the patients and a proactive approach ensure the achievement of
continuous biventricular pacing for the majority of patients.
Using surface ECG for cardiac resynchronization therapy optimization
V. Lebedeva, T. Lubimceva, and D. Lebedev
Almazov Federal Heart, Blood and Endocrinology Centre, Saint Petersburg, Russian
Federation
Background: Atrioventricular and interventricular delay (VVD) optimization is an important
part of CRT correction. The lack of this procedure or incorrect performance may reduce the
positive effect of cardiac resynchronization and enhance heart failure (HF). Widely used selec-
tion of VVD methods with different ways of echocardiography requires special skills and time-
consuming.
Aim: To assess the impact of VVD optimization in CRT devices based on changes in the width
of the QRS complex using ECG on intracardiac hemodynamic parameters in the long-term
period.
Materials and methods: 88 patients after CRT implantation were divided into 2 groups (I -
with selection of VVD, n = 49, II - without selection of VVD, n = 39) with sinus rhythm, com-
plete left bundle branch block, ejection fraction (EF) 35%.QRS complex was measured
before CRT implantation (QRSown), then every 6 months: QRS measurement in the temporary
device suppression mode (QRSno-st), measuring the width of the stimulated QRS complex
(QRSst) during the VVD optimization process. VVD selection was implemented by gradual
change the delay time of stimulation of the right/left ventricle (from 0 to 40 ms) and simultan-
eous measurement of the stimulated QRS width on ECG. The ﬁnal VVD result was assumed to
the narrowest QRS. Echocardiography was performed in all patients before CRT implantation
and then every 6 months. Observation period was 2 years.
Results: For 24 month follow-up there was signiﬁcant reducion in the QRSst width in Group I,
p = 0.042. Final values of the QRSst and QRSno-st width were lower in Group I, p = 0.015 and
p = 0.001 respectively. There are no signiﬁcant differences in baseline QRS and QRSst
between the groups. End-systolic and end-diastolic LV volume signiﬁcantly decreased in both
groups; reduction in the end-systolic volume was greater in Group I compared to Group II, p =
0.039. EF increased in both groups; percentage increase in EF was signiﬁcantly higher in
Group I, p = 0.048. Functional class (FC) of HF decreased in both groups; the ﬁnal FC value
was signiﬁcantly lower in Group I, 2.12 versus 2.64 in Group II, p = 0.001.
Conclusions: VVD optimization in CRT devices using surface ECG inﬂuences on hemo-
dynamic parameters in the long-term period. The narrowest QRS can be the sign of optimal
cardiac synchronization. This safe and reproducible method improves the electrical systole of
the myocardium and can adjust the conduction system of ventricles that leads subsequently to a
decrease in FC of HF.
Does left atrial early negative strain predict outcome after cardiac
resynchronization therapy?
N. Moreira1, F. Soares1, R. Teixeira1, N. Antonio1, L. Elvas1, R. Martins1, A.J. Barbosa1,
MJ. Ferreira2, and M. Pego1
1University Hospitals of Coimbra, Coimbra, Portugal; and 2Coimbra Medical School,
Coimbra, Portugal
Background and objectives: There is a lack of data in the literature regarding the left atrial
(LA) longitudinal strain (1) as predictor of prognosis in patients undergoing cardiac resynchro-
nization therapy (CRT). The aim of this paper was to evaluate LA contractile function as a pre-
dictor of hospitalization for heart failure in a population after CRT.
Methods: Prospective, longitudinal study of 79 consecutive patients referred to CRT between
October 2009 and April 2012. Median follow-up was 675 days (IQR 375 - 869). Clinical,
demographic and analytical data were collected at the time of implantation. Standard echocar-
diography evaluation and 2D speckle tracking (2D-ST) longitudinal strain analysis were per-
formed prior CRT. Left atrial contractile function was assessed with 2D-ST, as the early
negative peak 1 (P-waved timed analysis). The mean value of lateral, septal and roof 1 was
used. The prognostic performance was analyzed with receiver-operating characteristic (ROC)
curve and cutoff values were calculated. The Kaplan-Meier methodology was used to assess
event free survival.
Results:Mean age of the population was 65+9 years, 63% were male and there was idiopathic
etiology predominance (66%). The majority of the population was in NYHA class III (49 %).
The mean basal QRS duration was 145+ 30 ms and the mean left ventricle ejection fraction
was 24+ 7%. A threshold value of – 0.57% of early negative 1 had a sensitivity of 91.7%, and
a speciﬁcity of 53.4%, to predict hospitalization for heart failure (AUC 0,682, p , 0,05).
According to the proposed cut-off, patients with a LA early 1 higher than –0,57% had more
events on follow up (23.4 vs 3.1%, log rank p,0.05).
Conclusions: In our population, LA early negative 1 was predictor of hospitalization for heart
failure after CRT
Should reduction in left ventricular end-systolic volume be used to assess
response to biventricular pacing?
F. Soares, N. Moreira, N. Antonio, R. Teixeira, R. Martins, J. Cristovao, M. Ventura, L. Elvas,
L. Goncalves, and M. Pego
University Hospitals of Coimbra, Coimbra, Portugal
Introduction: A 15% reduction in left ventricular end-systolic volume (LVESV) following
Cardiac Resynchronization Therapy (CRT) is commonly used to assess response to this
therapy. However, controversy remains to whether this is the best parameter to predict outcomes
in these patients
Purpose: To evaluate response to CRT by LVESV, and its impact in mortality. In addition, we
aimed to assess prognostic impact of improvement in left ventricular ejection fraction (LVEF).
Methods: Prospective, longitudinal study of 79 consecutive patients undergoing CRT between
October 2009 and April 2012 in a single center. We collected demographic, clinical and analyt-
ical data at the time of implantation and at follow-up. Standard echocardiographic evaluation
was performed prior to and 6 months after device implantation. Response to CRT was deﬁned
as 15% reduction in LVESV. Primary endpoint was all-cause death at follow-up. Median
follow-up time: 714 days (IQR 425-869 days).
Results: Mean age of population was 65+ 9,4 years, 63% were male and 73% had idiopathic
dilated cardiomyopathy. The majority were in NYHA class III. Mean basal QRS duration was
144,7+ 29,8 ms. Following CRT, there was improvement in both LVESV (169,5+ 80,1 mL
VS 141,7+ 83,5 mL, p  0,001) and LVEF (24,5+ 7,1% VS 32,6+ 10,1%, p  0,001). In
Kaplan-Meyer analysis, response to CRT and any improvement in LVEF were associated with
higher survival (logrank p = 0,033 and p  0,001 respectively). In a Cox regression model,
only any improvement in LVEF remained associated with higher survival [hazard ratio 0,09;
95% conﬁdence interval 0,02-0,49; p = 0,005).
Conclusion: Response to CRT as assessed by left ventricular reverse remodeling was not asso-
ciated with higher event free survival after adjustment for improvement in LVEF. Any improve-
ment in LVEF was strongly associated with higher survival, suggesting that gain in contraction
is more important than reverse remodeling for survival.
P275 P276
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Relation of QRS duration to left ventricular dyssynchrony in patients with
dilated cardiomyopathy: tissue velocity and strain imaging study
H. Mohamed Fereig Hamed1, A. Hamdy1, M. Nabih2, A. Abd El Aziz3, and A. Ahmed Ali1
1Al-Azhar University, Cairo, Egypt; 2Ain Shams University, Cairo, Egypt; and 3CCU, Cairo
University, Cairo, Egypt
Background: One of the determining factors predicting the response and outcome of CRT is
the presence of left ventricular dyssynchrony (LVD). The aim of this study was to detect the re-
lation of QRS duration to the presence of LVD as determined by tissue velocity and strain
imaging (TVI & SI respectively) in patients with DCM whether ischemic (IDCM) or non-is-
chemic (NIDCM).
Methods: we studied 60 pts (45 M and 15 F, mean age 55.7+ 8.9 ys) with DCM, of whom 30
pts were diagnosed as NIDCM and 30 pts as IDCM. LVD was assessed from echo-Doppler by
measuring septal to posterior wall delay (SPWD) & LV pre-ejection period (LVPEP). TVI and
SI parameters of LVD were obtained by measuring time to peak systolic velocity (TSv) & time
to peak systolic strain (TS1) in 12 LV segments with calculation of maximum delay of TSv or TS1
between any 2 segments (TSv-max & TS1-max) and standard deviation of TSv or TS1 in the 12
segments (TSv-SD & TS1-SD). Pts were classiﬁed into 3 groups according to QRS duration [G1:
QRS . 150 ms (8 pts), G2 QRS 120-150 ms (26 pts) & G3 QRS , 120 ms (26 pts)].
Results: value of SPWD was higher in G1 (213+ 71 ms) compared to either G2 (120+ 56 ms)
or G3 (118+ 41 ms), p = 0.022 & p = 0.20 respectively, with no signiﬁcant difference between
G2 and G3, while values of LVPEP were higher in both G1 (164+ 29 ms) and G2 (140+ 35 ms)
compared to G3 (118+ 23 ms), p , 0.005 & p , 0.01 respectively with no signiﬁcant difference
between G1 and G2. Values of TSv-max & TSv-SD in G1 (111+ 26 ms & 37+8 ms) and in G2
(95+ 39 ms & 34+ 13 ms) indicated LVD according to the reference values in contrast to values
in G3 (93+ 47 & 31+ 13 ms), the differences between the 3 group (G1 vs G2, G1 vs G3 or G2
vs G3) were not statistically signiﬁcant. On the other hand, LVD parameters by SI (TS1-max &
TS1-SD) were higher in G1 compared to G3 (310+ 90 vs 205+ 80 ms, p = 0.013 & 100+ 36
vs 69+ 25 ms, p = 0.04 respectively). The differences of SI parameters between G1 & G2 and
between G2 & G3 were not signiﬁcant. Patients with NIDCM had higher values of SPWD,
LVPEP, TSv-SD, TS1-max & TS1-SD compared to pts with IDCM. There was a good correlation
between SI parameters of LVD with the corresponding TVI parameters of LVD.Correlation
between TSv-SD and TS1-SD revealed r = 0.71 (p , 0.0001) for the whole study group, r = 0.64
(p, 0.0005) in NIDCM pts and r = 0.79 (p , 0.0001) in IDCM pts.
Conclusions: LV dyssynchrony is more in patients with longer QRS duration. Patients with
NIDCM have more LV dyssynchrony than those with IDCM. Strain imaging can better identify
LV dyssynchrony than tissue velocity imaging.
Three-dimensional trajectory of coronary sinus lead tip in CRT recipients:
relations with left ventricular resynchronization
S. Severi1, D. Turco1, M. Margheri2, S. Argnani2, A. Dal Monte2, I. Rubino3, C. Corsi1,
and C. Tomasi2
1DEI, University of Bologna, Bologna, Italy; 2Santa Maria delle Croci Hospital, Department
of Cardiology, Ravenna, Italy; and 3Umberto I Hospital, Department of Cardiology, Lugo
(RA), Italy
Purpose: Cardiac resynchronization therapy (CRT) is an established treatment in heart failure
(CHF), but the relations between left ventricular (LV) dynamics and LV intravenous pace are
still a matter of investigation. We studied lead tip movements as a source of information about
resynchronization of LV mechanics in CRT recipients.
Methods: Three-dimensional reconstruction of CS lead tip trajectory (3DtT) throughout the
cardiac cycle by a novel ﬂuoroscopy-based method was performed in 22 CHF patients (19
male, mean age 70þ 10 yrs) undergoing CRT. Three 3DtT were computed: just before (T-1)
and immediately after (T0) biventricular pacing (BiV) start-up, and at 6-month follow-up (T1).
CRT response was deﬁned by the echocardiographic end-systolic volume reduction  15% at
T1. 3DtT were compared between responders (R: 9pts) and non-responders (NR:13 pts) at
T0,T-1 and T1.
Results: Variations of the ratio between 3DtT two main axes (S1/S2) and of 3DtT eccentricity
were statistically different between R and NR, pointing out a change of the 3DtT towards a sig-
niﬁcantly more circular shape at BiV start-up in the R group. Most remarkably, R and NR could
be completely separated by means of the percent variation of S1/S2 from T-1 to T0 (R: 47.5%
[31.5% 4 54.1%] vs NR: -25.6% [-67% 4 -6.5%]. This single marker computed at T0 could
have predicted CRT response at T1.
Conclusions: Our preliminary data showed that modiﬁcations of 3DtT induced acutely by BiV
were related to resynchronization and predicted volumetric response to CRT. The correspond-
ing LV functional phenomena are still indeterminate.
Is routine adjustment of pacing intervals after implantation worthwhile for
response following cardiac resynchronisation therapy (CRT)?
D.H. Brahmbhatt, V. Nayar, F.Z. Khan, L. Ayers, D.P. Dutka, and P.J. Pugh
Addenbrooke’s Hospital, Cambridge, United Kingdom
Introduction: A signiﬁcant number of patients do not experience improvement following Cardiac
Resynchronisation Therapy (CRT). Haemodynamically-guided adjustment of the intervals between paced cham-
bers, ("optimisation" of Atrio-Ventricular (AV) and left-right ventricular (VV) delays,) may be undertaken to
improve response to CRT. Evidence supporting this approach as standard is lacking, and many centres programme
CRT devices to deliver "out-of-the-box" intervals, undertaking optimisation only when clinical response is
lacking. We determine how often the "out-of-the-box" settings are optimal or acceptable, and how often CRT opti-
misation results in signiﬁcant change to the preset intervals.
Methods: Data were collected from 180 consecutive patients who underwent CRT followed by optimisation
within 24 hours. Optimisation was performed with serial adjustment of AV and VV intervals. Haemodynamic as-
sessment was undertaken using either echocardiography or Non-Invasive Cardiac Output Measurement. Optimal
pacing intervals were deﬁned as those that most augmented cardiac output. These ﬁnal settings were compared
with the preset intervals for that device and the difference (AV or VV adjustment) derived. An AV or VV
Adjustment of.40ms was considered clinically signiﬁcant. Data are presented as mean (SD).
Results: Optimal AV delay ranged from 60 to 200ms (mean 124ms (30)), VV delay ranged from 0 to 100ms
(mean 23ms (19)). Using preset pacing parameters, cardiac output was acutely augmented by 13.1 (34)%.
Optimised CRT produced further improvement of cardiac output, to 24.9 (32)% augmentation. "Out-of-the-box"
settings were found to be optimal in 11 (6.1%), or requiring only minor alteration in 120 (66.7%). A clinically sig-
niﬁcant alteration in AV delay was made in 40 (22.2%), in VV delay in 12 (6.7%) or in either parameter in 49
(27.2%).
Conclusions: Signiﬁcant adjustment of AV or VV delay is required in over a quarter of patients receiving CRT.
Optimisation of pacing intervals provides augmentation of cardiac output over and above the "out-of-the-box" set-
tings. These ﬁndings suggest that optimisation is an worthwhile component of standard resynchronisation therapy.
Effectively delivered CRT using wireless endocardial pacing in previous
CRT non-responder
F. Regoli, M. Acena, E. Pasotti, T. Moccetti, and A. Auricchio
Fondazione Cardiocentro Ticino, Lugano, Switzerland
Introduction: CRT non-response remains an important issue. We report the case of a CRT
non-responder who improves after implant of a wireless left ventricular endocardial cardiac
stimulator.
Case Report: Four years ago a patient with symptomatic drug-refractory ischemic-based heart
failure (HF) disease, NYHA class III, severe left ventricular dysfunction, and ventricular con-
duction delay with 130 msec duration QRS complex, underwent implantation of a atrio-biven-
tricular implantable cardioverter deﬁbrillator device (CRT-D) and then, due to worsening HF
progression because of moderate mitral regurgitation, Mitra-clip device positioning in
September 2009. Due to persistent severe symptoms (NYHA class IIII-IV), in May 2011 wire-
less cardiac stimulation system was placed to deliver CRT from the endocardium. This system,
that functions in parallel to a pre-existing device (ICD) has three components: 1) the receiver
endocardial electrode that ensures stimulation of the myocardium by converting ultrasound
energy into electrical energy; 2) the transmitter which senses right ventricular activity and
transmits a rapid ultrasound beam to the electrode; 3) the battery implanted subcutaneously in
the abdominal wall (Figure). Six months after implant of the new device the patient improved
to NYHA class II, had no HF-related hospitalization, and transthoracic echocardiogram
revealed a clear recovery of lateral wall kinesia with LVEF improvement to 33%.
Conclusion: The present case shows how wireless endocardial lateral wall stimulation effect-
ively delivered CRT in a patient in whom conventional transvenous epicardial stimulation
previously failed. This novel technology may be a solution to address the problem of CRT
non-response.
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Table 1. Adjustment of pacing intervals
Optimal Adjustment
Time /ms
0 1-20 21-40 41-60 61-80 81-100
AVAdjustment /n (%) 29 (16.1) 89 (49.4) 22 (12.2) 32 (17.8) 7 (3.9) 1 (0.6)
VVAdjustment /n (%) 50 (27.6) 65 (35.9) 53 (29.3) 11 (6.1) 0 (0) 1 (0.6)
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Triventricular pacing in patients non responders to cardiac
resynchronization
P. Mondoly, C. Cardin, A. Rollin, E. Thomson, R. Noblemaire, M. Rezai, P. Maury, M. Delay,
D. Carrie, and A. Duparc
University Hospital of Toulouse - Rangueil Hospital, Toulouse, France
Background: Patients with symptomatic heart failure despite a medical and electrical optimal
treatment still have a very poor prognosis, and there is no validated therapy to improve their
status.
Aim: To evaluate the impact of adding a second left ventricule lead to reach a triventricular
pacing in patients non responders to a conventional cardiac resynchronization.
Method: We included patients with a previous CRT device, who were initially or secondarily
non responders to this therapy, despite an effective rate of biventricular pacing up to 95%. A
second left ventricular lead was implanted via the coronary sinus with an endovascular way.
The two left ventricular lead were connected with an Y-adaptator. Patients implanted success-
fully were followed at 3, 6, 12, 24 months after the procedure. A positive response was deﬁned
as an NYHA class improvement, without hospitalization for heart failure. Device- related
adverse events and electrical parameters of the left ventricular leads were also collected during
the follow up.
Results: 19 patients were included, and 17 were implanted successfully of a second left ven-
tricular lead. 75% were in class 3 NYHA and 15% a class 4. The only intra-operative complica-
tion noted was an hemopneumothorax. Medium follow up was 18 month. 2 patients presented a
phrenic stimulation resulting in a triventricular pacing interruption. 2 patients presented an in-
fection and the device had to be removed. We didn’t note any re-intervention consequently to a
left ventricular lead dysfunction and only one reintervention because of a deﬁbrillator lead dys-
function. 8 patients died during the follow up, 6 from cardiac causes. After one year, 66% of
alive patients had still an effective triventricular pacing, all the others had at least a biventricu-
lar effective pacing. 55% of the patients had a positive response to triventricular pacing. Left
ventricular circuit impedance was lower than in conventional device, pacing thresholds didn’t
increase signiﬁcantly during the follow up.
Conclusion: In our study, triventricular pacing is a feasible technique which leads to a clinical
improvement in a half of these non responders patients with an acceptable rate of adverse
events. Triventricular pacing can be an interesting perspective when heart transplant or assist-
ance is not indicated.
T peak-t end interval as a risk factor for ICD therapies in patients with
arrhythmogenic right ventricular cardiomyopathy
K. Yalin, E. Golcuk, EB. Karaayvaz, A. Elitok, AK. Bilge, and K. Adalet
Istanbul University, Faculty of Medicine, Department of Cardiology, Istanbul, Turkey
Purpose: The Tpeak-Tend (Tpe) interval is an electrocardiographic index of transmural repo-
larization dispersion and has been reported to predict life- threatening arrhythmias in the long
QT syndrome, Brugada Syndrome, hypertrophic cardiomyopathy and systolic dysfunction.
However it is not studied in patients with ARVC. We hypothesised that Tpe at the time of
implant predict appropriate future therapy in patients with ARVC.
Methods:We evaluated 25 ARVC patients receiving an ICD for primary or secondary preven-
tion from 2004-2010 with follow up at our center. (16 M, 42+ 16 Y). Tpe was deﬁned as the
peak or nadir of T wave to the end of T wave and was measured in each precordial lead by a
single blinded observer. Appropriate ICD therapy was deﬁned as having VT/VF terminated by
either anti-tachycardia pacing or shock during f/u. The f/u period was 63þ -29 months.
Results: Upon presentation, two patients had suffered aborted sudden death, eight syncope,
and four presyncope. None of the patients had abnormal (.460 ms) QTc interval or QT disper-
sion. During f/u, nine patients experienced appropriate ICD therapies. Tpe were signiﬁcantly
prolonged in patients with ICD therapies versus patients without. (138.1+ 30.1 ms vs.
114.5+ 19.4 ms in V4; 145.7+ 37.7 ms vs 112.4+ 18.3 ms in V6, p = 0.029 and p = 0.008,
respectively).
Conclusions: Our study demonstrates signiﬁcant correlation between Tpe in V4 and V6 and oc-
currence of ICD therapies, suggesting that Tpe interval may be useful in risk stratiﬁcation of
patients with ARVC.
ST segment depression during supraventricular tachycardia determined by
VA intervals
S. Rivera, M. Ricapito, M. Badra, JF. Roux, and F. Ayala-Paredes
University Hospital of Sherbrooke (CHUS), Sherbrooke, Canada
Purpose: Faster tachycardia rates during supraventricular arrhythmias are associated with high
troponin levels. ST segment depression (STD) in supraventricular tachycardia has not been yet
associated with shorter tachycardia cycle lengths (TCL). Our objective is to determine a pos-
sible mechanism explaining STD and its relation with the TCL.
Methods: Patients admitted for SVT ablation between 2010-2012 were analyzed (n = 55).
AVNRT and AVRT were included. Exclusion criteria were: Bundle branch block; Ventricular
repolarization anomalies; Associated arrhythmias; Coronary artery disease and Coronary risk
factors. SVT measures were performed: QRS, ST, QT, T wave, TCL and VA interval length.
Pseudo right bundle branch block pattern was also considered. ST segment depression was
deﬁned as .2mm from the J point in .2 consecutive leads. Different ST morphologies were
analyzed: Ascendant STD (ASTD), Descendant STD (DSTD), and Horizontal STD (HSTD).
Two groups were compared, those who developed STD (group A) and those who didn’t
(Group B).
Results: Median age 52 years (IQR 32-62,5); Males 41,82%; 80% AVNRT; 20% AVRT;
41,82% developed STD (39,13% ASTD, 21,74% DSTD, 39,13% HSTD); AVRT VA median
136ms (IQR 125-150) and TCL 344ms (IQR 317-401ms); AVNRT VA median 54ms (IQR 43-
90) and TCL 345ms (IQR 303-377,5ms). Group A presented higher VA (median VA 115ms;
IQR 63-136ms vs. 53ms; IQR 40-84; p = 0.015). No TCL differences were observed within
both groups (334ms; IQR 305-376ms vs. 360ms; IQR 322-385,5; p = 0.67). Median VA and
TCL in ASDT were 48ms (IQR 44-66ms) and 344ms (IQR 326-402ms) respectively; VA
124ms (IQR 114-124ms) and TCL 384ms (IQR 288-420ms) in DSTD; VA 142ms (IQR 126-
146ms) and TCL 322ms (IQR 300-338ms) in HSTD; VA 48ms (IQR 44-66ms) and TCL
344ms (IQR 326-402ms) in Pseudo right bundle pattern. AVNRT developed STD in 35% of
cases while 72.73% of AVRTs showed STD.
Conclusions: ST segment depression is conditioned by retrograde atrial activation during SVT.
Retrograde P waves can distort ST segment depending on the VA interval length. This was
observed at VA intervals.120ms, without depending on TCL. AVRT has higher STD rates, as
VA intervals are longer than AVNRT. No TCL differences were observed between both groups,
suggesting that STD is not rate dependent.
Early repolization variant frequently detected in young adults in Algeria
W. Amara1, N. Hammoudi2, S. Bouallouche1, A. Elhraiech1, and R. Bougherbal2
1GHI Le Raincy-Montfermeil, Montfermeil, France; and 2EHS Maouche, Service de
Cardiologie, Alger, Algeria
Background: Early repolarization variant (ERV) is considered to be a benign condition, but re-
cently its presence has been related with a certain vulnerability to ventricular ﬁbrillation in
many case reports and case-control studies. The ERV was the subject of many studies in highly
developed countries and its prevalence is estimated between 3.3 and 6.7%. ERV prevalence in
the Maghrebian population is unknown. The aim of this study was to appreciate the prevalence
of the ERV within a sample group of healthy Algerian young adults.
Methods: ERV prevalence was assessed within a sample group of 441 healthy male and
female subjects (average age: 25 years old; age ranges: 18 to 36 years old) using 12-lead elec-
trocardiography. Three independent cardiologists interpreted the ECGs and ERV was stratiﬁed
according to the J-point elevation (0.1 mV) in the inferior, apicolateral or both leads asso-
ciated with QRS slurring or notching.
Results: The ERV pattern was found in 55 subjects (12.4%). A malignant ERV (.2mm) was
discovered in 5 subjects (0.9%). Seventeen subjects (3.8%) presented the ERV pattern in the
lateral leads, 16 (3.6%) in the inferior leads, and 22 (5%) in both lateral and inferior leads.
Notch pattern was present in 14 subjects (3.2 %), slur pattern in 30 subjects (6,8 %), and a com-
bination of the two patterns in 11 subjects (2.5%). The ERV pattern was more prevalent in
males (15.6%) than in females (11.2%). The ERV prevalence was not higher among the young-
est subjects. None of the participants experienced symptoms nor had a history of familial
sudden death.
Conclusion: ERV is a common ﬁnding among a young healthy Algerian population. Its preva-
lence seems to be more important than in highly developed countries.
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The JT interval is inversely correlated with ventricular depolarisation time
E. Kramarz, and K. Makowski
Military Institute of Health Services, Warsaw, Poland
Introduction: The QT interval is a measure of the duration of ventricular depolarisation and
repolarisation. Because the QT interval encompasses the ventricular depolarization period, it
has been suggested that the JT interval better describes the time of ventricular repolarisation
than the QT interval, particularly in cases with widened QRS complexes. In the present study
we tested the hypothesis that duration of both, QT and JT interval may be related to the QRS
complex width.
Methods: In 154 postinfarction patients (61+ 10 years, 130 men) with ventricular premature
beats (VPBs) on a standard ECG we compared the duration of QT and JT intervals in sinus
beats and in VPBs, and assessed the relations between QRS complex width and JT interval
length.
Results: The values of QT interval duration were greater in VPBs than in sinus beats, but sur-
prisingly the JT intervals were shorter in VPBs than in sinus beats (Table).
Multiple regression analysis revealed the signiﬁcant correlation between JT interval and RR
interval of basic sinus rhythm (beta ¼ 0.476, t ¼ 6.753, p ¼ 0.0001), and negative correlation
between JT interval and QRS complex width (beta ¼ –0.148, t ¼ –2.109, p ¼ 0.0366).
Conclusions: Widening of the QRS complex is associated with shortening of the JT interval.
Different results of clinical studies may be obtained when JT interval is substituted for QT
interval in patients with widened QRS complexes.
Sinus beats* VPBs t -value p-value
QRS complex (ms) 106+ 22 151+ 21 25.07 0.0001
QT interval (ms) 432+ 47 466+ 57 8.66 0.0001
JT interval (ms) 326+ 47 315+ 51 2.58 0.0107
* including 21 patients with complete bundle branch block; VPBs = ventricular premature
beats
Prevalence and clinical predictors of elevated electromagnetic QRS-
fragmentation index in patients with acute myocardial infarction undergoing
cardiac magnet ﬁeld imaging
T. Kleemann, K. Kouraki, M. Strauss, H. Zarif, R. Zahn, and U. Zeymer
Medizinische Klinik B, Klinikum Ludwigshafen, Ludwigshafen, Germany
Background: Magnet Field Imaging (MFI) is a non-invasive method to register cardiac electromagnetic activity.
Early reports have suggested a positive predictive value of an elevated electromagnetic QRS fragmentation index
for the occurrence of ventricular arrhythmias.
Aim of the study was to analyze patients with acute myocardial infarction (AMI) undergoing MFI investigation
and to ﬁnd independent predictors for an elevated electromagnetic QRS fragmentation.
Methods: A total of 344 consecutive patients with AMI underwent a MFI investigation between February 2011
and December 2012 and were analyzed. An electromagnetic QRS fragmentation index (eQFI) . 1.2 was deﬁned
as an increased eQFI.
Results: One hundred and seven patients (31%) presenting with AMI had an increased eQFI. 1.2. eQFI in acute
ST-elevation myocardial infarction was not different to patients with acute Non-ST elevation myocardial infarc-
tion. Independent predictors for an elevated eQFI in patients with AMI were increased QRS width. 110ms, atrial
ﬁbrillation, low EF, 40% and the presence of non-sustained ventricular tachycardia during holter ECG.
Conclusions: About one third of patients presenting with AMI had an increased eQFI. Increased QRS width,
low EF , 40%, atrial ﬁbrillation and non-sustained ventricular tachycardia were independent predictors for an
elevated eQFI in patients with AMI. Follow-up of patients is needed to determine the clinical relevance of eQFI
in AMI.
eQFI 1.2 eQFI, 1.2 p-value
Age (years) 65 (53 - 74) 62 (53 - 71) 0.36
Female 17% 25% 0.10
Acute STEMI 46% 48% 0.69
Ejection fraction,
40%
40% 24% 0.003
QRS width (ms) 105 (93 - 120) 90 (81 - 102) , 0.0001
Prior myocardial
infarction
13% 4.6% 0.005
Hypertension 83% 76% 0.15
Diabetes 37% 32% 0.38
Atrial ﬁbrillation 18% 7% 0.001
Cardiogenic shock 6% 1.3% 0.03
Ventricular ﬁbrillation 3.7% 2.5% 0.50
Relation of the depression with proarrhythmogenic electrocardiographic
parameters
S. Bulur1, Salih. Selek1, Sule. Bulur2, Ozan. Alper Alkoc3, Elif. Onder4, Sinan. Albayrak5, Yusuf. Aslantas5,
and Ismail. Ekinozu5, Melen Study
1Medeniyet University, School of Medicine, Department of Cardiology, Istanbul, Turkey; 2Marmara University
Pendik Training and Research Hospital, Departments of Physiology and Sports Physi, Istanbul, Turkey;
3Medeniyet University, Faculty of Medicine, Department of Anatomy, Istanbul, Turkey; 4Duzce University,
Faculty of Medicine, Internal Medicine, Department of Endocrinology and Metabolis, Istanbul, Turkey; and
5Duzce University, Faculty of Medicine, Departments of Cardiology, Istanbul, Turkey
Aim: We investigated the relationship of the depression and proarrythmogenic ECG parameters in metabolic
healty subjects.
Methods: A total of 2298 subjects with a mean age of 50 (age range 18 to 92) were interviewed. Subjects who had
smoking habit, diabetes, hypertension, coronary artery disease, dyslipidemia, chronic obstructive pulmonary
disease, cancer, chronic use of any drugs including antiplatelets, heavy drinkers, metabolic syndrome, ejection
fraction ,55%, creatinine .1.4 in men and .1.1 in women, abnormal liver function tests and an abnormal TSH
were excluded in a in a stepwise manner. The diagnosis of current (one month) major depression was made
according to the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Standart 12 lead ECG
recordings were made with a commercially available electrocardiography machine (Nihon Kohden, Japan) in 50
mm/sec velocity and 10 mV amplitude.
Results: Two hundred sixty-one participants (160 females (61%) and 101 males (39%) with a mean age of 40+
15) constituted the ﬁnal metabolic healthy cohort. ECG parameters were compared to individuals with and
without depression no statistical difference was determined between PR, QRS, QT and heart rate.The main carac-
teristics, blood pressure, laboratory and Ecg parameters of cohort are presented Tablo 1.
Conclusion: Pro arrhythmogenic ECG parameters of metabolically healthy and use any drug patients with depres-
sion was similar to individuals without depression.
Depression Control P
Age 35+ 12 41+ 16 0.007
SBP 109+ 12 113+ 14 0.043
Glucose 94+ 10 95+ 14 0.019
Creatinin 0.7+ 0.1 0.8+ 0.2 ,0.001
Htc 38+ 7 39+ 4 NS
PR 147+ 22 143+ 25 NS
QRS 91+ 11 91+ 13 NS
QTc 397+ 16 400+ 26 NS
Heart Rate 75+ 12 71+ 12 NS
Detection of atrial electromechanical dysfunction in non-dipper
pre-hypertensive patients
S. Ozturk, A. Erdem, F. Ozlu, S. Ayhan, and M. Yazici
Abant Izzet Baysal University, School of Medicine, Department of Cardiology, Bolu, Turkey
Introduction: A relationship between atrial conduction time and hypertension was shown in
previous studies. Increased atrial electromechanical intervals used to predict atrial ﬁbrillation
by measured tissue Doppler imaging (TDI). So we aimed to search if there was any association
between the non-dipping status and atrial electromechanical intervals in pre-hypertensive
patients.
Methods: Forty one non-dipper and 33 dipper pre-hypertensive subjects enrolled in the study.
Smoking, diabetes mellitus, hypertension, using antihypertensive drugs, congestive heart
failure, renal failure, myocardial infarction or cerebrovascular accident were exclusion criteria.
Systolic and diastolic blood pressures were measured with a mercury sphygmomanometer.
Twenty four hours blood pressure was measured with cuff-oscillometric method. All patients
were evaluated by transthoracic echocardiography. Using TDI, atrial electromechanical coup-
ling (PA) was measured from the lateral mitral annulus (PA lateral), septal mitral annulus (PA
septum), and right ventricular tricuspid annulus (PA tricuspid).
Results: Systolic and diastolic blood pressures were signiﬁcantly higher in subjects with non-
dipper phenomenon than dipper ones at night. Twenty four hours average systolic and diastolic
blood pressures were higher in non-dipper pre-hypertensive subjects, but this elevation was not
signiﬁcant. Left and right intraatrial (PA lateral-PA septum and PA septum-PA tricuspid) and
interatrial (PA lateral-PA tricuspid) electromechanical coupling intervals were measured sig-
niﬁcantly higher in non-dipper pre-hypertensive patients (31.3+ 3.9 vs 24.1+ 2.3 P = 0.001;
19.5+ 4.3 vs 13.8+ 2.1, P = 0.001; and 11.4+ 2.8 vs 8.8+ 1.5, P = 0.001). Also interatrial
electromechanical delay was negatively correlated with dipping levels.
Conclusion: This study showed that prolonged atrial electromechanical intervals were related
non-dipper pattern in pre-hypertensive patients. Prolonged electromechanical intervals may be
an early sign of subclinical atrial dysfunction and arrhythmias’ in non-dipper pre-hypertensive
patients.
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Microvolt T-wave alternation as predictor of ventricular tachyarrhythmic
events in patients with nonischemic dilated cardiomyopathy and ICD
T. Vaikhanskaya, I. Sidorenko, T. Kaptsiukh, T. Kurushko, and V. Hlianishcha
Republican Scientiﬁc and Practical Center "Cardiology", Minsk, Belarus
The microvolt T-wave alternation (mTWA), an elecrocardiographic (ECG) index of ventricular
repolarization, has been proposed as an non-invasive predictor of arrhythmic risk.
The aim of our work was to study ECG markers of myocardial electric instability: microvolt T-
wave alternation (mTWA), QT interval dispersion (dispQT) and heart rate turbulence (HRT)
for predicting ventricular tachyarrythmic events in patients with nonischemic dilated cardiomy-
opathy (niDCM) after implantation ICD devices.
Methods and results: The study included 32 patients with niDCM (aged 43,5 + 9,21
years;15,6% female, NYHA class 3,09+ 0,3; QRS 111+ 30,5ms; LVEF 25,6+ 3,9%; sinus
rhythm) who had ICD (n = 15) and CRT-D (n = 17) devices. Patients were followed 397+ 177
days (between visits 168+ 50); there were 1 death and 19 ICD discharges. We analyzed ven-
tricular ectopy by Holter ECG monitoring-24h (Oxford) and HRT (TO and TS), mTWA and
dispQT by software Intecard-7 (Belarus) with 7min ECG-12 recording (5 min of rest and 2 min
of exercise test 25Wt\m) during native conduction. Results were compared with telemetry ICD
/CRT-D devices. Patients with ICD shocks (events VT/VF) had abnormal dispQT and positive
mTWA (n = 17); pathological HRT detected in 7 patients. Markers of myocardial electrical in-
stability (mTWA, dispQT) were determined also in 15 patients (HRT in 4 pts) without ICD dis-
charges. Subgroup analysis showed that these indices (mTWA, TO, TS, QTd) were changed
signiﬁcantly (p ,0,001). After multivariate regression and ROC curve analysis, only indicator
mTWA remained signiﬁcance (mTWA  44mcV; S: 0,803; 95% AI: 0,586-1,00; p = 0,012)
and was emerged as independent predictor of VT/VF events in patients with niDCM and ICD.
Conclusions: Positive marker mTWAwas as an independent proarrhythmic predictor; identiﬁ-
cation of pathological mTWA 44 mcV in patients with niDCM and ICD require more pro-
active management.
What is the necessary intermittent rhythm monitoring frequency required
for reliable atrial ﬁbrillation recurrence detection? Insights from
continuously monitored patients using a robust probabilisti
E. Charitos1, U. Stierle1, PD. Ziegler2, H.H. Sievers1, and T. Hanke1
1Cardiac and Thoracic Surgery Clinic, Luebeck, Germany; and 2Medtronic Inc., Minneapolis,
United States of America
Purpose: Strategies for the detection of atrial ﬁbrillation (AF) recurrence after therapeutic
interventions for AF employ various intermittent rhythm monitoring durations (IRM) (24h, 7
days, 14 days, 30 days) and frequencies (number of IRM examinations per year). Although
there is signiﬁcant evidence in the literature that all IRM strategies will under detect AF recur-
rence in an unknown and inestimable number of patients, the optimal choice of IRM strategy
(IRM frequency and duration) remains more or less arbitrary. In the present work, using a
robust probabilistic approach we evaluate the necessary IRM frequency and duration required
for reliable (.95% probability) detection of AF recurrence.
Methods: Rhythm histories of 647 patients (mean AF burden, 0.12+ 0.22; median, 0.014;
687 patient-years) with implantable CM devices were reconstructed and analyzed. With the use
of computationally intensive simulation, we evaluated the accuracy and reliability of IRM of
various frequencies and durations on the probability of successful AF detection.
Results: The required IRM frequency for reliable (.95% probability) AF detection depends
on the amount (AF burden, p , 0.001) and temporal aggregation (AF density, p , 0.001) of
the AF recurrence as well as the duration of the IRM (p , 0.001). Reliable AF recurrence de-
tection can be obtained with IRM however this requires much higher frequencies than currently
recommended in the guidelines. Especially for paroxysmal AF (low burden, mid-to-high
density) required higher IRM frequency than currently recommended (.12 24h, .5 7d, .4
14d,.2 30d IRM per year, p , 0.0001). Lower frequencies will under detect AF recurrence in
an unknown percentage of patients and will introduce a signiﬁcant bias in the evaluation of
therapeutic interventions.
Conclusion: Reliable (.95% probability) AF recurrence detection requires a much higher
IRM frequency than currently recommended. Current IRM frequency recommendations will
under diagnose AF recurrence and thus misclassiﬁed an unknown proportion of patients as
being AF free.
Association of anabolic steroids and autonomic cardiovascular risk
in athletes
O. Barbosa Neto1, M. Marocolo Junior1, G. Ribeiro Mota2, E. Januario Nogueira2, R. Silva
Cortes2, and V.J. Dias Da Silva2, Research Group in Biodynamics and Human Performance
1Federal University of the Triangulo Mineiro, Sport Sciences Department - Health Sciences
Institute., Uberaba, Brazil; and 2Federal University of the Triangulo Mineiro, School of
Medicine, Uberaba, Brazil
The aim of the present study was to investigate the autonomic and morphofunctional cardiac
alterations on bodybuilders anabolic androgenic steroids (AAS) users. Forty-ﬁve male with
29.8+ 0.5 years-old participated voluntarily of this study and were separated in three groups:
sedentary subjects controls (SE, n = 15), bodybuilders AAS users (SU, n = 15) and AAS nonu-
sers (SN, n = 15). We evaluated heart rate (HR), arterial pressure (AP), as well as linear and
nonlinear parameters of HR variability (HRV) in resting and during the active postural maneu-
ver and electrocardiographic (ECG) and echocardiographic data at rest. Athletes making
abusive use of steroids presented elevated baseline levels of AP when confronted to AAS nonu-
sers and sedentary. The HRV parameters for both linear and nonlinear demonstrated that the
users group showed a higher sympathetic modulation and a lower parasympathetic modulation
is resting in comparison of the others groups. After the orthostatic test, however, we noted a
lesser response of HR and AP as well as the sympathetic modulation measured by means of
spectral analysis and symbolic nonlinear dynamic in SU groups in relation to SN and SE
groups. The left ventricular mass (LVM), as well as the LVM index and LV end-diastolic
volume was higher in trained groups than sedentary group. Furthermore, the LVM, LVM index,
the LV posterior wall thickness, the interventricular septal thickness and the thickness relative
of LV in end-diastolic were signiﬁcantly higher in the user group in relation to nonusers and
sedentary. The corrected values of QT interval (cQT) and QT interval dispersion (cQTD) were
higher in SU group in comparison to the sedentary. AAS users presented a shift of QRS elec-
trical axis towards to the left in comparison to the non users and sedentary volunteers. Our
results suggested that AAS users had a marked autonomic dysfunction, which may constitute
an important mechanism linking AAS abuse to increased cardiovascular risk. In addition, the
structural and functional alterations of the cardiac musculature resulting from the use of anabol-
ic steroids, by direct and/or indirect effects could provoke and perpetuate cardiovascular dis-
eases. Therefore, the increased cardiovascular risk associated to indiscriminate use of AAS
could be ascribed at least partially to the cardiac autonomic dysfunction.
Interruption of anabolic steroid treatment does not reverse the dysfunction
caused on ventricular repolarization and autonomic cardiac system in rats
M. Marocolo1, G. Ribeiro Da Mota1, D. Schimitz De Freitas2, W. Wey Moreira1,
and O. Barbosa Neto1
1Federal University of Triangulo Mineiro, Department of Sport Sciences, Uberaba, Brazil; and
2Faculdade Esta´cio de Sa´, Juiz de Fora, Brazil
Introduction: The illicit abuse of high-doses of anabolic androgenic steroids (AAS) has been
attributed as a main cause of several cardiovascular disorders. Previous studies have been
demonstrated that heart rate variability (HRV) may provide independent prognostic information
on ventricular arrhythmias and regular exercise improvement HRV. In addition, arrhythmic
events were described secondary to the intake of AAS.
Objectives: Thus, the objective of this study was to investigate the effects induced by chronic
administration of nandrolone decanoate (ND) on HRV and QT interval and whether they are re-
versible.
Methods: Female Wistar rats received weekly 10 mg/Kg of DECA (n = 8) or vehicle
(CONTROL, n = 7) for 8 weeks. During 9th to 14th week, none of groups received any type of
drugs. A custom-made elastic cotton jacket with two pieces of rectangular platinum electrodes
was used to acquire ECG before and after 8th and 14th weeks of protocol, in conscious state, in
a lead close to DII, with prominent R wave peaks for HRV and QT interval measurements.
Data were stored on a PC for ofﬂine processing. All recordings were conducted in a quiet envir-
onment during morning hours (07:00–11:00 h). The beat-to-beat R-R intervals were extracted
from the ECG signal and the time- and frequency-domain analysis was performed. For spectral
analysis two frequency bands were determined: low frequency (LF: 0.2–0.8 Hz), and high fre-
quency (HF: 0.8–2.5 Hz). Power (in ms2) was estimated as the area under the spectrum within
these frequencies ranges. A p , 0.05 was considered.
Results: SDNN (standard deviation of RR intervals), RMSSD (square root of the mean squared
differences of successive RR intervals) and pNN5 (percentage of successive RR interval differ-
ences greater than 5 ms) were reduced in DECA compared to CONTROL after 8 and 14 weeks
of protocol (p , 0.01). HF was signiﬁcantly reduced while LF/HF ratio was increased in
DECA compared to CONTROL groups on 8th and 14th weeks (p , 0.05). QT interval was
longer in DECA compared to CONTROL group after 8 (Control: 57+ 5.7 ms vs. DECA:
67+ 7.9 ms) and 14 weeks (Control: 70.4+ 5.2 ms vs. DECA: 77.1+ 7.9 ms) of protocol
(p , 0.05).
Conclusion: Supraphysiological doses of ND induces cardiac autonomic dysfunction and may
create a substrate for inducing electrical disturbances, increasing the time of ventricular repolar-
ization, in female rats. Key-words: anabolic androgenic steroids, regular exercise, heart rate
variability, cardiac autonomic dysfunction
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Pregnancy in patients with Brugada Syndrome
M. Rodriguez Manero, R. Casado-Arroyo, A. Sarkozy, E. Leyse, J. Sieira, M. Namdar,
GB. Chierchia, G. Conte, M. Levinstein, and P. Brugada
Free University of Brussels (ULB), Cardiovascular Centre, Heart Rhythm Management
Centre, Brussels, Belgium
Background: Little is known about the risks and outcomes of pregnancy in women with
Brugada syndrome (BS). We therefore evaluated pregnancy outcome in patients with BS.
Methods and results: A retrospective analysis was performed on all women with BS who were
pregnant. One hundred four women with a total of 219 deliveries were included. There were 15
spontaneous abortions. One infant died suddenly during the night 3 months after birth. Six
pregnant women reported to have suffered at least one syncope during the pregnancy. Of the 3
women who received an implantable cardioverter-deﬁbrillator (ICD) previous to the pregnancy,
none received ICD therapy. The 4 patients with previous aborted sudden cardiac death had no
events during the pregnancy. Of the 21 patients with syncope outside the setting of the preg-
nancy, 18 were asymptomatic and 3 suffered from a recurrent syncope during the pregnancy.
During the long term follow up (mean follow up of 71+ 60,24 months), two women received
appropriates shocks.
Conclusion: In this retrospective single center study, serious events were not more frequent
during pregnancy and the peripartum period in women with BS. The occurrence of syncope
during pregnancy was not associated to a worst outcome, neither during the peri and postpartum
period nor during long term follow up. The reported rate of miscarriage and sudden infant
death will require further studies to conﬁrm or rule out its association with BS.
Patients (n) 104
Age (years) 43,3 þ/- 12,9
Proband (n) 29 (27,8%)
Family history of SCD (n) 66 (63,4%)
First degree (n) 40
Asymptomatic (n) 60 (57,7%)
Previous syncope (n) 21 (19,2%)
Aborted SCD (n) 4
ICD implantation (n) 26 (25%)
Heart rate: an important confounder in the assessment of left atrial volume
P. Haemers1, R. Willems2, and P. Claus3
1
Catholic University of Leuven, Division of Experimental Cardiology, Leuven, Belgium;
2
Catholic University of Leuven,
Department of Cardiology, Leuven, Belgium; and
3
Catholic University of Leuven, Dept Cardiovascular Dis., Division Imaging
& Cardiovascular Dynamics, Leuven, Belgium
Purpose: Left atrial (LA) volume is an important prognostic risk factor in atrial ﬁbrillation (AF) management. Magnetic reson-
ance imaging (MRI) is considered the gold standard to assess cardiac volumes. LA volume is routinely corrected for body
surface. However, the inﬂuence of heart rate (HR) on LA volume is less well understood. This study investigates the inﬂuence
of a relatively small change in HR on LAvolumes.
Methods: MRI was performed on 13 sheep (weight-matched): 6 sheep during sinus rhythm with a mean HR of 76+9 beats
per minute (bpm) (SR76+ 9), and on 7 sheep during right atrial pacing at 90 bpm (AOO90). Short axis cine images, with an
interslice gap of 3-4mm, were acquired of the LA. LA volume (total, body and appendage) at maximal (LAmax), minimal
(LAmin) and precontraction (LApre) volume was calculated by the summation of disks method (ml). LA function was calcu-
lated by following formula: LA expansion index (LAexp): (LAmax–LAmin)/LAmin  100, LA passive emptying fraction
(LApas): (LAmax–LApre)/LAmax  100, LA conduit fraction (LAcon): (LVstroke volume-total LA empyting vol)/
LVstroke volume  100, LA active emptying fraction (LAact): (LApre-LAmin)/LApre  100.
Results: AOO90 resulted in signiﬁcant lower LA volumes compared with SR76+9 bpm. There was no signiﬁcant change in
the ratio of LA body to total volume and the ratio of LAA to total volume (SR76+ 9: 73.4+ 2.4% vs 26.6+ 2.4%, AOO 90:
73.3+ 2.4% vs 26.6+ 2.4%). Increase in HR altered most of the volume derived function parameters.
Conclusion: An increase in HR leads to a decrease of LA volume. This decrease is proportional for both the body of the LA
and the LAA. Furthermore, an increase in HR augments LA expansion index and the active emptying fraction. There is a de-
crease of the conduit fraction. The effect of HR should be considered as an important confounder in the assessment of LA
volume and volume derived parameters.
LAmax LApre LAmin LAexp LApas LAcon LAact
SR 76+ 9 50.5+ 3.2 40.6+ 2.6 37.6+ 2.5 34.4+ 12.4% 19.3+ 7.5% 70.8+ 9.0% 7.1+ 1.6%
AOO 90 36.1+ 1.9 27.0+ 3.0 23.1+ 2.4 57.2+ 15.9% 25.5+ 6.8% 56.9+ 5.9% 13.8+ 6.7 %
absolute
difference
14.3 13.6 14.5 22.7% 6.2% 13.9% 6.7%
relative
difference
28.5% 33.6% 38.6% 39.9% 24.3% 19.3% 48.6%
signiﬁcance p , 0.01 p , 0.01 p , 0.01 p , 0.05 p = ns p , 0.01 p , 0.05
Circadian and Seasonal variations of cardiac arrest and ventricular
arrhythmias in patients with arrhythmogenic right ventricular
cardiomyopathy
E. Chong1, Y.J. Lin2, and S.A. Chen2
1Alexandra Hospital, Singapore, Singapore; and 2Veterans General Hospital, Taipei, Taiwan
Purpose: Circadian and seasonal variations of sudden cardiac death (SCD) and ventricular
arrhythmias in patients with arrhythogenic right ventricular cardiomyopathy (ARVC) have not
been determined. The aim of the study was to explore the relationship of the incidence of SCD
and appropriate implantable cardioverter deﬁbrillator (ICD) therapy with circadian rhythm and
seasonal variation in AVRC patients.
Methods: This retrospective study included 126 ARVC patients. 98 (78%) patients were foren-
sic autopsy-proven ARVC deaths from the National Forensic Institute registry and 25 (20%)
patients were ARVC survivors who received ICD and subsequent appropriate ICD therapy. All
patients presented as SCD at the ﬁrst clinical manifestation. The timing and date of all malig-
nant events were analyzed.
Results: We analyzed 99 SCD events in the autopsy-proven ARVC deaths and 48 appropriate
ICD therapy episodes (1.92 per patient) in ARVC survivors. Appropriate ICD therapy records
showed a mean VT cycle length of 313þ/- 40 msec, (range 204 - 400 msec). Circadian distri-
bution analysis showed nocturnal peak (P, 0.05) in SCD events and appropriate ICD therap-
ies. The seasonal peak was clustered predominantly in the summer (P, 0.05) in both groups.
Conclusion: The incidence of ventricular arrhythmia and SCD events in ARVC patient demon-
strated marked circadian and seasonal variation. Nocturnal and summer time event peaks were
found in both ARVC survivors and non-survivors. Majority of the malignant events were not
related to daytime activities.
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